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List of Abbreviations 
7H9  -   Middlebrook 7H9 (agar/broth) 
A  -   adenine (DNA base) 
AHBA  -  amino-5-hydroxy-benzoic acid 
AM  -  aerial mycelium 
ANI  -  average nucleotide identity 
atpD  -  ATP synthase F1, beta subunit 
ACT  -  artemisinin based combination therapy 
BCE  -  before the common era 
BMSA  -  basal mineral salts agar 
bp  -  base pairs (DNA) 
C  -  cytosine (DNA base) 
CAS  -  Cerium (IV) ammonium sulphate 
cm  -  centimeters 
CSI  -  conserved signature indel 
CZ  -  Czapek solution (agar/broth) 
DNA  -  deoxy-ribonucleic acid 
DDH  -  DNA-DNA hybridisation 
dNTP   -   deoxyribonucleotide triphosphate 
DPG  -  diphosphatidylglycerol 
DSMZ  -   Deutsche Sammlung von Mikroorganismen und Zellkulturen 
et al.  -  et alia, “and others” 
EtBr  -  ethidium bromide 
EtOAc  -  ethyl acetate 
F  -  Forward 
g  -  grams 
G  -   guanine (DNA base) 
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oxyB  -  the glycopeptide monooxygenase B 
gyrB  -  DNA gyrase subunit B gene 
HGT  -  horizontal gene transfer 
HIV  -  human immunodeficiency virus 
HPLC  -  high performance liquid chromatography 
HR-LCMS -  high resolution liquid chromatography mass spectrometry  
I  -  inosine (nucleoside) 
IC50  -  half maximal inhibitory concentration 
i.e.   -   id est, “it is” or “that is (to say)” 
ISP  -  International Streptomyces project  
kb   -   kilobase pairs (DNA) 
keto synthase -  keto synthase 
L  -  litres 
LPSN  -  list of prokaryote names withstanding in nomenclature 
M  -  molar 
MDR  -  multi-drug resistant  
MeOH  -  methanol 
min   -  minutes 
mL   -   milliliters 
MLSA  -  multilocus sequence analysis 
mm  -  millimeters 
mm2   -   square millimeters 
mM  -   millimolar 
mol%  -  mole percent 
MTT  -   thiazolyl blue tetrazolium bromide 
n/a  -  not available 
N/A  -  not applicable 
NCBI  -  National Center for Biotechnology Information 
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ng  -   nanograms 
NMR   -  nuclear magnetic resonance spectroscopy  
NRP  -  non-ribosomal peptide 
NRPS  -  non-ribosomal peptide synthetase 
nt  -  nucleotides (DNA) 
OD  -  optical density 
PC  -  phosphatidylcholine 
PCR  -  polymerase chain reaction 
pH  -  potential Hydrogen 
PI  -  phosphatidylinositol 
pLDH  -  parasite lactate dehydrogenase 
R  -  reverse 
RBR  -  relative binding ratio 
recA  -  recombinase A gene 
Rf   -   retention factor 
RNA  -  ribonucleic acid 
rpm  -   revolutions per minute 
rpoB  -  RNA polymerase beta subunit 
rRNA  -  ribosomal RNA 
s   -   seconds 
S  -  Svedberg 
sp. nov.  -   species nova, “new species” 
ssDNA  -  single stranded DNA  
subsp.  -  subspecies 
T   -   thymine (DNA base) 
TB  -  tuberculosis 
TE  -  Tris-EDTA 
TLC  -  thin layer chromatography 
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Tm  -  melting temperature 
TMPD  -  N, N, N′, N′-tetramethyl-p-phenylenediamine 
tRNA  -  transfer RNA 
trpB  -  tryptophan synthetase, beta subunit 
U   -   units 
vs  -  versus 
v/v  -   volume for volume 
WCSP  -  whole cell sugar pattern 
WHO  -  world health organisation 
w/v   -  weight for volume 
XDR   -  extensively drug-resistant  
ZOI  -  zone of inhibition 
μg   -   micrograms 
μL  -  microlitre 
μM  -   micromolar 
λ   -   phage Lambda  
&  -  and 
°C  -  degrees Celsius  
>   -   “greater than” or “more than” 
≥  -  “greater than or equal to” 











Soil was collected from a compost heap in a Mowbray suburban garden and a compost heap in a Plumstead 
suburban garden. The soil and ‘worm tea’ of a vermiculture farm from the same Mowbray suburban garden 
were also sampled. Using four different types of media (7H9, CZ, ISP2 and GOT) 135 isolates were 
putatively identified as actinobacteria based on colony morphology. These isolates were screened for 
antimycobacterial activity against the test bacterium Mycobacterium aurum A+. A Kribbella strain, isolated 
and identified by an intern in the lab, and a Micromonospora strain, isolated and identified during the authors 
Honours project, were also screened for antimycobacterial activity. Sixty-four (64) actinobacterial isolates 
displayed moderate antibiotic activity or higher (ZOI >1001 mm2) based on the standard overlay method. 
Kribbella strain SK5 displayed very strong antimycobacterial activity (3309 mm2).  
Forty (40) of the actinobacterial strains that exhibited moderate/strong/very strong antimycobacterial activity 
and/or had interesting morphological features were selected for genus identification via a standard 
nucleotide-nucleotide blastn analysis of their 16S rRNA gene sequences. Thirty-one (31) strains were 
identified as Streptomyces species, six strains were identified as Micromonospora species, one strain was 
identified as a Nocardia species, one strain was identified as a Kitasatospora species, and one strain was 
identified as a member of the genus Tsukamurella. These isolates were subjected to phylogenetic analysis 
using the partial 16S rRNA gene sequences. Based on analysis of the 16S rRNA gene sequences, 
Streptomyces strain PR10 was found to be the most interesting of the Streptomyces isolates and should 
be pursued as a novel species (99.7% sequence similarity to the top blastn hit and less than 98.8% 
sequence similarity from the third blastn hit onwards). Further analysis of the gyrase subunit B (gyrB) gene 
sequence of the Kitasatospora isolate (strain PR3) revealed that the isolate is more closely related to 
members of the genus Streptomyces. Further evidence to support the assignment of strain PR3 to the 
genus Streptomyces (rather than Kitasatospora) is that it has two Streptomyces-specific gyrB gene indels 
signatures. Tsukamurella strain G4 was noted for characterisation as a novel species.  
The potential for seven isolates to produce ansamycin, glycopeptide, non-ribosomal peptide, and/or Type-
II polyketide antibiotics was determined by detection of antibiotic biosynthetic gene clusters using PCR. 
Strain M27 demonstrated the potential to produce all the aforementioned antibiotics. Strain Y10 
demonstrated the potential to produce a non-ribosomal peptide antibiotic. Strains PR10, PR28, PR47 and 
UK1 demonstrated the potential to produce Type-II polyketide and non-ribosomal peptide antibiotics. The 
PCR products were sequenced and analysed via blastn to compare them to the known antibiotic 
biosynthetic gene sequences in the GenBank database. The non-ribosomal peptide synthetase (NRPS) A 
domain sequences were analysed using the NRPSpredictor2 software to identify the A domain substrate 
specificity. 
Solvent extraction was done on the broth cultures of Streptomyces strains PR3, UK1 and Y30 and Kribbella 
strain SK5 to isolate the antimycobacterial compounds. It was found that the cell mass extract of the three 
10 
 
Streptomyces isolates had active compounds against M. aurum A+. The culture broth extract of the 
Kribbella isolate was found to have an active compound against M. aurum A+ and Staphylococcus aureus 
ATCC 25923. One-dimensional and two-dimensional TLC of the culture broth extract from strain SK5 
revealed that a single compound was active against M. aurum A+ and S. aureus ATCC 25923. 
Nocardamine was purified from the culture broth extract of strain SK5 by Mr Kojo Acquah (PhD student, 
Department of Chemistry, University of Cape Town). In a side-by-side spot bioautography analysis of the 
purified nocardamine and the strain SK5 culture broth extract, it was found that the active compound in the 
culture broth extract was not nocardamine, because nocardamine only had activity against M. aurum A+ 
while the culture broth extract had activity against M. aurum A+ and S. aureus ATCC 25923.  
Using the polyphasic taxonomic approach, Kribbella strain SK5 was tentatively characterised as a novel 
species, for which the name Kribbella stellenboschensis sp. nov. is proposed. The closest phylogenetic 
relatives were identified as the type strains of Kribbella aluminosa, Kribbella karoonensis, Kribbella 
pittospori, Kribbella shriazensis, ‘Kribbella sindirgiensis’ and ‘Kribbella soli’. Genetic distances of 0.030 and 
0.016 were calculated for ‘K. soli’ and ‘Kribbella sindirgiensis’, respectively, for the concatenated gene 
sequence of five housekeeping genes (gyrB, rpoB, recA, relA, and atpD). Thus, DNA-DNA hybridisation 
(DDH) will need to be carried out to confirm that strain SK5 is a separate species. Phenotypic differences 
were observed between strain SK5 and all the type strains of the most closely related species. 
Chemotaxonomically, strain SK5 possessed the key characters definitive of the genus Kribbella: i) MK-
9(H4) as the major menaquinone; ii) LL-diaminopimelic acid as the diagnostic diamino acid; iii) anteiso-C15:0 
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Actinobacteria (phylum Actinobacteria) are Gram positive bacteria that contain a high G + C content in their 
DNA. Actinobacteria are one of the largest taxonomic units within the major lineages of the domain Bacteria 
(Figure 1). They are also amongst the richest sources of natural products with clinical applications (Barka 
et al., 2016; Goodfellow and Fiedler, 2010; Prescott et al., 2008; Buchanan, 1917). In 1997, Stackebrandt 
et al. established a hierarchical classification system for the actinobacteria using the 16S rRNA gene. As 
of 2017, the phylum Actinobacteria is comprised of six classes, 23 orders, and 53 families based on the 
outline stipulated on the Bergey’s Manual Trust website (https://www.bergeys.org/outlines.html). The class 
Actinobacteria is comprised of nine orders, 11 suborders, and 45 families. The order Actinomycetales is 
















Figure 1: Phylogenetic position of the phylum Actinobacteria in the domain Bacteria based on 16S rRNA gene sequences. The 
scale bare indicates 10 nucleotide substitutions per 100 nucleotides. Figure taken from Stackebrandt et al. (1997).  
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The 16S rRNA gene and alternative ‘housekeeping’ genes have been used to establish the phylogeny of 
Actinobacteria and individual groups within the class separately (Verma et al., 2013). Actinobacteria display 
numerous morphologies: highly differentiated branched hyphae, fragmenting hyphae, rod shaped, and/or 
rod-coccoid forms (Ventura et al., 2007). The filamentous actinobacteria are commonly referred to as 
actinomycetes whose name is a derivative of the Greek words for ray (aktis or aktin) and fungi (mukēs), 
because of their resemblance to filamentous fungi. This is why they were originally believed to be a 
transitional form between bacteria and fungi (Barka et al., 2016).  
Actinobacteria are mostly saprophytic, soil-dwelling microorganisms with the ability to utilise a broad range 
of nutritional resources. They also play important roles in decomposition and the cycling of nutrients. They 
are best known for the turnover of complex biopolymers. Despite the long focus on the soil-dwelling variants 
of actinobacteria, they have also been found to be prolific in other environments with variable temperatures, 
pH, and salinity, such as plants, animals, and the aquatic environment (Barka et al., 2016; Mincer et al., 
2002). Being generally mesophilic, actinobacteria grow optimally between 25 and 30°C. However, 
thermophilic actinobacteria have been isolated from environments that experience temperatures up to 60°C 
(Edwards, 1993).  
One of the most important and well-known features of actinobacteria is their ability to produce secondary 
metabolites that have a suite of different applications, particularly in the pharmaceutical industry. 
Actinobacteria are the source of a plethora of antibiotics discovered to date. Seventy (70) to 80% of all 
antibiotics were predominantly isolated from Streptomyces species in the early days of antibiotic research 
(Bérdy, 2005). The isolation of streptomycin from Streptomyces griseus in 1944 lead to the exploration, and 
exploitation, of the Streptomyces genus for the discovery of antibiotics (Barka et al., 2016; Watve et al., 
2001). Today, the Actinomycetales are still the largest group from which bioactive metabolites have been 
isolated, with more than 10 000 active compounds having been discovered (Bérdy, 2005). To keep up in 
the ‘arms race’ against antibiotic resistance, researchers are looking towards unexplored habitats that are 
possibly teeming with biologically diverse organisms with chemically distinct natural compounds. 
Additionally, the importance for the discovery of ‘rare actinomycetes’ has been recognised, because their 
discovery increases the chances of finding structurally variable bioactive molecules (Bérdy, 2005).  
However, to continue isolating from soil environments is not a futile task. Novel species of actinobacteria 
that demonstrate antibiotic activity are still continuously being isolated from soil environments (Genilloud, 
2017; Také et al., 2017). One can even turn towards soil types that have not been well studied, such as 
vermiculture farms, which have previously been demonstrated as a rich source of the rarer actinobacteria 
(Yami et al. 2003). The isolation and characterisation of novel species is vital in the search for new 
antibiotics. Consequently, the procedures to describe a bacterium as a novel species have become 




1.2 Bacterial taxonomy 
1.2.1 A brief history 
Since Aristotle first conceived the idea of a species approximately 2400 years ago, scientists have laboured 
over trying to establish a set of rules that would group organisms effectively (Richter & Róssello-Móra, 
2009). A reliable system of classification is a vital tool that is needed for the effective study of life. Taxonomy 
is a field consisting of three integral parts, namely classification, nomenclature and identification (Prescott 
et al., 2008). Natural classification is one of the oldest classification systems, which groups members based 
on shared characteristics that reflect the biological nature of the organisms. The taxonomic study of 
prokaryotic life is one of the youngest and more dynamic classification systems (Róssello-Móra & Amann, 
2001). Unlike in zoological classification, the evolutionary relationships between prokaryotes is not apparent 
from their morphological traits, as there are few observable differences between simple bacterial cells 
(Róssello-Móra & Amann, 2001). Metabolic, physiological and morphological characteristics were the first 
features used to classify bacteria (Staley, 2006). However, these characteristics on their own are not 
sufficient to establish the evolutionary relatedness between bacteria. Fortunately, evolutionary relationships 
between microbes can be studied by molecular means. Molecular advancements that have come about 
since the late 1960’s have taken microbial taxonomy forward in great strides (Staley, 2006). These 
advancements included determining the mol% G + C content of the DNA, DNA-DNA hybridisation (DDH), 
the analysis of 16S rRNA gene sequences, and the analysis of other ‘house-keeping’ genes (Labeda et al., 
2017; Curtis & Meyers, 2012; Richter & Róssello-Móra, 2009; Busse et al., 1996). The Average Nucleotide 
Identity (ANI) between 2 genome sequences is one of the more recent advancements and is considered 
an alternative ‘gold standard’ to DDH in distinguishing between bacterial species (Richter & Róssello-Móra, 
2009). In turn, a polyphasic taxonomic approach is used for the identification of new species of bacteria.  
1.2.2 Polyphasic taxonomy  
The term “polyphasic taxonomy” was coined by Colwell (1970) and, since then, taxonomists have come to 
realise the importance of including multiple characteristics when grouping microorganisms. Polyphasic 
taxonomy has become the standard for prokaryote classification (Sutcliffe et al., 2012). The different types 
of information used in polyphasic taxonomy integrate genotypic, phenotypic and phylogenetic information 
(Colwell, 1970).  
1.2.2.1 Phenetic classification  
Before the advent of molecular techniques in classification, morphology, physiology and growth conditions 
were the only aspects that taxonomists could utilise for classification. These are known as the classical 
characteristics (Prescott et al., 2008; Róssello-Móra & Amann, 2001). Grouping organisms based on these 
phenotypic characteristics is called the phenetic system (Prescott et al., 2008). This includes the use of a 
plethora of tests to note any observable differences between microorganisms. Phenetic classification is an 
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inefficient method to classify microorganisms independently of other techniques, because of their overall 
simple phenotypic profiles, as well as the false assumption that all traits are weighted equally (Prescott et 
al., 2008). However, the inclusion of experimental techniques, such as enzymatic capabilities, substrate 
utilisation, and growth conditions did help with finding observable differences (Róssello-Móra & Amann, 
2001). The analysis of phenotypic characteristics is a tedious task in the classification of a new taxon due 
to the time and skill required. Furthermore, the phenotypic characteristics of a new isolate must be 
determined in parallel with those of its closest phylogenetic relatives (i.e. all strains must be grown under 
exactly the same conditions) so that the observed characteristics are comparable. 
1.2.2.2 Genotypic classification   
The elucidation of the structure of deoxy-ribonucleic acid (DNA) and the understanding of the principles 
behind heredity were important advances in science as a whole. And now, with access to an abundance of 
DNA sequence data, the analysis of 16S rRNA gene sequences are the centrepiece for the description of 
a novel bacterial taxon (Tindall et al., 2010). However, other genes are also being used in analysing the 
relationships between bacterial species.  
1.2.2.2.1 16S rRNA gene sequences 
The use of 16S rRNA gene sequences to assess the relationships between microorganisms has been one 
of the most influential methods in microbial taxonomy. This approach, pioneered by Woese and Fox, is now 
widely accepted with hundreds of thousands of sequences in databases such as GenBank 
(https://www.ncbi.nlm.nih.gov/genbank/) and the Ribosomal Database Project (https://rdp.cme.msu.edu/) 
(Prescott et al., 2008). 
The information gained from 16S rRNA gene sequence data is generally the first indication of whether a 
bacterium is novel. The current, agreed upon, threshold establishing that a bacterial species is novel is 97% 
16S rRNA gene sequence similarity and was proposed by Stackebrandt & Goebel (1994). However, 
sequence similarity greater than 97% does not imply that one does not have a novel taxon. Meier-Kolthoff 
et al. (2013) demonstrated that the threshold for actinobacterial species specifically, is 98.8%, with a 
maximum probability of error of 0.5%. That is, there is only a 0.5% probability that two strains that have a 
16S rRNA gene sequence similarity of 98.7% or less do not belong to different species. However, other 
supporting data are needed to prove novelty, such as the phenotypic differences, chemotaxonomic 
differences, and possibly also analysis of additional genes for greater resolution between an isolate and its 
closest phylogenetic relatives. These are the types of information that are used in modern polyphasic 
actinobacterial taxonomy. It is important to note that high quality sequence data must be used to ensure 
accurate descriptions. However, whole-genome derived and multiple-gene derived relatedness evaluations 
are better to delineate species (Konstantinidis & Tiedje, 2007). The 16S rRNA gene is too highly conserved 
to distinguish between different species that are very closely related to each other, as strains of such 
species have very high 16S rRNA gene sequence similarities (Fox et al., 1992).  
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1.2.2.2.2 DNA-DNA Hybridisation 
DDH, developed in the 1980’s, has been the ‘gold standard’ for describing a novel species, by illustrating 
that two genomes are dissimilar to one another (Goris et al., 2007; Staley, 2006; Chun & Rainey, 2014). 
DDH is used when the 16S rRNA gene sequence similarity between bacteria is 97% or higher because a 
stable, detectable, DNA hybrid will not form if the DNA molecules are too different (Meier-Kolthoff et al., 
2013; Tindall, et al., 2010; Prescott et al., 2008). The premise of DDH is that, in a mixture of denatured 
genomic DNAs from two bacterial strains, the single-stranded DNA (ssDNA) from the two strains will form 
a DNA hybrid at a hybridisation temperature of about 25°C below the average melting temperature (Tm) of 
the two genomic DNAs if there is less than 15% base mispairing. Non-complimentary strands remain single 
stranded (Stackebrandt & Goebel, 1994). Due to strains from related species having similar base 
compositions, a higher hybridisation temperature will lead to only the similar/same strands forming double-
stranded DNA (i.e. the conditions for base pairing are very stringent). At hybridisation temperatures 10°C 
or 15°C below the Tm, only almost identical DNA molecules should hybridise (Prescott et al., 2008). DDH 
experiments are largely based on relative binding ratio (RBR) methods where the results are given as a 
percentage hybridisation. A percentage hybridisation of 70% is considered the threshold for distinguishing 
between species (Wayne et al., 1987). Thus, two strains that have a DNA relatedness by DDH of 70% are 
considered to belong to the same genomic species and two strains that have a DNA relatedness of <70% 
by DDH are considered to belong to different genomic species. DDH is used in conjunction with 16S rRNA 
gene phylogenetic analyses and phenotypic comparisons to describe a new species of bacterium. 
Despite DDH being the ‘gold standard’ for many decades, there are some problems associated with using 
the technique. It is a time consuming and labour intensive procedure, because of the amount of high quality 
DNA required for the process. Another main drawback of the technique is that an incremental database 
cannot be established for future reference (Goris et al., 2007).  
1.2.2.2.3 Nucleic acid base composition 
Comparing the DNA base compositions between two genomes is considered one of the simplest techniques 
to determine similarity. The Tm of a DNA molecule is considered a direct measure of the G + C content. 
DNA with a higher G + C content will denature at higher temperatures due to the presence of more hydrogen 
bonds between the bases (Prescott et al., 2008). Within prokaryotic genera, the G + C content does not 
tend to differ by more than 10%, despite great variations between genera (Prescott et al., 2008). Currently, 
the methods of choice for determining G + C content are based on high-performance liquid chromatography 
(HPLC) (Tindall et al., 2010). However, Kim et al. (2015) identified a high level of discrepancy between the 
experimental-based and genome sequence-driven methods of G + C content determination. The G + C 
range for strains within the same species is generally confined to less than 1mol%. Experimental-based 
methods were guilty of G + C content falling well out of this acceptable range of 1% (Kim et al., 2015). 
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1.2.2.2.4 Multilocus Sequence Analysis (MLSA)  
The 16S rRNA gene sequence has been heavily relied on for bacterial classification, despite its 
shortcomings (Curtis & Meyers, 2012). These shortcomings are that the 16S rRNA gene is only a small 
portion of the genome, it does not encode a protein, and has a slow evolution rate. Thus, any insertions 
and deletions (indels) have a much greater distorting effect on the phylogenetic relationships (Curtis & 
Meyers, 2012). Additionally, the 16S rRNA gene does not provide sufficient resolution for differentiation 
between closely related species (Curtis & Meyers, 2012). Thus, an MLSA approach is used to provide a 
more accurate and robust representation of the evolutionary relationships between bacteria. MLSA also 
overcomes the challenges of DDH by not being as laborious and time consuming, whilst also generating 
information that can be stored in a database (Curtis & Meyers, 2012). MLSA uses multiple, translated, 
‘housekeeping’ genes that are concatenated in frame and then compared to other concatenated sequences 
using phylogenetic analysis. Housekeeping genes are genes essential to cell growth. This allows one to 
identify different species within a genus, based on clades within a tree and, because there are several 
genes involved in the comparison, there is greater resolution (Gevers et al., 2005). The genes selected for 
MLSA should fit the following criteria: they must be i) ubiquitous; ii) well separated from each other within 
the genome; iii) only occur as a single copy per genome; iv) be over 900 bp in length; v) be insusceptible 
to Horizontal Gene Transfer (HGT) or recombination; and vi) have at least two regions of high conservation 
that can be amplified and sequenced using specific PCR primers (Adékambi et al., 2011). The genetic 
distance between concatenated sequences can be calculated and gives an indication of the novelty of a 
strain. For example, Curtis & Meyers (2012) showed that a 4099-nt concatenated gene (gyrB-rpoB-recA-
relA-atpD) genetic distance of ≥0.04 correlates to DDH values of less than 70% between all type strains in 
the Kribbella genus. Based on this method, if a new Kribbella strain has a genetic distance of ≥0.04 to all 
Kribbella type strains, it represents a novel species in the genus.  
1.2.2.2.5 Average Nucleotide Identity (ANI) 
Average Nucleotide Identity (ANI) is determined by comparing the genome sequences of two bacterial 
strains. The problems in delineating bacteria at the species level, which are observed when using the 16S 
rRNA gene, are avoided when using ANI. This is due to the high level of resolution that one can achieve 
when the entire genome is being compared (Konstantinidis & Tiedje, 2005; Konstantinidis & Tiedje, 2007). 
In addition, analysis using ANI is less prone to being affected by HGT events (Konstantinidis & Tiedje, 
2005).  
A pairwise analysis of DDH and ANI illustrated a strong linear correlation, such that the 70% DDH threshold 
corresponded to 95% ANI, with an R2 value of 0.93 (Konstantinidis & Tiedje, 2005; Konstantinidis & Tiedje, 
2007; Goris et al., 2007). Different species can even be identified at genetic similarity percentages as high 
as 98-99% ANI (Konstantinidis & Tiedje, 2004). Thus, ANI is a robust method to measure the evolutionary 
distance between organisms.  
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With the decreasing price of DNA sequencing, the use of whole genomes for comparison is becoming more 
prevalent, because the number of whole genome sequences available is growing. Moreover, the mol% G 
+ C content of an organism is available after genome sequencing, which has historical value in bacterial 
taxonomy (Chun & Rainey, 2014). 
1.2.2.2.6 Molecular signatures 
Molecular signatures (amino acid signature sequences and indels) have recently been identified following 
the increased availability of DNA sequences of genes other than the 16S rRNA gene. These molecular 
characteristics are uniquely shared amongst different groups of microorganisms and are thus important for 
defining evolutionary relationships. These molecular characteristics are called conserved signature indels 
(CSIs), which are lengths of gene or protein sequence that are unique to specific groups of organisms (Gao 
& Gupta, 2012). The rationale behind this is that an identified CSI is most parsimoniously explained by the 
change in the genetic code occurring in a common ancestor, which was then vertically passed on. Gao & 
Gupta (2012) identified three indels in three genes (cytochrome-c oxidase subunit 1, CTP synthetase, and 
glutamyl-tRNA synthetase) that were distinctly found in the phylum Actinobacteria. More recently, Meyers 
identified amino acid signatures in DNA gyrase subunit B (GyrB) (2014) and recombinase A (RecA) (2015) 
in genera in the family Streptosporangiaceae. 
1.2.2.3 Chemotaxonomic classification  
Chemical taxonomy (chemotaxonomy) involves the identification of chemical markers in a cell (i.e. diamino 
acids in the peptidoglycan, whole cell sugar pattern, polar lipids, respiratory isoprenoid quinones and 
cellular fatty acids). There are many chemotaxonomic features that can be assessed, but only a few will be 
discussed here: 
1.2.2.3.1 Diamino acids in the peptidoglycan 
Diamino acids are essential to the crossing linking of the pepdtidoglycan layer of the cell wall in Gram 
positive and Gram negative bacteria. The Gram negative bacteria display a uniform distribution of meso-
diaminopimelic acid while Gram positive bacteria demonstrate great variation in the type of diamino acid in 
their cell walls. This variation observed in Gram positive bacteria has been vital in their classification. These 
differences include: amino acid sequence variation of the peptide stems, the mode of cross-linkage between 
the stems and the type of diamino acid present (e.g. LL-diaminopimelic acid, meso-diaminopimelic acid, 
2,4-diaminobutyric acid, L-lysine and ornithine) (Busse et al., 1996).  
1.2.2.3.2 Whole cell sugar pattern 
The analysis of the whole cell sugars is widely used in the classification of Gram positive bacteria. Different 
groups of bacteria have characteristic whole cell sugar patterns (WCSPs). In some cases, there is no 
characteristic sugar pattern for a genus (e.g. Streptomyces) (Busse et al., 1996).  
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1.2.2.3.3 Polar lipids 
Being the main constituents of bacterial membranes, polar lipids are important for classification. Common 
bacterial polar lipids are phospholipids, such as phosphatidylethanolamine, phosphatidylserine, 
phosphatidylmethylethanolamine, phosphatidylglycerol, diphosphatidylglycerol, phosphatidylcholine and 
phosphatidylinositol. There are also glycophospholipids, aminophospholipids, glycolipids, aminolipids and 
lipids. Polar lipids are observed and identified, using different stains, via their Rf values after thin layer 
chromatography (TLC). In Gram positive bacteria there are five different phospholipid types (PI-PV) (Busse 
et al., 1996). 
1.2.2.3.4 Respiratory isoprenoid quinones 
Constituents of the bacterial cytoplasmic membrane and the mitochondrial membrane, respiratory 
isoprenoid quinones play an important role in the electron transport chain. The different types of quinones, 
the length of the isoprenoid side chain, and the number of saturated isoprenoid units are all used to 
characterise bacteria. In Gram positive bacteria, the characteristic differences between menaquinones are 
the length of the isoprenoid side chain and the number of saturated isoprenoid units (Busse et al., 1996).  
1.2.2.3.5 Cellular fatty acids 
Fatty acids are present in the cytoplasmic membrane of all bacteria. There are structural differences 
between the fatty acids that are vital for the classification of bacteria. These structural differences include 
the chain length (8 – 20 is the typical number of carbon atoms), whether they are saturated or unsaturated, 
the branching pattern, the presence of cyclopropane moieties, and whether there is a hydroxyl group on 
the second or third carbon. The cellular fatty acid profile of bacteria is dictated by the growing conditions 
and thus it is very important to standardise the growing conditions used. A side-by-side analysis between 
all strains in the study should always be done (Busse et al., 1996).  
1.2.3 Moving forward in taxonomy 
One of the issues that bacterial taxonomists still need to develop further is the concept of a bacterial species 
(Staley, 2006). The current species definition has caused much debate with some believing that the 
definition is ‘pragmatic’ and covers what is considered to be necessary to characterise a novel species. 
However, others believe that the current species definition is too conservative and does not truly highlight 
the prokaryotic diversity in nature (Rosselló-Mora & Amann, 2001). Rosselló-Mora & Amann (2001) laid out 
a comprehensive review of the species concept for prokaryotes, which is definitely a starting point. Their 
suggestion is that a phylo-phenetic species definition is introduced as follows: “a monophyletic and 
genomically coherent cluster of individual organisms that show a high degree of overall similarity with 
respect to many independent characteristics, and is diagnosable by a discriminative phenotypic property”. 
Thompson et al. (2013) suggested a genomic species definition. They proposed the replacement of 
phenotypic tests with genome information, because one can deduce the phenotypic properties based on 
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the genes present. The problem with this approach is that it infers that genes present will be expressed, 
which is not true. Thus, Thompson et al. (2013) did note the complexity of metabolism and admitted that 
culture-based experiments may still be required. In the future, however, such culture-based experiments 
will not be as predominant as they are in today’s characterisation process. It should also be noted that 
some believe that the concept of a species does not apply to bacteria, because of extensive HGT. 
Due to the increased availability of whole genome sequences, taxonomists are predicting that we will move 
away from the single gene phylogenetic analyses that are widely used at present (Sutcliffe et al., 2012). 
Instead, whole genome comparisons will complement the polyphasic taxonomic approach of species 
classification, where taxonomy will be dependent on genome signatures (Thompson et al., 2013). The 
Antonie van Leewenhoek Journal of Microbiology is already encouraging authors to submit the genome 
sequence of the type strain when describing a novel species, demonstrating the emphasis being placed 
upon genome sequences 
(http://static.springer.com/sgw/documents/1521975/application/pdf/Description+of+novel+taxa+I4A+Jan1
8+update.pdf). Genome sequencing will encompass the high-quality 16S rRNA gene sequencing that is 
currently required when classifying a novel species and it will provide the DNA G + C content, which has 
been historically relevant in bacterial taxonomy (Chun & Rainey, 2014). Using the entire content of the 




Antibiotics are chemical compounds that interfere with some essential process or structure within the 
bacterial cell, while having as minimal effect on the host as possible. The term antibiotic was first coined in 
1942 by Waksman and translates directly to “against life’’. These small compounds act against microbial 
life in two ways: bacteriostatic and bactericidal. Bacteriostatic antibiotics prevent bacterial growth, while 
bactericidal antibiotics kill bacteria (Yoneyama & Katsumata, 2006). The main targets for antibacterial 
antibiotics are: i) cell wall biosynthesis, ii) protein synthesis and iii) DNA replication and repair (Walsh, 
2000). Natural products have been the main source of antibiotics (~80%), either as the main ingredient or 
as the inspiration for the active compound (Harvey, 2007). During the early period of antibiotic research, it 
was found that natural product compounds were useful for more than just treating bacterial and fungal 
infections, because some of them had antitumor activities too. Since the golden era of antibiotic discovery, 
the scope of research concerning natural products has dramatically increased (Bérdy, 2005).  
1.3.1 Natural products 
Natural products are chemical compounds that are derived from either the primary or secondary metabolism 
of living organisms (Bérdy, 2005). Their use has been documented throughout historical folklore to treat 
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various ailments (Dias et al., 2012). Some of the earliest recordings of natural product use in medicine date 
back to 2600 Before the Common Era (BCE), where around 1000 plant-derived substances were used to 
treat ailments in Mesopotamia (Cragg & Newman, 2013).  
In contrast to primary metabolites, secondary metabolites are chemically diverse, low molecular weight 
compounds that have various targets and modes of action (Bérdy, 2005). Natural products have been the 
greatest contributors to the drug industry in the history of medicine (Watve et al., 2001). The ‘golden era’ of 
antibiotics saw interest in the penicillin, griseofulvin and gramicidin antibiotics. The discovery of penicillin 
from the fungus Penicillium notatum is believed by many to be the main event which ignited the drive for 
the discovery of novel and diverse antibiotics from naturally occurring microorganisms (Cragg & Newman, 
2005). However, after the discoveries of streptomycin, chloramphenicol, the tetracyclines and the 
macrolides, Streptomyces took centre stage (Bérdy, 2005). Between 1983 and 1994, 39% of the 520 
approved drugs were either natural products or derivatives of them. Additionally, around 60-80% of 
antibacterial and anticancer agents were natural product derivatives (Harvey, 2000). Thus, one can see 
that natural products have contributed considerably to the medical field.  
Between the 1970s and 1990s, we saw a waning in the efficiency of antibiotic research. This was due to 
the increasing costs of research and the rediscovery of known compounds or analogues of known 
compounds (Bérdy, 2005). Thus, natural products fell out of the limelight in the 1990’s in favour of other 
modern technologies such as in silico screening, computer-assisted design of small-molecule ligands, 
combinatorial chemical synthesis, and combinatorial biocatalysis (Watve et al., 2001). This is emphasised 
by the image in Figure 2. The figure illustrates the apparent lack of discovery of novel antibacterial agents 
since the late 1980s. It is suspected that this “Discovery Void” is in fact due to Big Pharma withdrawing from 
research in the area and not due to a lack of innovation (Silver, 2011).  
However, interest in natural products has been revived. It has become ever more apparent that only a small 
fraction of an incredibly diverse pool of biological diversity has been explored, especially when it comes to 
bacteria (Watve et al., 2001). This means that there is vast pool of molecular diversity that is waiting to be 
tapped. This structural diversity, that is inherent to natural products, is thus being recognised once again. 
A prime example for the discovery of novel antibiotics is the marine environment. The world’s oceans cover 
more than 70% of the earth’s surface, and are thus home to a vast and diverse resource of potential drugs 
(Cragg & Newman, 2013). The marine environment has already been demonstrated as a rich source for 
bioactive compounds with thousands of new metabolites being reported since the 1980’s (Cragg & 







One of the main advantages of looking for natural products as drug leads is that the active compounds that 
exhibit drug-like properties are often small molecules. Thus, they are cheaper to develop than other 
biotechnological products or products from combinatorial chemistry (Harvey, 2000). It is incredibly important 
to try and access this untapped natural product diversity, because the unchecked use of antibiotics since 
their introduction in the 1940’s has led to a strong selection pressure for antibiotic resistance (Yoneyama & 
Katsumata, 2006). The constant pressure of antibiotics on bacterial populations, and the misuse of 
antibiotics, has led to the need for the continuous discovery of novel antibiotics.  
Figure 2: The “Discovery void.  Figure taken from Silver (2011).  
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1.3.2 Antibiotic resistance 
Antibiotic resistance is a major health problem that effects people from all walks of life and presents a 
challenge to the effective treatment of both community and hospital-acquired infections (Genilloud, 2017). 
Upon the introduction of antibiotics around the 1950s to treat microbial infections, the rise of antibiotic 
resistance during therapy was observed (Davies, 1994). Multidrug resistant bacteria are one of the major 
causes for treatment failure today (Davies,1994) and we see drug resistant pathogens being associated 
with all 15 antibiotic classes (Levy & Marshall, 2004). It has also been noted that there is an ever-decreasing 
rate of novel antibiotic discovery (Kwon et al., 2012).  
We are also presented with a conundrum: the increased use of antibiotics will lead to the increased speed 
of antibiotic resistance development (Yoneyama & Katsumata, 2006). This conundrum is further highlighted 
by the fact that clinically significant antibiotic resistance typically shows up within months to years of the 
introduction of a new antibiotic (all dependent on the type of antibiotic and how it is administered). For 
example, evidence of antibiotic resistance to penicillin appeared within two years of its initial administration 
(Walsh, 2000). The rapid onset of resistance is a major problem due to the lengthy process required for a 
new drug to be discovered and introduced to the market (Walsh, 2000). Bacteria already have an advantage 
in the antibiotics ‘arms race’ because of their inherent nature: the bacterial life cycle has a rapid generation 
time with high bacterial count. Along with the rate of mutation of ~1 in 107 within a bacterial count of 1010, 
one can expect mutations to occur frequently. If these mutations confer antibiotic resistance to an individual 
bacterium, that individual could thrive in the host by being able to grow and take up the space left by the 
antibiotic sensitive bacteria that have been killed by the antibiotic. Thus, antibiotic resistance will have 
developed. Antibiotic use itself is a driving factor promoting antibiotic resistance. Additionally, sub-
therapeutic levels of drug administration all but guarantees the development of drug resistance (Walsh, 
2000). Therefore, it is incredibly important for individuals taking antibiotics to see the course through. The 
blame for antibiotic resistance does not just lie with antibiotic users failing to finish courses or the bacteria 
themselves and their inherent ability to rapidly evolve, but also lies with doctors for over-prescribing 
antibiotics (i.e. prescribing an antibiotic when it is unnecessary to do so). Many doctors give in to their 
patients’ demands and prescribe antibiotics for the treatment of ailments that cannot be cured with 
antibacterial drugs (such as viral infections). The Centers for Disease Control and Prevention estimated 
that annually, ~50 million of ~150 million prescriptions were unnecessary in the United States of America 
(USA) (Levy, 1998). Despite this, bacteria would still have developed antibiotic resistance, but the rate of it 




1.3.2.1 Bacterial strategies for antibiotic resistance development 
Bacterial resistance arises due to the presence of resistance genes, which can encode a number of 
functions such as: i) ejecting antibiotics from the cells with ‘efflux’ pumps, ii) degrading antibiotics via the 
production of enzymes, iii) altering/inactivating the antibiotic compounds and/or iv) the structure of the drug 
target can be altered such that the antibiotic cannot recognise it and bind to it anymore (Walsh, 2000; Levy, 
1998). These genes conferring resistance can be present on the bacterial genome (acquired by mutation 
and/or vertical gene transfer) or on small pieces of circular, extrachromosomal DNA, called plasmids 
(acquired by HGT). (Levy, 1998).  
1.3.2.2 Strategies to overcome resistance 
Current drugs generally target the same pathways essential to bacterial life (see the beginning of section 
1.3). Thus, one popular strategy to combat antibiotic resistance is to find bioactive compounds that have 
different targets to the currently used antibiotics (Yoneyama & Katsumata, 2006). This can be achieved by 
using the prowess of genome sequencing (Genilloud, 2017). Rosamond & Allsop (2000) compared the 
genomes of Haemophilus influenzae, Mycoplasma, Streptococcus pneumoniae, Streptococci, Chlamydia 
pneumoniae, Klebsiella, and Pseudomonas aeruginosa to 4289 Escherichia coli genes, and found that 
there were 246 conserved genes. Sixty-eight (68) of these genes were not found in humans and 18 were 
deemed essential to the bacteria. It was finally deduced that three of the essential genes were suitable 
candidates as drug targets for new respiratory-tract antibiotics (Rosamond & Allsop, 2000). 
There are a couple things to consider when using a genomics based approach to identify potential drug 
targets: i) the gene must be essential, which can be determined by gene inactivation studies; and ii) the 
target gene must be expressed during the infection process in the lifecycle of the microbe (McDevitt & 
Rosenberg, 2001). Potential targets identified using the genomics bases approach for novel drug leads 
include aminoacyl-tRNA synthetases, polypeptide deformylase, fatty acid biosynthesis, DNA replication, 
protein secretion, cell division, peptidoglycan biosynthesis, signal transduction, aromatic amino acid 
biosynthesis and isoprenoid biosynthesis pathways, amongst others (McDevitt & Rosenberg, 2001). There 
is still a long way to go using this strategy, but it has provided a sense of optimism for the future of antibiotic 
discovery.  
In addition to looking for potential drug targets using a genomics approach, one can also look at the 
antibiotic biosynthetic potential of naturally occurring microbes to produce different types of antibiotics. 
Analysis of microbial genomes has already revealed that there is a rich antibiotic biosynthetic potential, 
especially within the actinomycetes (Genilloud, 2017). Screening the genomes allows for the rapid 
identification of the antibiotic biosynthetic potential of an isolate (Wood et al., 2007) and thus its potential 
for further work.  
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It is all well and good to have identified potential drug targets and/or leads for novel drugs based on 
biosynthetic potential, but we need the actual antibiotic compounds themselves to combat the drug resistant 
pathogens. One of the main strategies put into place by the pharmaceutical companies to develop new 
drugs is the development of new antibiotics that are modified versions of existing ones. However, this 
approach has proven to be difficult, because changing the chemical groups leads to altered 
pharmacokinetics. These changes and their consequences are difficult to predict, such as increasing 
activity but losing stability (Yoneyama & Katsumata, 2006). Researchers are also looking at the synthetic 
development of novel structural classes of antibiotics. A few examples include the oxazolidinones, 
linezolids, and glycolipodepsipeptides (Walsh, 2000). By synthesising new classes of antibiotics, one can, 
in practice, have the final say concerning the activity of the compound. Lastly, the search for novel, naturally 
occurring antibiotics is not over. As pointed out by Genilloud (2017), actinomycetes are still a good source 
for the discovery of novel antibiotics. To enrich the isolation of compounds with novel chemical diversity, 
many researchers are mining underexplored environments. This promotes the isolation of novel microbes 
(actinobacteria specifically in many cases), which increases the chances of finding chemically diverse 
bioactive compounds. However, current cultivation based methods for isolating microbes fail to isolate most 
of the microbes in the environment (Genilloud, 2017). Thus, we fail to characterise numerous compounds 
that could be active against the multi-drug resistant pathogens that we face today, because we cannot grow 
the organisms that produce them. Consequently, new cultivation techniques are needed to enable the 
isolation of the biological and chemical diversity that researchers have hitherto been unable to access. This 
does not imply that current techniques will not allow the isolation of new microbes and their suite of bioactive 
molecules, but rather that researchers have a lower chance of isolating them using current techniques. One 
of the main sources for the isolation of novel antibiotics is microbes, and more specifically the 
actinobacteria.  
1.3.2.3 Mycobacterium tuberculosis: a case of antibiotic resistance 
Drug resistant strains of Mycobacterium tuberculosis are prevalent in South Africa and cause either 
multidrug-resistant tuberculosis (MDR TB) or extensively drug-resistant TB (XDR TB). MDR TB strains are 
resistant to at least two of the most potent TB drugs: isoniazid and rifampin. XDR TB strains are resistant 
to isoniazid, rifampin, any fluoroquinolone, and at least one of the 3 injectable second-line drugs 
(https://www.cdc.gov/tb/topic/drtb/default.htm). The End TB strategy set in place by the WHO has an overall 
aim to end the global TB epidemic. They hope to have a 90% reduction in TB related deaths and an 80% 
reduction in the incidence of TB by 2030, in comparison to 2015 (http://www.who.int/tb/en/). 
According to the 2016 WHO Global Tuberculosis report (http://www.who.int/tb/en/), South Africa was 
named as one of the seven countries contributing to 64% of the global incidence of new TB cases (10.4 
million TB cases). In the African region, the incidence of individuals infected with the human 
immunodeficiency virus (HIV) and TB is the highest globally, where 81% of TB patients are also HIV-
positive. In Southern Africa, the proportion of TB patients who live with HIV exceeds 50%. Consequently, 
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TB is the leading killer of HIV-positive individuals, where one in three HIV deaths are TB related. This 
emphasises the need for novel antibiotics with superior antitubercular activity.  
 
1.4 Aim of this study 
Historically, microorganisms have been an abundant source for natural product discovery, as mentioned 
previously, with actinobacteria being at the forefront of this arms race against antibiotic resistant pathogens. 
Today we need novel antibiotics with new mechanisms of action and superior bioactivity. This general goal 
of isolating novel actinobacteria to screen for antimycobacterial activity was the overall focus of the present 
study.  
The aims of this study were to isolate environmental actinobacteria (based on colony morphology) from two 
compost heap samples and the soil and ‘worm tea’ of a vermiculture farm. These isolates were tested for 
antimycobacterial activity against the test bacterium Mycobacterium aurum A+. M. aurum A+ has been 
shown to have a similar antibiotic susceptibility profile to M. tuberculosis (Namouchi et al., 2017; Phelan et 
al., 2015; Gupta & Bhakta 2012; Chung et al., 1995). Isolates that exhibited strong bioactivity against M. 
aurum A+ were selected for further analysis by sequencing of the 16S rRNA gene to determine genus 
identity. These isolates were also tested for their antibiotic biosynthetic potential, at the genetic level, using 
the polymerase chain reaction (PCR) and primers specific to the core genes of known antibiotic biosynthetic 
gene clusters. The extraction and preliminary analysis of the active compounds (via TLC) was attempted 
on strains that exhibited both strong antimycobacterial activity and that have the potential to be novel 
species based on phylogenetic analyses of the 16S rRNA gene. The particular focus of the study was 
Kribbella strain SK5, which produces strong antimycobacterial activity and is believed to be a novel species 
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SCREENING ENVIRONMENTAL ACTINOBACTERIA FOR 




One hundred and seventy-five (175) presumptive actinobacteria were isolated from two compost soil 
samples and a vermiculture farm. These sources were situated in suburban gardens in the southern 
suburbs of Cape Town, Western Cape Province, South Africa. Following further morphological 
examination of the isolates, 24 were deemed not to be actinobacteria or were too contaminated for 
further work. Screening for antimycobacterial activity commenced with 137 of the putative 
actinobacteria, using the test bacterium Mycobacterium aurum A+, which is a non-pathogenic bacterium 
shown to have a similar antibiotic susceptibility profile to Mycobacterium tuberculosis. Thirty-five (35) 
strains demonstrated strong (2001-3000 mm2) or very strong (> 3000 mm2) antimycobacterial activity.  
The antibiotic-producing isolates were selected for 16S rRNA gene amplification and sequencing. Five 
strains were also chosen due to activity on the border of moderate (1001-2000mm2) and strong activity. 
Many additional isolates were selected based on morphological characters that were distinct from the 
other isolates. Sequence analysis of the PCR-amplified 16S rRNA genes revealed the following 
biodiversity: six Micromonospora strains, one Kitasatospora strain, one Nocardia strain, 31 
Streptomyces strains, and one Tsukamurella strain. Analysis of the Gyrase Subunit B gene sequence 
for the Kitasatospora isolate revealed that it was more closely related to the genus Streptomyces, via 
the detection of a molecular signature that was only present in the Streptomyces species. The 
phylogenetic position of these strains in their respective genera was assessed by constructing 
neighbour-joining and maximum likelihood trees. The Streptomyces isolates were responsible for the 
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Microbes are prolific producers of natural products with medicinal and agricultural relevance (Busti et 
al., 2006). More specifically, actinobacteria of the Streptomyces genus are the most well-known 
antibiotic producers, responsible for producing approximately 45% of the antibiotics discovered to date 
(Lazzarini et al., 2000). However, a problem presents itself: the re-isolation of known actinobacteria and 
thus known antibacterial compounds or even the re-isolation of known antibacterial compounds from 
novel species. Due to the Streptomyces genus being prolific and easily cultivated, it has been 
thoroughly studied and there are 823 species in the genus with validly-published names, according to 
the List of Prokaryotic Names with Standing in Nomenclature (LPSN) 
(http://www.bacterio.net/streptomyces.html). Despite this, mathematical modelling by Watve et al. 
(2001) estimated that only about 3% of the existing compounds that are produced by the Streptomyces 
genus has been discovered. Nonetheless, the undiscovered antibiotic potential will not be easy to 
access and identify because many environmental actinobacteria cannot be cultured using standard 
microbiological techniques. Isolating a novel Streptomyces species will lead to an increased likelihood 
of isolating novel bioactive compounds because biological diversity underpins chemical diversity. 
However, a better approach is to search for novel actinobacteria of the rarer genera because you are 
more likely to isolate a novel species (and novel species are more likely to produce antibiotics with 
novel structures than strains of known species are). 
Genilloud (2017) highlighted the continued importance of actinobacteria as a source of novel antibiotics 
and emphasised that new strategies are being, and need to be, developed to isolate novel species that 
have previously been inaccessible. This will allow researchers to tap into that undiscovered natural 
product potential. The current understanding is that microbiologists have barely accessed the natural 
microbial diversity. Less than 1% of naturally occurring microorganisms have been cultivated using 
conventional microbiological techniques (Hamaki et al., 2005). Thus, using a suite of media of differing 
nutrient compositions, and/or un-sampled areas, one may increase the chances of dipping into that 
previously untapped microbial diversity (Hamaki et al., 2005). 
In this study, different environmental sources were sampled to get a broad range of actinobacterial 
isolates. Two different compost soil samples were chosen, because these are known to be rich in 
microbial diversity. Additionally, a vermiculture farm was sampled (both the soil and the ‘worm tea’) to 
access a different resource that could be rich in microbial diversity. Vermicomposting is a non-
thermophilic process where organic matter is oxidised and stabilised in the presence of earthworms 
and microflora to produce a product called ‘vermicompost’ in which the nutrients are more readily 
available to plants due to increased solubility (Kharrazi et al., 2014; Atiyeh et al., 2002). Vermicompost 
is known for having a large and diverse microbial population (Kharrazi et al., 2014). This makes it an 
ideal source to isolate novel actinobacteria. 
Stable portions of the genetic code are used to assess the relatedness between species. The 5S, 16S 
and 23S rRNA genes, and the regions between these genes, are amongst the main candidates for 
phylogenetic analysis (Clarridge, 2004). There is high sequence conservation in these genes making 
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them ideal markers of evolutionary distance and the relatedness between organisms. However, the rate 
of change in the genes between organisms, and even within the gene itself, is not uniform (Clarridge, 
2004).  Other genes can also be used to assess the relatedness between organisms such as the 
following housekeeping genes: gyrB (DNA gyrase subunit B) (Meyers, 2014), recA (recombinase A) 
(Meyers, 2015), and rpoB (RNA polymerase beta subunit). These housekeeping genes experience a 
higher rate of mutation than the 16S rRNA gene and one can observe greater differences in percentage 
sequence similarity between closely related species. Using these genes to phylogenetically compare 
microorganisms in conjunction with the 16S rRNA gene, chemotaxonomic and physiological 
characterisation make for more robust taxonomic classifications of actinobacteria. Meier-Kolthoff et al. 
(2013) showed that there are general and phylum-specific 16S rRNA gene sequence-similarity 
thresholds for predicting the likelihood of two strains belonging to the same species. At a probability of 
error equal to 0.5%, the actinobacterial threshold for distinguishing between species is 98.8% 16S rRNA 
gene sequence similarity (Meier-Kolthoff et al., 2013). When the percentage sequence similarity 
exceeds this threshold, other tests such as DDH are required to assess species novelty. Following the 
isolation of presumptive actinobacterial colonies, the isolates were screened for biological diversity by 
amplification of the 16S rRNA gene using conserved universal PCR primers, F1 and R5 (Cook and 
Meyers, 2003). The PCR products were sequenced and compared to the curated EzBioCloud database 
(https://www.ezbiocloud.net/). 
The aim of this chapter was to isolate actinobacteria from environmental sources in search of novel 
species that may produce secondary metabolites with antimycobacterial activity. The environmental 
samples were plated on various nutrient media to encompass a wide range of nutrient conditions to 
isolate a diverse variety of bacteria. Colony morphology was used to identify actinobacteria. Those 
colonies with interesting morphological characters were chosen, to try and decrease the number of 
Streptomyces isolates. These isolates were screened for antimycobacterial activity using the test 
bacterium M. aurum strain A+. M. aurum A+ is a non-pathogenic microorganism, and it grows faster 
than M. tuberculosis. Isolates exhibiting strong or very strong activity against M. aurum strain A+ were 
identified to the genus level by partial 16S rRNA gene sequencing and analysis. Some isolates that did 
not have strong antimycobacterial activity were also identified to the genus level due to their having 
morphological features that were intriguing. Phylogenies were constructed to determine the 






2.3 Materials & Methods 
2.3.1 Bacterial cultivation 
2.3.1.1 Sample collection 
The actinobacteria isolated in this project originated from three different soil samples. One compost soil 
sample and a vermicompost sample (soil and ‘worm tea’ separately) were from a suburban garden in 
Mowbray, Cape Town, South Africa. A second compost soil sample was taken from a suburban garden 
in Plumstead, Cape Town, South Africa. The two compost samples are thus named the Mowbray 
compost sample and the Plumstead compost sample. 
2.3.1.2 Sample preparation 
Half of each sample was treated and the other half was untreated (except the worm tea sample, which 
was left untreated). The treated samples were heated at 60°C for 1 hour, in sterile glass Petri dishes. 
The rest of the procedure is the same for the treated and untreated samples. Approximately 0.1g of soil 
was suspended in 1mL sterile water in a benchtop centrifuge tube and agitated for 5 min using a vortex 
mixer to dislodge the microorganisms from the soil. The suspension was left for 5 minutes for the soil 
particles to settle. The supernatant was serially diluted in sterile distilled water to 10-4, and 100μL of the 
10-3 and 10-4 fractions were plated out in duplicate on International Streptomyces project medium No. 
2 (ISP2) (Shirling & Gottlieb, 1966), Czapek solution agar (CZ) (Atlas, 2004), Middlebrook agar (7H9) 
supplemented with 10mM glucose (albumin-catalase supplement omitted), and GOT nutrient medium 
(Tormo et al., 2003). These four media were chosen because they have very different nutrient 
compositions to allow for the isolation of bacteria with different nutrient preferences. All media were 
supplemented with nalidixic acid (10μg/mL) and cycloheximide (50μg/mL) to inhibit the growth of Gram-
negative bacteria and fungi, respectively. The plated dilutions were incubated at 30°C for up to 30 days. 
The worm tea sample was handled in the same manner as the supernatant of the vortexed soil samples. 
2.3.1.3 Isolation 
Presumptive actinobacterial colonies (colonies slightly sunken into the agar and exhibiting aerial 
mycelium or (in the absence of aerial mycelium) a leathery or wrinkled surface) were sub-cultured at 
regular intervals throughout the 30 day incubation period. Strains were sub-cultured onto plates of the 
same medium as that on which they were isolated (without antibiotics). Colonies were sub-cultured 
using a sterile toothpick. The sub-cultured isolates were incubated at 30°C for up to 7 days, and named 
according to the medium they were isolated from and numbered chronologically: M - 7H9, C - CZ, G - 
GOT, and Y - ISP2. The source of the isolate was recorded. Isolates that were incorrectly identified as 
actinobacteria were later discarded. If necessary, isolates were re-streaked several times to obtain pure 
cultures. Stock cultures were made from a spore suspension or a broth culture. Spore suspensions 
were prepared by adding 2-3 loopfuls of spores to 2 mL of sterile water and shaking vigorously to 
disperse the hydrophobic spores. Stock cultures were prepared by mixing 700μL of spore suspension 
or broth culture with 300μL 50% (w/v) sterile glycerol in a sterile benchtop centrifuge tube. Stock cultures 
were stored at -20°C. 
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2.3.2 Screening for antimycobacterial activity 
Testing for antimycobacterial activity was done using the standard overlay method. The isolates that 
morphologically resembled actinobacteria were screened for antimycobacterial activity against the test 
bacterium M. aurum A+. The isolates were stab inoculated (four per plate) using sterile toothpicks into 
ISP2, CZ, 7H9, and Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) medium #553 
(https://www.dsmz.de/microorganisms/medium/pdf/DSMZ_Medium553.pdf) agar plates and incubated 
at 30°C for 10 days. On the 9th day of incubation, M. aurum A+ was inoculated into a 5 mL 2YT broth 
(see recipe below) for overnight growth (14-18 hours) at 37°C, with shaking. Prior to overlaying the stab 
inoculation plates, the purity of the M. aurum A+ culture was confirmed by Gram stain and streaking 
15μL of the culture for single colonies on a 2YT agar plate. The optical density of the M. aurum A+ 
culture was measured using a BECKMAN DU®-64 spectrophotometer. The optical density (OD) was 
used to calculate the appropriate amount of M. aurum A+ that was to be added to the sloppy agar, such 
that the OD600nm X Volume of culture (μL) = 160. This empirical formula was used to ensure that the 
amount of test bacterium used in the overlays was consistent between experiments. Overlays were 
performed using 6 mL sloppy 2YT agar (0.7% agar) inoculated with the appropriate amount of M. aurum 
A+ and poured gently over the stab inoculated plates, making sure not to wash any spores off the 
actinobacterial colonies. The overlays were incubated at 37°C for 48 - 72 hours. Antimycobacterial 
activity was observed as a zone of clearing around the colonies where the test bacterium did not grow. 
The zone of inhibition (ZOI) is equal to the area of the zone of clearing minus the area of the 
actinobacterial colony. The presence or absence of aerial mycelium on the actinobacterial colonies was 
recorded before performing the test-bacterium overlays. The area of the ZOI is measured in mm2 and 
is also recorded as one of the following: <100mm2 – very weak; 100-1000mm2 – weak; 1001-2000mm2 
– moderate; 2001-3000mm2 – strong; >3000mm2 – very strong. If the ZOI was not able to be read 
accurately due to overlapping zones, the isolates were tested again individually. Recipe for medium 2YT: 
16.0g Pancreatic digest of Casein (Tryptone) (Biolab), 10.0g Yeast extract (Biolab), 5.0g NaCl (Saarchem/MERCK), in 1L distilled 
water, followed by adjusting the pH to 7.0. 15g agar (Biolab) was added to 1L 2YT broth to make 2YT agar. The medium was 
autoclaved at 15psi for 15 minutes. 
2.3.3 Genus identification 
2.3.3.1 Genomic DNA extraction 
Genomic DNA was extracted as per the method of Wang et al. (1996), with the following alterations. 
The cell mass was suspended in lysozyme buffer at a concentration of 25mg lysozyme/mL, and 
incubated at 37°C overnight (14-18 hrs). Additionally, the genomic DNA was re-dissolved in a volume 
of Tris-EDTA (TE) buffer (pH 7.8) that was dependent on the size of the DNA pellet. Following DNA 





2.3.3.2 PCR amplification of the 16S rRNA and gyrB genes 
The 16S rRNA gene was amplified via PCR for sequence analysis using the universal bacterial primers 
F1 (5’-AGAGTTTGATCITGGCTCAG-3’) and R5 (5’-ACGGITACCTTGTTACGACTT-3) (I = inosine) 
(Cook & Meyers, 2003). ‘F’ denotes a forward primer while ‘R’ denotes a reverse primer. The gyrB gene 
was amplified via PCR using the following sequence specific primers pairs: GgyrB-F1 (GF1) & 7G-gyrB-
R (7GR), GgyrB-F2 (GF2) & KgyrB-R1892 (K-R1892), 7G-gyrB-R (7GF) & GgyrB-R1 (GR1), and 7GF 
& KgyrB-R (KR) (Meyers, 2014). PCR was performed in 50 μL reactions with the following components: 
2 mM MgCl2 (4 mM MgCl2 for gyrB), 150μM of each dNTP, 0.5 μM of each primer (1.5 μM of each 
primer for gyrB), 1U Super-Therm Taq polymerase (JMR Holdings, USA), and 100 - 500ng/μL of 
template DNA (500ng/μL for gyrB). The PCR programme can be seen in Table 1 below.  





The PCR products were detected on a 0.8% agarose gel, using ethidium bromide (EtBr) at 0.8μg/mL 
(EtBr stock concentration = 10mg/mL), following electrophoresis at 90-100V in 1 X TAE tank buffer 
(Sambrook et al., 1989). A PstI digestion of bacteriophage λ DNA was used as the molecular marker. 
The agarose gel was visualised at 260nm using a BIORAD ChemiDoc™ XRS+. 
2.3.3.3 Sequencing and blastn analysis 
PCR products were purified for sequencing using an MSB® Spin PCRapace kit (STRATEC Molecular, 
Berlin, Germany), according to the manufacturer's instructions. The purified DNA was diluted to 50ng/μL 
in elution buffer for sequencing. Sanger sequencing reactions were performed by Macrogen Europe 
(Amsterdam, The Netherlands) using the universal primers: 518F (5'CCAGCAGCCGCGGTAATACG3') 
and 800R (5'TACCAGGGTATCTAATCC3') for determining the sequence of the 16S rRNA gene. 
Sequencing results were edited using Chromas version 2.6.4 
(http://technelysium.com.au/?page_id=13). Edited partial 16S rRNA gene sequences were submitted 
to the EzBioCloud database (https://www.ezbiocloud.net/identify) and analysed using a standard 
nucleotide-nucleotide Blast (blastn) search (Altschul et al., 1997) to identify each isolate to the genus 
level based on the top hits by percentage sequence similarity. The gyrB gene sequences were 
sequenced using the appropriate primers (dependent on the primers used in the PCR) and edited as 
above prior to blastn analysis (https://blast.ncbi.nlm.nih.gov/Blast.cgi). 
Step Temperature (°C) Time 
   
1 (initial denaturation) 96 2 min 
2 (denaturation) 96 30s 
3 (annealing) 56 20s 
4 (extension) 72 30s 
5 (final extension) 72 5 min 
6 20 Hold 
Steps 2-4 were carried out 30 times before 




2.3.3.4 Phylogenetic analysis of identified strains 
2.3.3.4.1 16S rRNA gene phylogeny 
For the isolates that were identified as Streptomyces, the type strain 16S rRNA gene sequence of each 
of the top 5 hits was downloaded from the NCBI database (https://www.ncbi.nlm.nih.gov/). Where 
strains had similar blastn results, the next top hits in line were selected, as above. For isolates that were 
identified to a non-Streptomyces genus, the type strain 16S rRNA gene sequence of each of the top 10 
hits was downloaded from the NCBI database. Where strains had similar blastn results, the next top 
hits in line were selected, as above. Where the genus was comprised of only a few species with validly-
published names, the 16S rRNA gene sequences were downloaded for all type strains in the genus. 
Multiple sequence alignments of 16S rRNA gene sequences were generated using MUSCLE (Edgar, 
2004) or ClustalW (Larkin et al., 2007) in the Molecular Evolutionary Genetics Analysis version 6.0 
(MEGA6) software (Tamura et al., 2013).  Each alignment was edited such that columns containing any 
insertions or deletions were removed from the alignment. The length of the aligned, edited sequences 
was recorded. The alignments were then used to construct maximum likelihood (Felsenstein, 1981) and 
neighbour-joining (Saitou and Nei 1987) phylogenetic trees using the MEGA6 software. 
2.3.3.4.2 Gyrase subunit B gene phylogeny 
The available gyrB gene sequences for members of the Kitasatospora genus were downloaded to 
compare to the gyrB gene sequence generated for strain PR3.  A multiple sequence alignment and 





2.4 Results & Discussion 
2.4.1 Isolation 
A total of 175 putative actinobacterial strains was isolated from the three different environmental 
sources. Forty-seven (47) strains were isolated from the vermicompost soil, 21 strains were isolated 
from the ‘worm tea’, 68 were isolated from the Mowbray compost soil sample, 37 were isolated from 
the Plumstead compost sample, and two isolates were contaminants selected from sub-cultured plates. 
All isolates were selected based on known actinobacterial colony characteristics (see section 2.3.1.3). 
After sub-culturing, 24 of these isolates were determined to be non-actinobacterial species, or pure 
cultures could not be obtained. These 24 isolates were discarded without further analysis. 
2.4.2 Screening for antimycobacterial activity 
Of the remaining presumptive actinobacterial isolates, 135 were screened for antimycobacterial activity 
using the test bacterium, M. aurum A+ (Table 2). With these, strain 54Y(WT) which was isolated in a 
previous study (the author’s B.Sc.(Honours) laboratory project), was also screened for 
antimycobacterial activity. Strain SK5, isolated by a student doing an internship in the lab, was also 
included here due to already-demonstrated strong activity and being a member of the Kribbella genus 
(Table 3). A positive result here implies the potential for an isolate to produce an antibiotic with 
antitubercular properties (i.e. activity against M. tuberculosis). Thirty-two (32) isolates exhibited no 
antimycobacterial activity on any of the media, 41 exhibited very weak/weak activity (ZOI  100 
mm2/100-1000 mm2), 28 exhibited moderate activity (ZOI 1001-2000 mm2), 16 exhibited strong activity 
(ZOI 2001-3000 mm2), and 20 exhibited very strong activity (ZOI >3000 mm2). In general, most of the 
isolates in the strong and very strong range of activities morphologically resembled actinobacteria of 
the Streptomyces genus. Isolates of importance are those which exhibited strong (strains C4, C20, 
M19, M33, PR4, PR10, PR11, PR29, PR35, PR47, Y2, Y11, Y30, Y31, Y38, Y39) or very strong (strains 
C3, C14, M7, M8, M18, M20, M40, PR3, PR28, SK5, Y5, Y10, Y12, Y14, Y15, Y16, Y20, Y40, Y41, 
UK2) activity (Table 2). Strains C23, M27, M42, PR24, and PR36 may also be of interest because their 
activities were on the border of moderate and strong bioactivity (Table 2). It is important to note that the 
antibiotic activity of each isolate varied depending on the medium on which it was grown. Most of the 
isolates with strong or very strong activity only exhibited such activity on one of the four test media 
used. This is likely due to specific nutrient conditions required for antibiotic biosynthesis (Prescott et al., 
2008). Interestingly, when activity was recorded as moderate or greater, it was when the isolates were 
grown on either DSMZ #553 or ISP2 media (88% of all recorded activity greater than 1000 mm2). This 
is unexpected because secondary metabolites, such as antibiotics, are typically made when the 
environmental conditions are challenging (i.e. low nutrient conditions), which nutrient-rich media like 
DSMZ #553 and ISP2 do not represent (Martin & Demain, 1980; Tormo et al., 2003). This observation 
may be due to very good growth and thus almost complete utilisation of the nutrients resulting in 
starvation conditions and thus secondary metabolite production within the ten-day growth period. 
Another reason could be that nutrient rich conditions promoted growth and thus more cells are 
contributing to antibiotic production leading to a stronger antibiotic response. A possible reason for a 
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general weak antibiotic response on medium 7H9 is that glucose is known to interfere with the 
biosynthesis of many antibiotics (Martin & Demain, 1980). Thus, glucose should either be exchanged 
for a different carbon source or the medium should be replaced with a different medium. 
Strain PR3 is of interest because it had very strong activity on DSMZ Medium #553 and ISP2 (ZOIs of 
4852 and 4040 mm2, respectively), strong activity on 7H9 medium (2778 mm2), and moderate activity 
on CZ medium (1238 mm2) (Table 2). Strain PR28 also demonstrated good activity on all four of the 
test media: moderate activity on CZ medium (1914 mm2), strong activity on 7H9 and DSMZ #553 media 
(2038 mm2 and 2964 mm2, respectively), and very strong activity on ISP2 medium (5740 mm2) (Table 
2). These isolates are ideal strains to work with for antibiotic extraction because they produce strong 
activity on various media with different nutrient compositions. It is noteworthy that Kribbella strain SK5 
had a very strong zone of activity at 3309 mm2 (on ISP2 medium), because members of the genus 
Kribbella are not well known for antibacterial antibiotic production. This makes the strain a priority for 
further study (strain SK5 is discussed in detail in Chapter 3). It is important to note that a lack of antibiotic 
activity here does not imply that the microbe is not producing bioactive molecules, or that it does not 
have the biosynthetic capability to produce an active compound. Activity could be induced under other 
environmental conditions, or against a different kind of test bacterium (Gram negative bacteria, for 
example). 
2.4.3 Genus identification 
The following strains were selected for genus identification via sequencing of the 16S rRNA gene and 
blastn analysis due to a strong or very strong bioactivity against M. aurum A+:  C3, C4, C20, M7, M8, 
M20, PR3, PR4, PR10, PR11, PR28, PR29, PR35, PR47, Y5, Y10, Y12, Y14, Y16, Y20, Y30, Y31, 
Y38, Y39. Strain PR10 was also interesting morphologically, exhibiting an orange substrate mycelium 
and white aerial mycelium. Strains C23, G2, M13, M27, PR24, PR36, and UK1 were also selected for 
16S rRNA gene sequencing because they had moderate antibiotic activity and interesting colony 
morphologies. Strains G3, G4, M26, M28, PR6, PR22, and 54Y(WT) were chosen for sequencing purely 
due to displaying interesting colony morphologies. Strains G3, M26, M28 and 54Y(WT) were bright 
orange in colour, slightly wrinkled, and formed a black spore mass. Strain G4 had a slightly wrinkled, 
‘dry-looking’, pale orange cell mass. Strain PR22 had pink substrate mycelium and a light pink spore 
mass. Table 3 shows each strain’s top hit based on an EzBioCloud analysis. Strains C4 and Y31 were 
not compared to the EzBioCloud database because good quality sequences could not be obtained. A 
new round of DNA extraction and PCR amplification followed by cloning into a vector is suggested to 







Table 2: Antimycobacterial activity of environmental actinobacterial isolates against M. aurum A+ on DSMZ #553, CZ, 7H9, and 
ISP2 agar, using the overlay method. The presence (+) or absence (-) of aerial mycelium (AM) was recorded before overlaying 
with M. aurum A+. Zones of inhibition (ZOI) were calculated and assigned an arbitrary measure of the strength of the 
antimycobacterial activity: VW = Very weak, W - weak, M - moderate, S - strong, VS - very strong activity and n/a – no activity 
Overlays were incubated at 37 °C for 48-72 hours. 
 
Strain Medium AM ZOI Activity# Strain Medium AM ZOI Activity# 
C1 DSMZ #553 + - n/a C16 DSMZ #553 + - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + - n/a 
 ISP2 + - n/a  ISP2 + - n/a 
C2 DSMZ #553 + - n/a C17 DSMZ #553 + - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + - n/a 
 ISP2 + 1737 M  ISP2 - 414 W 
C3 DSMZ #553 + - n/a C18 DSMZ #553 + - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + 314 W  7H9 + - n/a 
 ISP2 + 4048 VS  ISP2 + - n/a 
C4 DSMZ #553 + - n/a C19 DSMZ #553 - 40 W 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 - - n/a 
 ISP2 + 2964 S  ISP2 - - n/a 
C5 DSMZ #553 + - n/a C20 DSMZ #553 - 2325 S 
 CZ + - n/a  CZ + 366 W 
 7H9 + - n/a  7H9 - - n/a 
 ISP2 + - n/a  ISP2 - - n/a 
C6 DSMZ #553 + - n/a C21 DSMZ #553 - - n/a 
 CZ + 484 W  CZ + - n/a 
 7H9 + - n/a  7H9 - - n/a 
 ISP2 + - n/a  ISP2 - - n/a 
C7 DSMZ #553 + - n/a C22 DSMZ #553 + - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + 553 W  7H9 + - n/a 
 ISP2 + - n/a  ISP2 + - n/a 
C8 DSMZ #553 + - n/a C23 DSMZ #553 + 1936 M 
 CZ + - n/a  CZ + 50 W 
 7H9 + 462 W  7H9 + 89 W 
 ISP2 + - n/a  ISP2 + 1993 M 
C9 DSMZ #553 + - n/a C24 DSMZ #553 + - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + 283 W  7H9 + - n/a 
 ISP2 + - n/a  ISP2 + - n/a 
C10 DSMZ #553 + - n/a C25 DSMZ #553 + - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + 503 W  7H9 + - n/a 
 ISP2 + - n/a  ISP2 + - n/a 
C11 DSMZ #553 + - n/a C26 DSMZ #553 - 1549 M 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + 469 W 
 ISP2 + - n/a  ISP2 - - n/a 
C12 DSMZ #553 + - n/a C31 DSMZ #553 - 90 VW 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + - n/a 
 ISP2 + - n/a  ISP2 - - n/a 
C13 DSMZ #553 + - n/a C32 DSMZ #553  - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + 408 W  7H9 + - n/a 
 ISP2 + 1131 M  ISP2 - - n/a 
C14 DSMZ #553 + 3139 VS G1 DSMZ #553 + - n/a 
 CZ + 45 VW  CZ + - n/a 
 7H9 + - n/a   7H9 + 484 W 
 ISP2 + 864 W  ISP2 - 318 W 
C15 DSMZ #553 + 89 VW G2 DSMZ #553 - - n/a 
 CZ + - n/a   CZ - - n/a 
 7H9 + 460 W  7H9 - - n/a 
 ISP2 - - n/a   ISP2 - 1106 M 
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Table 2 (continued): 
 
 
Strain Medium AM ZOI Activity# Strain Medium AM ZOI Activity# 
G3 DSMZ #553 - - n/a M18 DSMZ #553 - 4287 VS 
 CZ - - n/a  CZ + - n/a 
 7H9 - - n/a  7H9 + - n/a 
 ISP2 - - n/a  ISP2 + 126 W 
G4 DSMZ #553 - 625 W M19 DSMZ #553 - 2489 S 
 CZ - - n/a  CZ + 704 W 
 7H9 - - n/a  7H9 + - n/a 
 ISP2 - 574 W  ISP2  - n/a 
M1 DSMZ #553 + 1623 M M20 DSMZ #553 + 3536 VS 
 CZ + - n/a  CZ + - n/a 
 7H9 + 441 W  7H9 + 304 W 
 ISP2 + 330 W  ISP2 + 1390 M 
M2 DSMZ #553 - 1117 M M21 DSMZ #553 + - n/a 
 CZ + - n/a  CZ - - n/a 
 7H9 + - n/a  7H9 - - n/a 
 ISP2  - n/a  ISP2 + 163 W 
M3 DSMZ #553 + 1513 M M22 DSMZ #553 + 283 W 
 CZ + 138 W  CZ - - n/a 
 7H9 + 679 W  7H9  - n/a 
 ISP2 + 173 W  ISP2 - - n/a 
M4 DSMZ #553  - n/a M23 DSMZ #553 + 352 W 
 CZ + 99 W  CZ + - n/a 
 7H9 + 1307 M  7H9 - - n/a 
 ISP2 - 302 W  ISP2 - - n/a 
M6 DSMZ #553 + 330 W M24 DSMZ #553 - 481 W 
 CZ + 453 W  CZ - - n/a 
 7H9 + 264 W  7H9 - - n/a 
 ISP2 + - n/a  ISP2 - - n/a 
M7 DSMZ #553 + 4497 VS M25 DSMZ #553 - 1085 M 
 CZ + - n/a  CZ - - n/a 
 7H9 + - n/a  7H9 - - n/a 
 ISP2  - n/a  ISP2 - 1483 M 
M8 DSMZ #553 + 4852 VS M26 DSMZ #553 - - n/a 
 CZ + - n/a  CZ - - n/a 
 7H9 + - n/a  7H9 - - n/a 
 ISP2  - n/a  ISP2 - - n/a 
M9 DSMZ #553 + 439 W M27 DSMZ #553 - 1697 M 
 CZ + 622 W  CZ - - n/a 
 7H9 + 761 W  7H9 - - n/a 
 ISP2 + 44 VW  ISP2 - 1238 M 
M10 DSMZ #553 - - n/a M28 DSMZ #553 - 414 W 
 CZ + 182 W  CZ - - n/a 
 7H9 + 69 VW  7H9 - - n/a 
 ISP2  - n/a  ISP2 - 1233 M 
M11 DSMZ #553 + - n/a M29 DSMZ #553 - - n/a 
 CZ - 574 W  CZ + - n/a 
 7H9 + 566 W  7H9 + - n/a 
 ISP2 - 78 VW  ISP2 - - n/a 
M12 DSMZ #553 + - n/a M31 DSMZ #553 - 94 VW 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 - - n/a 
 ISP2 + - n/a  ISP2 - 16 VW 
M13 DSMZ #553 + - n/a M32 DSMZ #553 - 88 VW 
 CZ + 1549 M  CZ - - n/a 
 7H9 + 419 W  7H9 - 57 VW 
 ISP2 - 75 VW  ISP2 - - n/a 
M14 DSMZ #553 + - n/a M33 DSMZ #553 + - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + - n/a 
 ISP2 + - n/a  ISP2 + 2766 S 
M15 DSMZ #553 + 409 W M34 DSMZ #553 + - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + 389 W 
 ISP2 + 169 W  ISP2  - n/a 
M17 DSMZ #553 - - n/a M35 DSMZ #553 - 427 W 
 CZ + 625 W  CZ - - n/a 
 7H9 + - n/a  7H9 - - n/a 
 ISP2 + 276 W  ISP2 - 145 W 
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Strain Medium AM ZOI Activity# Strain Medium AM ZOI Activity# 
M41 DSMZ #553 - - n/a PR19 DSMZ #553 - - n/a 
 CZ - - n/a  CZ + - n/a 
 7H9  - n/a  7H9 + - n/a 
 ISP2 + - n/a  ISP2 + 1358 M 
M42 DSMZ #553 + 1901 M PR22 DSMZ #553 + - n/a 
 CZ + 189 W  CZ + - n/a 
 7H9 + 38 VW  7H9 + - n/a 
 ISP2 - 1901 M  ISP2 + - n/a 
M39 DSMZ #553 - - n/a PR23 DSMZ #553 - 629 W 
 CZ - - n/a  CZ + - n/a 
 7H9  - n/a  7H9 + - n/a 
 ISP2 - - n/a  ISP2 + 588 W 
M40 DSMZ #553 + 4035 VS PR24 DSMZ #553 + 1763 M 
 CZ - - n/a  CZ + - n/a 
 7H9 - - n/a  7H9 + - n/a 
 ISP2 + 1342 M  ISP2 + 1710 M 
PR1 DSMZ #553 + - n/a PR28 DSMZ #553 - 2964 S 
 CZ + - n/a  CZ + 1914 M 
 7H9 + - n/a  7H9 + 2038 S 
 ISP2 + - n/a  ISP2 + 5740 VS 
PR3 DSMZ #553 + 4852 VS PR29 DSMZ #553 + 2832 S 
 CZ + 1238 M  CZ + - n/a 
 7H9 + 2778 S  7H9 + - n/a 
 ISP2 - 4040 VS  ISP2 - - n/a 
PR4 DSMZ #553 + 2196 S PR32 DSMZ #553 - 1624 M 
 CZ + - n/a  CZ + - n/a 
 7H9 + 623 W  7H9 + - n/a 
 ISP2 + 1291 M  ISP2  - n/a 
PR6 DSMZ #553  - n/a PR34 DSMZ #553 + 1478 M 
 CZ + - n/a  CZ + 332 W 
 7H9  - n/a  7H9 + 302 W 
 ISP2  - n/a  ISP2 - 115 W 
PR7 DSMZ #553 + - n/a PR35 DSMZ #553 + 2675 S 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + 374 W 
 ISP2  - n/a  ISP2 + 78 VW 
PR10 DSMZ #553 - - n/a PR36 DSMZ #553 - 1817 M 
 CZ + - n/a  CZ + - n/a 
 7H9 + 2061 S  7H9 + - n/a 
 ISP2 - 2400 S  ISP2 - - n/a 
PR11 DSMZ #553 - 285 W PR37 DSMZ #553  - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + 2734 S  7H9  - n/a 
 ISP2 - 2213 S  ISP2 + 1002 M 
PR12 DSMZ #553 + - n/a PR44 DSMZ #553 + - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + - n/a 
 ISP2  - n/a  ISP2 + - n/a 
PR14 DSMZ #553 + 436 W PR46 DSMZ #553  - n/a 
 CZ + 389 W  CZ + - n/a 
 7H9 + 260 W  7H9 + 947 W 
 ISP2 + 214 W  ISP2 - - n/a 
PR15 DSMZ #553 + - n/a PR47 DSMZ #553 + 2327 S 
 CZ + - n/a  CZ + 192 W 
 7H9 + - n/a  7H9 + 134 W 
 ISP2  - n/a  ISP2 + 1830 M 
PR17 DSMZ #553 + - n/a PR48 DSMZ #553 + 182 W 
 CZ + - n/a  CZ + 870 W 
 7H9 + 5 VW  7H9 + 519 W 
 ISP2 + - n/a  ISP2 + 1483 M 
PR18 DSMZ #553 + - n/a Y1 DSMZ #553 - 65 VW 
 CZ + - n/a  CZ + - n/a 
 7H9 + 5 VW  7H9 + - n/a 
 ISP2 + - n/a  ISP2 - 28 VW 
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Table 2 (continued): 
 
 
Strain Medium AM ZOI Activity# Strain Medium AM ZOI Activity# 
Y2 DSMZ #553 + 2793 S Y20 DSMZ #553 + 3661 VS 
 CZ + - n/a  CZ + - n/a 
 7H9 + 469 W  7H9 + 981 W 
 ISP2 + 648 W  ISP3 - 723 W 
Y3 DSMZ #553 + - n/a Y21 DSMZ #553 - - n/a 
 CZ + - n/a  CZ + 1056 M 
 7H9 + 594 W  7H9 + - n/a 
 ISP2 - 651 W  ISP2 - - n/a 
Y4 DSMZ #553 + - n/a Y28 DSMZ #553 - - n/a 
 CZ + - n/a  CZ - - n/a 
 7H9 + - n/a  7H9 - - n/a 
 ISP2 - - n/a  ISP2 - 1458 M 
Y5 DSMZ #553 + 3649 VS Y29 DSMZ #553 + - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + 94 W 
 ISP2 + 911 W  ISP2 + - n/a 
Y6 DSMZ #553 - - n/a Y30 DSMZ #553 + 2765 S 
 CZ + 572 W  CZ - - n/a 
 7H9 + - n/a  7H9 + 157 W 
 ISP2 - - n/a  ISP2 + - n/a 
Y7 DSMZ #553 + 1208 M Y31 DSMZ #553 + 2772 S 
 CZ + - n/a  CZ - - n/a 
 7H9 + - n/a  7H9 + 235 W 
 ISP3 - - n/a  ISP2 + - n/a 
Y8 DSMZ #553 + - n/a Y33 DSMZ #553 - - n/a 
 CZ + - n/a  CZ - - n/a 
 7H9 + - n/a  7H9 - - n/a 
 ISP2 - - n/a  ISP2 - 126 W 
Y9 DSMZ #553 - - n/a Y34 DSMZ #553 - - n/a 
 CZ + - n/a  CZ - - n/a 
 7H9 + - n/a  7H9 - - n/a 
 ISP2 - 198 W  ISP2 - - n/a 
Y10 DSMZ #553 + 1650 M Y35 DSMZ #553 - - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + - n/a 
 ISP2 + 3673 VS  ISP2 - - n/a 
Y11 DSMZ #553 + - n/a Y36 DSMZ #553 + 1291 M 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + - n/a 
 ISP2 + 2298 S  ISP2 - 90 VW 
Y12 DSMZ #553 + 3040 VS Y37 DSMZ #553 - - n/a 
 CZ + - n/a  CZ - - n/a 
 7H9 + - n/a  7H9 - - n/a 
 ISP2 - - n/a  ISP2  - n/a 
Y13 DSMZ #553  - n/a Y38 DSMZ #553 + 2407 S 
 CZ + 332 W  CZ - 63 VW 
 7H9 + - n/a  7H9 + 231 W 
 ISP2  - n/a  ISP2 + 2327 S 
Y14 DSMZ #553 - 3196 VS Y39 DSMZ #553 + - n/a 
 CZ + - n/a  CZ + - n/a 
 7H9 + - n/a  7H9 + - n/a 
 ISP2 + 2288 S  ISP2 + 2819 S 
Y15 DSMZ #553 + 122 n/a Y40 DSMZ #553 + - n/a 
 CZ + 3290 VS  CZ + - n/a 
 7H9 + - n/a  7H9 + - n/a 
 ISP2 + - n/a  ISP2 + 3246 VS 
Y16 DSMZ #553 + 3444 VS Y41 DSMZ #553 + 4460 VS 
 CZ + - n/a  CZ + - n/a 
 7H9 + 215 W  7H9 + 157 W 
 ISP2 + 179 W  ISP2 + 2778 S 
Y18 DSMZ #553 - - n/a Y42 DSMZ #553 + - n/a 
 CZ + 294 W  CZ + - n/a 
 7H9 + - n/a  7H9 + - n/a 
 ISP2 - 718 W  ISP2 + - n/a 
Y19 DSMZ #553 - - n/a Y43 DSMZ #553 + 378 W 
 CZ + 537 W  CZ + 40 VW 
 7H9 + - n/a  7H9 + 94 VW 
 ISP2 - 741 W  ISP2 + - n/a 
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Strains C23, G4, PR3, and PR10 were selected for additional sequencing using the 800R primer. 
Strains C23 and PR10 were chosen because the first round of sequencing (with primer 518F) provided 
partial 16S rRNA gene sequences that had percentage sequence similarities of less than 99% to their 
corresponding top hits. This was interesting because they both were identified as Streptomyces strains 
(Table 3) and such low sequence similarity is unusual in the genus. Thus, they are potentially novel 
species. Strain G4 was also selected because the initial sequencing of the 16S rRNA gene with primer 
518F identified the isolate as a member of the Tsukamurella genus. This is a rare genus with only 14 
species with validly-published names (http://www.bacterio.net/tsukamurella.html) and strain G4 may be 
a novel member of the genus. Strain PR3 was selected because its antimycobacterial activity was very 
strong based on the agar overlay method (see Table 2), as well as demonstrating antimalarial activity 
(Chapter 4). Other ‘rare’ species of actinobacteria identified in this study were 6 Micromonospora strains 
and 1 Nocardia strain. Micromonospora strains G2, M27, and M28 exhibited moderate antibiotic activity. 
These strains are thus of interest for further analysis. 
As expected, the predominant genus that demonstrated strong or very strong antimycobacterial activity 
was Streptomyces. Strain PR3, preliminarily identified as a Kitasatospora strain, falls into this group, 
because the genus is closely related to Streptomyces (Labeda et al., 2017). Even in extreme 
environments, the members of the Streptomyces genus make up most isolates with strong antibacterial 
activity (Mohammadipanah & Wink, 2016). This result highlights the predominance that the 
Streptomyces genus has in the natural product research field. By screening for antimycobacterial 
activity prior to genus identification, the chances of identifying a pool of isolates dominated by 
Streptomyces were high. A different approach could be taken where the isolates with interesting 





Strain Medium AM ZOI Activity# Strain Medium AM ZOI Activity# 
Y44 DSMZ #553 + 460 W UK1 DSMZ #553 - 1620 M 
 CZ + 50 VW  CZ - - n/a 
 7H9 + 94 VW  7H9 + 521 W 
 ISP2 + - n/a  ISP2 - - n/a 
Y46 DSMZ #553 + - n/a UK2 DSMZ #553 + 3793 VS 
 CZ + 20 VW  CZ + 45 W 
 7H9 + 83 VW  7H9 + 66 W 
 ISP2 - 1085 M  ISP2 + 2263 S 
Y51 DSMZ #553 + - n/a SK5 DSMZ #553 - - n/a 
 CZ + 151 W  CZ - - n/a 
 7H9 + 120 W  7H9 - - n/a 
 ISP2 + 1391 M  ISP2 + 3309 VS 
54(Y)
WT 
DSMZ #553 - - n/a      
 CZ - - n/a      
 7H9 - - n/a      
 ISP2 - - n/a      
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Table 3: Identification of the isolates which had strong antimycobacterial activity and/or were morphologically interesting, to the 
genus level, based on EzBioCloud analyses. %Sequence similarity is the similarity over the query alignment of a partial 16S 
rRNA gene sequence obtained by Sanger sequencing using the 518Fprimer. ᶧ Strains have 16S rRNA gene sequences longer 





















2.4.4 Phylogenetic analysis of identified strains 
2.4.4.1 Micromonospora isolates 
The genus Micromonospora is currently comprised of 79 species with validly published names 
(http://www.bacterio.net/micromonospora.html). The genus was described by Ørskov (1923) and then 
emended by Gao et al. (2014). Micromonospora species are widely distributed in the environment, from 
rhizosphere and mangrove forest soil (Thawai et al., 2015; Zhang et al., 2015, respectively) to Black 
Sea sediment (Veyisoglu et al., 2016). 




C3 Streptomyces violaceus 100 941 
C20 Streptomyces carpinensis 99.2 759 
C23 ᶧ Streptomyces cacaoi subsp. cacaoi 100 1405 
G2 Micromonospora aurantiaca 99.9 924 
G3 Micromonospora aurantiaca 100 922 
G4 ᶧ Tsukamurella pseudospumae 99.6 1452 
M7 Streptomyces althioticus 100 941 
M8 Streptomyces althioticus 100 938 
M13 Streptomyces cellulosae 99.5 941 
M20 Streptomyces violaceus 100 927 
M26 Micromonospora aurantiaca 100 936 
M27 Micromonospora aurantiaca 100 931 
M28 Micromonospora aurantiaca 99.9 930 
M42 Streptomyces cacaoi subsp. cacaoi 100 943 
PR3 ᶧ Kitasatospora albolonga 100 1430 
PR4 * Streptomyces lasiicapitis 99.7 614 
PR6 Streptomyces malachitospinus 99.9 941 
PR10 ᶧ Streptomyces antibioticus 99.7 1481 
PR11* Streptomyces bobili 99.5 417 
PR22 Nocardia asteroides 99.9 926 
PR24 Streptomyces olivaceus 99.6 937 
PR28 Streptomyces neopeptinius 99.3 943 
PR29 Streptomyces althioticus 100 941 
PR35 Streptomyces bacillaris 100 928 
PR36 Streptomyces althioticus 100 927 
PR47 Streptomyces pratensis 100 929 
SK5 ᶧ Kribbella karoonensis 99.7 1463 
Y2 Streptomyces roseoviolaceus 99.7 942 
Y5 Streptomyces violaceus 100 940 
Y10 Streptomyces roseoviolaceus 100 940 
Y11 Streptomyces violaceus 100 937 
Y12 Streptomyces althioticus 100 927 
Y14 Streptomyces althioticus 99.7 939 
Y16 Streptomyces violaceus 100 938 
Y20 Streptomyces violaceus 100 944 
Y30 Streptomyces cacaoi subsp. cacaoi 100 959 
Y38 Streptomyces cacaoi subsp. cacaoi 100 935 
Y39 Streptomyces violaceus 99.6 730 
UK1 Streptomyces diastaticus subsp. ardesiacus 99.7 931 
UK2 Streptomyces cacaoi subsp. cacaoi 99.8 935 
54Y(WT) Micromonospora aurantiaca 100 926 
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The phylogenetic position of strains G2, G3, M26, M27, M28 and 54Y(WT) in the genus 
Micromonospora was determined by the construction of a 16S rRNA gene sequence phylogenetic tree 
using the type strains of the genus (Figure 3). These strains were selected because they had moderate 
antimycobacterial activity (Table 2) and/or interesting morphological features. These interesting 
morphological characters were suggestive that the isolates were Micromonospora species: all the 
colonies were slightly raised and folded, deep orange in colour, and later formed a mucous-like black 
spore mass (Genilloud, 2015). All the isolated strains shared the same closest phylogenetic relative: M. 
aurantiaca strain ATCC 27029T (CP002162) (Figure 3). M. aurantiaca was also the top hit based on a 
blastn analysis (Table 3). All the strains had between 99.9 and 100% 16S rRNA gene sequence 
similarity (over 922-936 bp) to M. aurantiaca. This suggests that the six isolates are either very closely 
related species or they are clones of the same Micromonospora strain. Longer 16S rRNA gene 
sequences will need to be obtained to clarify this. Additionally, gyrB gene sequence similarity should 
also be assessed and a phylogeny constructed. The gyrB gene exhibits greater sequence variation 
between species of the same genus, and clones of the same species would be expected to have 100% 
gyrB gene sequence similarity. 
Strains G2, G3 and M28 were isolated from the treated “worm tea” portion of the vermiculture farm. 
Strains M26 and M27 were isolated from the treated soil of the vermiculture farm. Strain 54Y(WT) was 
isolated from the worm tea of the same vermiculture farm, but a year prior, in the author’s B.Sc. 
(Honours) project. It is noteworthy that the isolates appear in different sections of the farm and, if they 
are clones of the same environmental strain, this shows that it can survive in both a terrestrial and 
aquatic environment (soil and worm tea). Furthermore, it would show that the same strain (54Y(WT)) 
seems to be present in the farm over the space of a year. This could imply that the strain is established 
in the vermiculture. The isolation plates also suggested that there is a predominance of 
Micromonospora strains in the vermiculture farm. The agar plates were riddled with small orange 
colonies with black spores, which resembled known Micromonospora colony morphology. However, 
only strains G2, G3, M26, M27 and M28 were confirmed to belong to the genus Micromonospora. Yami 
et al. (2003) also isolated actinomycetes from vermicompost and found that 57% of the isolates were 
Micromonospora strains, 31% were Nocardia strains and 12% were Streptomyces strains. The results 














 Strain M27  
 Strain M28  
 Strain M26  
 Strain G3  
 Strain G2  
 Micromonospora aurantiaca ATCC 27029T (CP002162) 
 Strain 54(Y) WT  
 Micromonospora marina JSM1-1T (AB196712) 
 Micromonospora maritima D10-9-5T (HQ704071) 
 Micromonospora sediminicola SH2-13T (AB609324) 
 Micromonospora purpureochromogenes ATCC 27007T (X92611) 
 Micromonospora saelicesensis Lupac 09T (AJ783993) 
 Micromonospora brunnea ATCC 27334T (X92605.1) 
 Micromonospora palomenae NEAU-CX1T (NR 136848.1) 
 Micromonospora nickelidurans K55T (HQ174560.2) 
 Micromonospora coxensis 2-30-b (28) T (AB241455) 
 Micromonospora noduli GUI43T (FN658649.2) 
 Micromonospora parathelypteridis NEAU-JXY5 16ST (KU997023.1) 
 Micromonospora vulcania NEAU-JM2 16ST (KF956808.1) 
 Micromonospora profundi DS3010T (KF494813.1) 
 Micromonospora ureilytica GUI23T (FN658641.1) 
 Micromonospora vinacea GUI63T (FN658651.1) 
 Micromonospora luteifusca GUI2T (FN658633.1) 
 Micromonospora zamorensis CR38T (FN658656) 
 Micromonospora (16) 
 Micromonospora matsumotoense 6393-CT (AF152109) 
 Micromonospora humi P0402T (GU459068) 






Figure 3: Maximum likelihood tree of the Micromonospora genus using partial 16S rRNA gene sequences of 883bp. Bootstrap values 
were calculated from 1000 resampled datasets. Bootstrap values above 70% are shown. The numbers in parenthesis indicates the 
number of species in that compressed clade. Asterisks indicate topological conservation between the neighbour-joining tree and the 




2.4.4.2 Nocardia isolate 
The first Nocardia strain was isolated by Eppinger (1891) from a patient with pneumonia and a brain 
abscess (McNeil & Brown, 1994). The genus Nocardia was formally established by Blanchard (1896) 
with the description of Nocardia asteroides. To date there are over 100 species with validly published 
names (http://www.bacterio.net/nocardia.html). The genus has grown rapidly from just 16 described 
species in the year 2000 (Maldonado et al., 2000). Nocardia are aerobic, rod-shaped, Gram-positive 
actinobacteria. Despite being widespread in natural habitats, notably the soil and organic matter (McNeil 
& Brown, 1994; Orchard et al. 1977), the most attention has been given to the taxonomy of Nocardia 
with clinical significance (Maldonado et al., 2000), such as those nocardiae which cause mycetoma and 
nocardiosis (McNeil & Brown, 1994). 
Strain PR22 was selected for 16S rRNA gene sequencing because its morphology resembled the 
morphology of known Nocardia species. The strain did not have any antimycobacterial activity (Table 
2). Strain PR22 was isolated from the Plumstead compost sample. The phylogenetic position of strain 
PR22 in the genus Nocardia was observed via the construction of a 16S rRNA gene phylogenetic tree, 
using the type strains of some of the Nocardia species with validly published names (Figure 4). Strain 
PR22 groups with Nocardia neocaledoniensis SBHR OA6T (AY282603) and N. asteroides DSM 43757T 
(AF430019) with 90% bootstrap support (Figure 4). These three strains form a distinct clade within the 
Nocardia genus, with little sequence variation over the 816 nucleotides compared. This phylogeny is in 
line with the blastn analysis of the 16S rRNA gene sequence where N. asteroides was the top hit based 
on percentage sequence similarity (Table 3). As only an 816 bp alignment was used to construct the 
16S rRNA gene sequence tree in Figure 4, a longer sequence is needed for a more robust comparison 
of strain PR22 to the known Nocardia species. The gyrB gene could also be sequenced to further 
assess the phylogenetic position of strain PR22 in the Nocardia genus. Following this, one could 
determine whether the strain is worthy for characterisation as a novel species in the genus. No further 
characterisation of strain PR22 was undertaken, as it exhibited no antimycobacterial activity and 
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 Nocardia asteroides DSM43757T (AF430019) 
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Figure 4: Maximum likelihood tree of 64 species of the Nocardia genus using partial 16S rRNA gene sequences of 816bp. Bootstrap 
values were calculated from 1000 resampled datasets. Bootstrap values above 70% are shown. The numbers in parenthesis indicate 
the number of species in the compressed clades. Asterisks indicate topological conservation between the neighbour-joining tree and 




2.4.4.3 Streptomyces isolates 
Streptomyces albus, the type species of the genus Steptomyces, was first described as Streptothrix 
alba by Rossi-Doria (1891), which was then emended by Krainsky as Actinomyces albus before being 
established as the type species of the genus Streptomyces (Waksman & Henrici, 1943). The 
Streptomyces genus is the largest of the actinobacteria, with 823 species with validly-published names 
(http://www.bacterio.net/streptomyces.html). 
Phylogenetic analysis of the Streptomyces isolates had to be separated into sections due to the high 
number of known Streptomyces species with validly-published names required for comparison. To 
determine the position of the isolates in the genus, a phylogeny was constructed using the type strains 
of Streptomyces species with validly-published names. The phylogenetic trees in Figures 5, 6 and 7 
were constructed with all the isolates and the top 5 blastn hits of each strain (where top hits overlapped, 
the next top hit was selected). 
Figure 5 shows the phylogenetic positions of strains C3, M20, PR6, PR24, UK1, Y5 and Y20, based on 
partial 16S rRNA gene sequences, with some of the type strains in the Streptomyces genus. Strains 
C3, M20, Y5 and Y20 all group with Streptomyces arenae ISP 5293T (AJ399485), Streptomyces 
daghestanicus NRRL B-5418T (DQ442497), Streptomyces hydrogenans NBRC 13475T (AB184868), 
Streptomyces janthinus ISP 5206T (AJ399478), Streptomyces koyangensis VK-A60T (AY079156), 
Streptomyces luteogriseus NBRC 13402T (AB184379), Streptomyces massasporeus NBRC 12796T 
(AB184152), Streptomyces purpurascens JCM 4509T (AB045888), Streptomyces roseoviolaceus 
NRRL ISP 5277T (AJ399484), Streptomyces violaceus NBRC 13103T (AB184315), and Streptomyces 
violarus NBRC 13104T (AB184316) with 85% bootstrap support and no sequence variation as indicated 
by branch length. These 11 Streptomyces type strains were all in the top 11 hits based on 16S rRNA 
gene blastn analyses, with 100% sequence similarity over approximately 800 nucleotides. Strains C3, 
M20, Y5 and Y20 were all isolated from the Mowbray compost soil sample and could be clones of the 
same environmental Streptomyces strain. However, longer 16S rRNA gene sequences could help to 
distinguish between the strains. In addition, gyrB gene sequence analysis would also assist in 
determining whether these strains are clones of a single strain by determining whether their gyrB 
sequences are identical. 
In Figure 5, strain PR6 groups with Streptomyces malachitospinus NBRC 101004T (AB249954) and 
Streptomyces parvulus NBRC 13193T (AB184326), albeit with weak bootstrap support (47%). However, 
the topology is conserved between the neighbour-joining and maximum-likelihood trees (denoted by 
the asterisk). S. malachitospinus was the top hit and S. parvulus was the fourth hit by pairwise sequence 
alignment on the EzBioCloud database with 99.89 and 99.68% sequence similarity, respectively. 
Figure 5 shows strain PR24 grouping with Streptomyces olivaceus NBRC 3200T (AB184743) and 
Streptomyces pactum NBRC 13433T (AB184398) with weak bootstrap support (54%), but conserved 
topology (see asterisk). S. olivaceus and S. pactum were the first and second hits on the EzBioCloud 
database; both with 99.57% sequence similarity over 937 base pairs of sequence. This isolate could be 
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promising for further work because of the moderate antimycobacterial activity (Table 2), but the 
biodiversity of the isolate will need to be assessed using a longer 16S rRNA sequence and gyrB gene 
sequence analysis. 
Strain UK1 was a contaminant on one of the sub-culture plates and was selected for further analysis 
because it exhibited antimycobacterial activity. The strain groups with S. diastaticus subsp. ardesiacus 
NRRL B-1773T (DQ026631) with 75% bootstrap support (Figure 5).  S. diastaticus subsp. ardesiacus 
was also the top hit on the EzBioCloud database (Table 3). 
 
 Streptomyces rubrogriseus LMG 20318T (AJ781373) 
 Streptomyces violaceolatus DSM 40438T (AF503497) 
 Streptomyces lienomycini LMG 20091T (AJ781353) 
 Streptomyces coelescens DSM 40421T (AF503496) 
 Streptomyces hyderabadensis OU-40T (FM998652) 
 Streptomyces diastaticus subsp. ardesiacus NRRL B-1773T (DQ026631) 
 Strain UK1  
 Strain PR24  
 Streptomyces olivaceus NBRC 3200T (AB184743) 
 Streptomyces pactum NBRC 13433T (AB184398) 
 Streptomyces alboflavus NRRL B-2327T (JNXT01000131) 
 Streptomyces coeruleorubidus ISP 5145T (AJ306622) 
 Streptomyces malachitospinus NBRC 101004T (AB249954) 
 Streptomyces parvulus NBRC 13193T (AB184326) 
 Strain PR6  
 Streptomyces flavofungini NBRC 13371T (AB184359) 
 Streptomyces muensis MBRL 179T (JN560155) 
 Streptomyces violaceochromogenes NBRC13100T (AB184312) 
 Streptomyces arenae ISP 5293T (AJ399485) 
 Streptomyces daghestanicus NRRL B-5418T (DQ442497) 
 Streptomyces hydrogenans NBRC 12475T (AB184868) 
 Streptomyces janthinus ISP 5206T (AJ399478) 
 Streptomyces koyangensis VK-A60T (AY079156) 
 Streptomyces luteogriseus NBRC 13402T (AB184379) 
 Streptomyces massasporeus NBRC 12796T (AB184152) 
 Streptomyces purpurascens JCM 4509T (AB045888) 
 Streptomyces roseoviolaceus NRRL ISP 5277T (AJ399484) 
 Streptomyces violaceus NBRC 13103T (AB184315) 
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Figure 5: Maximum likelihood subtree tree of Streptomyces species using partial 16S rRNA gene sequences of 870bp as the query 
alignment. Bootstrap values were calculated from 1000 resampled datasets. Bootstrap values above 70% are shown. Asterisks 
indicate topological conservation between the neighbour-joining tree and the maximum likelihood tree. The scale bar indicates 5 
nucleotide changes in 10 000 base pairs.  This is a subtree of the full 16S rRNA gene phylogenetic tree of all 104 Streptomyces 
species depicted in Figures 5, 6, and 7. 
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Figure 6 depicts the phylogenetic positions of the following strains in comparison to selected type strains 
of species in the Streptomyces genus using a partial 16S rRNA gene sequence: C23, M7, M8, M13, 
PR29, PR36, Y12, Y14 and Y30.  
Strains M7, M8, PR29, PR36, Y12 and Y14 group with the following Streptomyces species with weak 
bootstrap support (52%) and no topological conservation in the neighbour-joining tree: Streptomyces 
althioticus KCTC 9752T (AY999808), Streptomyces erythrogriseus LMG 19406T (AJ781328), 
Streptomyces griseoflavus LMG 19344T (AJ781322), Streptomyces griseoincarnatus LMG 19316T 
(AJ781321), Streptomyces labedae NBRC 15864T (AB184704), Streptomyces matensis NBRC 12889T 
(AB184221), Streptomyces silaceus NRRL B-21466T (LIRJ01000287), Streptomyces variabilis NRRL 
B-3984T (DQ442551) (Figure 6). Isolates M7, M8, Y12, and Y14 were isolated from the Mowbray 
compost soil sample while strains PR29 and PR36 were isolated from the Plumstead compost sample. 
Despite a geographical difference in the source of the samples, the strains still share high sequence 
similarity. This is not uncommon for members of the Streptomyces genus. In the EzBioCloud analysis, 
these strains shared the same top 9 hits in almost the same order. Further analysis would require longer 
16S rRNA gene sequences and repeating the phylogenetic analysis. As mentioned before, analysis of 
the genetic distances between the gyrB gene sequences of the isolates will also help delineate the 
strains. 
Strain M13, isolated from the Mowbray compost sample, groups with the species that are also the top 
five hits on the EzBioCloud database (Figure 6): Streptomyces carpinensis NBRC 14214T (AB184574) 
Streptomyces cellulosae NRRL B-2889T (DQ442495), Streptomyces gancidicus NBRC 15412T 
(AB184660), Streptomyces prasinosporus NBRC 13419T (AB184390) and Streptomyces 
pseudogriseolus NRRL B-3288T (DQ442541). The sequence comparison was over 941 base pairs, so 
a longer 16S rRNA gene sequence will assist in determining whether the strain is likely to represent a 
new species and is therefore worth investigating further. Over 941 nucleotides, the top hit (the type 
strain of S. cellulosae) shared 99.47% of the 16S rRNA gene sequence (Table 3). 
Strains C23 and Y30 are in the same clade with Streptomyces cacaoi subsp. cacaoi NBRC 12748T 
(AB184115) with 95% bootstrap support (Figure 6). This agrees with the blastn analysis (Table 3). 
Despite the 100% 16S rRNA gene sequence similarity between the isolates and S. cacaoi subsp. cacaoi 
(over 1405 bp), the hits following S. cacaoi subsp. cacaoi all shared sequence similarity of less than 
98.5%. Being producers of a strong antimycobacterial antibiotic makes these strains worthy of further 
characterisation. It would be useful to compare other genes (e.g. gyrB, rpoB, recA, relA, and atpD (ATP 
synthase F1, beta subunit)) between strain C23 and S. cacaoi subsp. cacaoi to see if they can be 
separated as different species. Interestingly, strain C23 was isolated from the soil of the vermiculture 
farm, while strain Y30 was isolated from the Mowbray compost sample. However, these soil samples 
are very close to each other in the same suburban garden and the soil from the compost heap is used 
for the vermicompost. Therefore, these isolates could either be strains of the same species or clones 
of the same strain. Gyrase subunit B gene sequencing would also shed light on the likelihood that 
strains C23 and Y30 belong to a new species. A comparison of the gyrB gene sequence to that of S. 
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cacaoi subsp. cacaoi would allow one to quickly discern whether they are novel species or clones of 
the same environmental isolate. 
Figure 7 shows the phylogenetic position of strains PR10, PR28, PR35 and PR47 in the Streptomyces 
genus based on partial 16S rRNA gene sequences. These strains were isolated from the Plumstead 
compost soil sample. 
Streptomyces antibioticus NRRL B-1701T (AY999776) is the closest phylogenetic relative to strain 
PR10 with 98% bootstrap support (Figure 7) and the top hit according to a blastn analysis. Strain PR28 
is on the periphery of the clade containing Streptomyces cyaneus NRRL B-2296T (AF346475) and 
Streptomyces griseoruber NRRL B-1818T (LIQS01000280), neither of which were the top hit according 
to a blastn analysis (Table 3). Strains PR35 and PR47 are in the same major clade with 95% bootstrap 
support, but branch into different sub-clades. The strains are in the same clades as their respective top 
hits from blastn analyses: Streptomyces bacillaris NBRC 13487T (AB184439) and Streptomyces 
pratensis ch24T (JQ806215), respectively. Strains PR10 and PR28 seem to be the most interesting 
based on the phylogenetic analysis. Their branch lengths demonstrate sequence variation between 
them and their closest relatives. Strain PR10 was of particular interest (based on colony morphology 
and strong antimycobacterial activity) and a longer 16S rRNA gene sequence was generated by 
additional sequencing using the 800R primer. A blastn analysis of the longer sequence (1481 bp, Table 
3) revealed that only the top two hits share greater than 98.7% sequence similarity: S. antibioticus and 
S. griseoruber. Strain PR10 has the potential to be described as a novel species of Streptomyces using 
the polyphasic taxonomic approach and DDH should be carried out to show that it is not the same 
species as S. antibioticus and S. griseoruber.  
The first step in taking strain PR28 forward would be to generate a longer 16S rRNA gene sequence to 
assess how similar it is to the rest of the Streptomyces genus. Following this, the gyrB gene sequence 
can also be used to assess the novelty of the isolate by comparison to the gyrB gene sequences of its 
closest relatives determined from the analysis of the 16S rRNA gene sequence. 
Except for a few isolates identified to the genus Streptomyces, the general trend was for the isolates to 
group with high sequence conservation to the known Streptomyces species. This implies that many of 
these isolates are not likely to belong to new species. However, to provide support for this conclusion, 
many isolates will need to have longer 16S rRNA gene sequences generated to allow for a more robust 
comparison to the known members of Streptomyces. The high sequence similarities were to be 
expected, because the Streptomyces genus is known to have very high 16S rRNA gene sequence 
similarities between closely related species. This high sequence conservation makes it difficult to 
identify the isolates that one should pursue for characterisation as a new species and in turn their 
potential to produce chemically diverse natural products. This is one of the many reasons why 
researchers are turning towards the rarer genera to discover novel actinobacteria and in turn novel 
bioactive compounds. However, strain PR10 is worthy of characterisation as potentially novel species 
in the Streptomyces genus. Physiological characters, chemotaxonomy, DDH or ANI should be used to 
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Figure 6: Maximum likelihood tree of Streptomyces species using partial 16S rRNA gene sequences of 870bp. Bootstrap values were 
calculated from 1000 resampled datasets. Bootstrap values above 70% are shown. The numbers in parenthesis indicate the number of species 
in that compressed clade. Asterisks indicate topological conservation between the neighbour-joining tree and the maximum likelihood tree. 
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Figure 7: Maximum likelihood tree of Streptomyces species using partial 16S rRNA gene sequences of 870bp as the query alignment. 
Bootstrap values were calculated from 1000 resampled datasets. Bootstrap values above 70% are shown. The numbers in parenthesis 
indicates the number of species in that compressed clade. Asterisks indicate topological conservation between the neighbour-joining tree and 










2.4.4.4 Strain PR3: Kitasatospora or Streptomyces? 
The genus Kitasatospora was described by Ōmura et al. (1982) and then subsequently incorporated 
into the Streptomyces genus (Wellington et al., 1992) only to be reinstated as Kitasatospora in 1997 
(Zhang et al., 1997). Currently the genus has 23 species with validly published names 
(http://www.bacterio.net/kitasatospora.html) and Labeda et al. (2017) recently suggested the transfer of 
another nine Streptomyces species to the genus Kitasatospora based on an MLSA of the following five 
house-keeping genes: atpD, gyrB, rpoB, recA, and trpB (tryptophan synthetase, beta subunit). 
Kitasatospora are aerobic, Gram-positive, chemo-organotrophic actinomycetes which form a network 
of branching hyphae (Groth et al., 2003). 
Strain PR3 is a fast-growing actinobacterium that was isolated from the Plumstead compost sample. 
On ISP2, strain PR3 has a substrate mycelium that is off white to brown in colour and a white spore 
mass that resembles chalk. The top hit based on an EzBioCloud blastn analysis was Kitasatospora 
albolonga NBRC 13465T (Table 3). However, the rest of the hits in the list were all Streptomyces 
species. Consequently, a 16S rRNA gene sequence phylogenetic tree was constructed using all 32 
type strains from the genus Kitasatospora with validly-published names and 100 Streptomyces type 
strains with validly-published names to determine the phylogenetic position of strain PR3 (Figure 8). 
Based on the 16S rRNA gene sequence phylogeny, strain PR3 groups with the Streptomyces species, 
along with K. albolonga NBRC 13465T (AB184425) and Kitasatospora cinereorecta NBRC 15395T 
(AB184646). In a 16S rRNA gene sequence phylogeny generated with only the sequences from the 
Kitasatospora genus, those strains that grouped with the Streptomyces species in Figure 8 also 
branched off from the main clade of Kitasatospora species (Appendix A). Due to the high conservation 
of the 16S rRNA gene sequence between the two genera, additional information is needed to assign a 
genus identification to strain PR3. 
Labeda et al. (2017) used an MLSA with 5 house-keeping genes to reassess the taxonomic status of 
Streptomyces species which were believed to have been incorrectly classified. From the phylogenetic 
tree generated, Labeda et al. (2017) proposed the transfer of the following Streptomyces species, 
among others, to the genus Kitasatospora: K. albolonga (basonym Streptomyces albolongus), K. 
cinereorecta (basonym Streptomyces cinereorectus) and K. misakiensis (basonym Streptomyces 
misakiensis). Interestingly, these transferred species are the ones that group separately from the other 
Kitasatospora species in Figure 8. Thus, the 16S rRNA gene sequence analysis cannot be relied upon 
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Figure 8: Maximum likelihood tree of the Kitasatospora genus and 100 members of the Streptomyces genus using partial 16S rRNA gene 
sequences of 1320bp and rooted with Tsukamurella paurometabola DSM 20162T (CP001966). Bootstrap values were calculated from 1000 
resampled datasets. Bootstrap values above 70% are shown. The numbers in parenthesis indicate the number of species in that compressed 
clade. Asterisks indicate topological conservation between the neighbour-joining tree and the maximum likelihood tree. The scale bar indicates 




A gyrB gene sequence was generated for strain PR3 to compare to the seven available Kitasatospora 
gyrB gene sequences. A ClustalW alignment of gyrB gene sequences from strain PR3, Kitasatospora 
species and closely-related Streptomyces species was generated (Table 4) and a phylogenetic tree 
was constructed (Figure 9). ClustalW was used because it produced a better alignment of the 
sequences than MUSCLE. Table 4 shows a region of the alignment from MEGA6 where the 
Kitasatospora gyrB sequences exhibit two deletions (of 24 and 15 nt), which distinguish them from the 
Streptomyces gyrB sequences. The larger, 24-nt deletion is present in all the Kitasatospora sequences 
and is absent from all the Streptomyces sequences used in the alignment. The 24-nt deletion is absent 
from strain PR3, suggesting that it belongs to the genus Streptomyces. 
Table 4: Multiple sequence alignment of gyrB gene sequences from members of the Kitasatospora genus, Streptomyces genus, 
and strain PR3. The alignment was generated using ClustalW in the Mega6 programe. 
Kitasatospora azatica KCTC 9699 gyrB (JF424118) GACGAGCGCG------------------------AGGAGCACACCGA---------------CGACGAGG 
Kitasatospora cineracea KCTC 19932 gyrB (JF424126) GACGAGCGCG------------------------CCAAGCACCTGGA---------------CGAGGAGG 
Kitasatospora cystarginea KCTC 9746 gyrB (JF424123) GACGAGCGTG------------------------CCGAGCACCTGGA---------------CGAGGAGG 
Kitasatospora griseola KCTC 9745 gyrB (JF424122) GACGAGCGTG------------------------CCGAGCACGCCGA---------------CGAGGAGG 
Kitasatospora kifunensis KCTC 9734 gyrB (JF424120) GACGAGCGCG------------------------AGGAGCACTTCGA---------------CGACCAGG 
Kitasatospora mediocidica KCTC 9733 gyrB (JF424119) GACGAGCGCG------------------------CCAAGCACCTGGA---------------GGAGGAGG 
Kitasatospora niigatensis KCTC 19933 gyrB (JF424127) GACGAGCGCG------------------------CCAAGCACCTGGA---------------CGAGGAGG 
Strain PR3  GACGAGCGCGAGTCGGCCAAGGCCACGGCGGGCGCCGACAGCGCCGAGGCCACCGAGGTCCCCGAGGAGG 
Streptomyces lunaelactis MM109T gyrB (KM207219) GACGAGCGCGAGTCGGCGAAGGCCACCGCCGGTGCTGACACCGTCGAGGAGG---------CGGCCGAGG 
Streptomyces cavourensis KCCM 40666 gyrB (HQ995508) GACGAGCGCGAGTCGGCCAAGGCCACGGCGGGCGCCGACAGCGCCGAGGCCACCGACGTCCCCGAGGAGG 
Streptomyces bacillaris gyrB KCTC 9018T (HQ995507) GACGAGCGCGAGTCGGCCAAGGCCACGGCGGGCGCCGACAGCGCCGAGGCCACCGAGGTCCCCGAGGAGG 
Streptomyces globisporus gyrB KCTC 9026T (HQ995513) GACGAGCGTGAGTCGGCGAAGGCGACGGCGGGCGCGGACAGCGCCGATCGAGTCGAGCCCGCCGAGGAGG 
Streptomyces azureus gyrB NRRL B-2655T (EU277659) GACGAGCGCGAGTCGGCGAAGGCCACGGCCGGCGCGGACGAGGCCGGCGAGG---------ACGAGAAGC 
Streptomyces pulveraceus gyrB DSM 41657T (HQ823601) GACGAGCGCGAGTCGGCGAAGGCGACGGCGGGTGCGGACGTCGCCGAGGTGGCCGAGATCGCCGAGGCGG 
Streptomyces gelaticus gyrB DSM 40065T (HQ823589) GACGAGCGCGAGTCGGCGAAGGCGACGGTGGGTGCCGAGGTCGCCGAGGTGGCCGAGGTCGCCGAGGCGG 
Streptomyces mauvecolor gyrB DSM 41702T (HQ823596) GACGAGCGCGAGTCGGCGAAGGCGGTCTCGGGCGCGGACTCCGCGGAGGAGG---------CCGAGGAGC 
Streptomyces sindenensis gyrB NBRC 12915T (HQ995522) GACGAGCGTGAGTCGGCGAAGGCGACGGCGGGTGCGGACAGCGCCGAGGCGACCGAGGTCCCCGAGGAGG 
Streptomyces polyantibioticus gyrB SPRT (HQ823600) GACGAGCGGGAGTCGGCGAAGGCCGTCTCCGGGGCGGACTCGGCCGAGGAGT---------CGGAAGTCG 
 
Meyers (2014) showed that molecular signatures, such as indels, can be used to distinguish between 
genera in the family Streptosporangiaceae. The gyrB gene alignment (Table 4) shows that strain PR3 
contains a molecular signature that is only present in the gyrB gene sequences of Streptomyces 
species. This implies that strain PR3 is a member of the Streptomyces genus. However, it must be 
borne in mind that gyrB gene sequences are only available for about a quarter of the members of the 
genus Kitasatospora, so the analysis should ideally be repeated to include the entire genus to confirm 
that the two deletions are common to all members of the genus. 
Figure 9 shows the phylogenetic position of strain PR3 based on Kitasatospora and Streptomyces gyrB 
gene sequences. Strain PR3 groups with most of the Streptomyces clade (Streptomyces azureus NRRL 
B-2655T is on the periphery) with 75% bootstrap support (Figure 9). The Kitasatospora species group 
together with 100% bootstrap support. This evidence, along with the alignment evidence, suggests that 
strain PR3 is a Streptomyces species. However, chemotaxonomic work will validate which genus strain 
PR3 belongs to. If strain PR3 is a Streptomyces species it will have the following chemotaxonomic 
characters: LL-diaminopimelic acid as the diagnostic diamino acid in the peptidoglycan, phospholipid 
pattern type II, no diagnostic sugars, MK-9 (H6, H8, H4) as the major menaquinones, and a DNA G+C 
content between 69 and 78 mol% (Locci et al. 1989). If strain PR3 is a Kitasatospora species, it will 
have the following chemotaxonomic characters instead: meso- and LL-diaminopimelic acid, MK-9(H6, 
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H8) as the major menaquinones, phospholipid pattern type II, galactose as a whole-cell diagnostic sugar 
and a DNA G + C content in the same range as the Streptomyces genus (Takahashi, 2017; Li et al. 
2009). The major chemotaxonomic differences between the two genera are the presence of galactose 
as a diagnostic sugar in Kitasatospora and the fact that Kitasatospora contains both meso- and LL-
diaminopimelic acid in the peptidoglycan. 
An MLSA is also recommended to determine the phylogenetic position of strain PR3 in relation to the 















2.4.4.5 Tsukamurella isolate 
Members of the Tsukamurella genus, established by Collins et al. (1988), are aerobic, Gram-positive, 
non-spore forming, rod-shaped cells (Nam et al., 2003; Collins et al., 1988). Tsukamurella species have 
commonly been isolated from human patients (Goodfellow & Kumar, 2012; Woo et al., 2009, 2003), but 
have also been isolated from terrestrial and aquatic sources (Olson et al., 2007; Park et al., 2009; Weon 

















Figure 9: Maximum likelihood tree of Kitasatospora and Streptomyces species using partial, 1723bp gyrB gene sequences. Bootstrap 
values were calculated from 1000 resampled datasets. Bootstrap values above 70% are shown. Asterisks indicate topological 
conservation between the neighbour-joining tree and the maximum likelihood tree. The scale bar indicates 20 nucleotide changes in 
1000 base pairs. 
 
 Strain PR3 gyrase subunit B  
 Streptomyces cavourensis KCCM 40666 DNA gyrase subunit B (HQ995508) 
 Streptomyces bacillaris KCTC 9018T DNA gyrase subunit B (HQ995507) 
 Streptomyces sindenensis NBRC 12915T DNA gyrase subunit B (HQ995522.1) 
 Streptomyces globisporus KCTC 9026T DNA gyrase subunit B (HQ995513) 
 Streptomyces pulveraceus DSM 41657T DNA gyrase subunit B (HQ823601) 
 Streptomyces gelaticus DSM 40065T DNA gyrase subunit B (HQ823589) 
 Streptomyces lunaelactis MM109T DNA gyrase subunit B (KM207219) 
 Streptomyces mauvecolor DSM 41702T DNA gyrase subunit B (HQ823596) 
 Streptomyces polyantibioticus SPRT DNA gyrase subunit B (HQ823600) 
 Streptomyces azureus NRRL B-2655T DNA gyrase subunit B (EU277659) 
 Kitasatospora azatica KCTC 9699 gyrase subunit B (JF424118) 
 Kitasatospora kifunensis KCTC 9734 gyrase subunit B (JF424120) 
 Kitasatospora cystarginea KCTC 9746 gyrase subunit B (JF424123) 
 Kitasatospora griseola KCTC 9745 gyrase subunit B (JF424122) 
 Kitasatospora mediocidica KCTC 9733 gyrase subunit B (JF424119) 
 Kitasatospora cineracea KCTC 19932 gyrase subunit B (JF424126) 















Strain G4, isolated from the untreated portion of the vermicompost soil sample, is a Gram positive, rod 
shaped, orange-coloured actinobacterium with a wrinkled and dry-looking colony morphology. The 
Tsukamurella genus is small: there are only 14 species with validly-published names 
(http://www.bacterio.net/tsukamurella.html). This makes this isolate of keen interest for characterisation 
as a potentially novel species. The top three hits based on the 16S rRNA gene sequence of 1542bp on 
the EzBioCloud data base were Tsukamurella pseudospumae N1176T (AY238513), Tsukamurella 
spumae N1171T (Z37150) and Tsukamurella sunchonensis SCNU5T (AF150494), respectively, all with 
99.58% sequence similarity. T. pseudospumae, T. spumae and T. sunchonensis, were all isolated from 
the foam of activated sewage sludge (Nam et al., 2004; Nam et al., 2003; Seong et al., 2003). The 
phylogenetic position of strain G4 was observed with the construction of a 16S rRNA gene tree using 
all the Tsukamurella species with validly-published names (Figure 10). Strain G4 only groups with T. 
spumae of the top three hits from the blastn analysis (bootstrap support of 98%), while T. 
pseudospumae, and T. sunchonensis group separately (Figure 10). 
Only two other Tsukamurella species have been isolated from soil, namely Tsukamurella 
carboxydivorans and Tsukamurella soli. T. carboxydivorans Y2T has a 16S rRNA gene sequence 
similarity of 99.31% with strain G4, while T. soli JS18-1T has a 16S rRNA gene sequence similarity of 
96.18% with strain G4. Polyphasic taxonomy and DDH will need to be used to determine whether strain 
G4 belongs to a distinct genomic species from T. pseudospumae, T. spumae and T. sunchonensis. 
2.4.4.4.1 Should Tsukamurella soli be re-classified? 
T. soli strain JS18-1T (FJ917743), described by Weon et al. (2010), forms a deep branch in the 
Tsukamurella phylogenetic tree constructed using 1401bp of common 16S rRNA gene sequence. This 
deep branch is immediately suggestive that there is something amiss with the classification of this 
species. To suggest that T. soli does not belong to the Tsukamurella genus, one needs to look at the 
sequence information and chemotaxonomic characters of the strain. 
In the paper describing T. soli, the levels of sequence similarity reported between the type strain and 
the rest of the genus was 95.4–96.5 % (Weon et al., 2010). According to Meier-Kolthoff et al. (2013) 
this is clearly well below the cut-off threshold for classifying a strain as a new species of actinobacterium. 
Table 5 below highlights this low 16S rRNA gene sequence similarity with a homology matrix created 
using DNAMAN version 4.13 (Lynnon Biosoft). The column in red shows the low sequence similarity 
between T. soli and the type strains of the rest of the Tsukamurella species with validly-published names 
(Table 5). The next lowest percentage similarity between two Tsukamurella type strains is 97.7% 
(Tsukamurella serpentis and Tsukamurella spongiae; Table 5, highlighted in blue). The very low 16S 
rRNA gene sequence similarities between the type strain of T. soli and other members of the genus are 
in the range suggestive of a novel genus. However, sequence comparisons are not enough to draw any 
concrete conclusions. 
Chemotaxonomically, T. soli is not very different from the rest of the members of the Tsukamurella 
genus.  However, the proportion of fatty acid C18:1 ω 9c is unusually low in the type strain of T. soli at 
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14.1%, while in the other Tsukamurella type strains the proportion of C18:1 ω 9c is 20 to 45.4% (Tang et 
al. 2016). 
This information suggests that T. soli could be a member of a different genus, but a more thorough 
comparison needs to be done to provide support for a proposal to transfer T. soli to another genus. 
According to Barka et al. (2016) the closest genus relative is Gordonia. Thus, a chemotaxonomic 
comparison can be done to identify whether T. soli is in fact a member of the genus Gordonia. However, 
T. soli is more closely related to all the Tsukamurella species before any other genus. Thus, it is more 
likely that T. soli would form a new, closely related, genus possibly named “Pseudotsukamurella” or 
“Allotsukamurella”. Sequence analysis of the gyrB and other housekeeping genes should also be used. 
An MLSA of all members of the genus and other closely related genera using a set of housekeeping 
genes (such as atpD, gyrB, rpoB, recA, and trpB) would be the ideal method, because this would provide 
a more robust assessment of the phylogenetic position of T. soli. 
 
 Tsukamurella pseudospumae N1176
T (AY238513) 
 Tsukamurella sunchonensis SCNU5
T (AF150494) 
 Tsukamurella hongkongensis HKU52
T (KP888572) 
 Tsukamurella sinensis HKU51
T (KP888571) 
 Tsukamurella pulmonis IMMIB D-1321
T (X92981) 
  Tsukamurella spongiae K362T (AY714239) 
  Tsukamurella carboxydivorans strain Y2
T (EU521689) 
 Tsukamurella tyrosinosolvens DSM 44234
T (AY238514) 
  Tsukamurella strandjordae ATCCBAA-173
T (AF283283) 
 
Tsukamurella paurometabola DSM 20162T (CP001966) 
  Tsukamurella inchonensis ATCC700082T (AF283281) 
  Tsukamurella spumae N1171
T (Z37150) 
 Strain G4 
 Tsukamurella serpentis HKU54
T (KT581020) 








Figure 10: Maximum likelihood phylogenetic tree using the 16S rRNA gene to compare strain G4 to members of the Tsukamurella genus. 
The tree was constructed based on 1401 bp of common sequence. Bootstrap values were calculated from 1000 resampled datasets. 
Bootstrap values above 70% are shown. Asterisks indicate topological conservation between the neighbour-joining tree and the maximum 









Table 5: 16S rRNA gene sequence similarity matrix for all the type strains in the Tsukamurella genus. 
 
T. soli             100% 
T. carboxydivorans  95.9% 100% 
T. hongkongensis  96.2% 99.1% 100% 
T. inchonensis      96.1% 99.3% 98.9% 100% 
T. paurometabola    96.0% 99.1% 99.1% 99.4% 100% 
T. pseudospumae     95.9% 99.5% 99.4% 99.2% 99.0% 100% 
T. pulmonis         95.9% 99.6% 99.4% 99.4% 99.1% 99.6% 100% 
T. serpentis        96.1% 98.5% 98.2% 99.0% 98.9% 98.5% 98.6% 100% 
T. sinensis         96.2% 99.4% 99.6% 99.1% 99.3% 99.4% 99.6% 98.6% 100% 
T. spongiae         95.0% 98.7% 98.5% 98.5% 98.2% 98.7% 99.1% 97.7% 98.7% 100% 
T. spumae          95.9% 99.3% 99.2% 99.6% 99.2% 99.7% 99.4% 98.9% 99.1% 98.5% 100% 
T. strandjordii      96.1% 99.5% 99.1% 99.5% 99.5% 99.4% 99.6% 98.9% 99.4% 98.7% 99.3% 100% 
T. sunchonensis     95.9% 99.5% 99.4% 99.2% 99.0% 100 % 99.6% 98.5% 99.4% 98.7% 99.7% 99.4% 100% 
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ANTIBIOTIC EXTRACTION FROM Kribbella STRAIN SK5 AND 
DESCRIPTION OF STRAIN SK5 AS Kribbella 
stellenboschensis sp. nov 
3.1 Summary 
Seven actinobacterial isolates (Kribbella strain SK5, Streptomyces strains PR10, PR28, PR47, UK1 and 
Y10 and Micromonospora strain M27) were tested for the biosynthetic potential to produce ansamycin, 
glycopeptide, non-ribosomal peptide and Type-II polyketide antibiotics using PCR primers specific to the 
different antibiotic biosynthetic genes. Strain Y10 demonstrated the potential to produce a non-ribosomal 
peptide antibiotic. Strain M27 demonstrated the potential to produce ansamycin, glycopeptide, and Type-II 
polyketide antibiotics. Strains PR10, PR28, PR47, SK5, and UK1 demonstrated the potential to produce 
Type-II polyketide and non-ribosomal peptide antibiotics. Strains PR3 and Y30 were not screened for their 
antibiotic biosynthetic potential due to low quality DNA at the time. Following this, strains PR3, SK5, UK1 
and Y30 were subjected to antibiotic extraction and their crude extracts were tested for activity against M. 
aurum A+, Staphylococcus aureus ATCC 25923, and Escherichia coli ATCC 25922. Strains PR3 and Y30 
were not screened for their antibiotic biosynthetic potential due to low quality DNA. The cell broth extracts 
of the Streptomyces isolates (strains PR3, UK1 and Y30) dissolved in methanol (MeOH) were active against 
M. aurum A+. Emphasis was placed on the analysis of the crude extract from Kribbella strain SK5, which 
displayed a pattern of activity that was dependent on the growth conditions. The culture broth extract of 
strain SK5 exhibited activity against M. aurum A+ and S. aureus ATCC 25923 when strain SK5 was 
incubated at 22°C or 30°C, with Rf values for the active molecule of 0.37 and 0.72 by 1D TLC when using 
100% ethyl acetate (EtOAc) and 100% MeOH as the solvent systems, respectively. The cell mass extract 
of strain SK5 exhibited activity against M. aurum A+ and S. aureus ATCC 25923 when strain SK5 was 
incubated at a fluctuating temperature (~25°C to 30°C) with Rf values of 0.54 and 0.4 by 1D TLC using 
100% EtOAc as the solvent system and 0.56 using 100% MeOH as the solvent system. Strains PR3 and 
UK1 also displayed antimalarial activity against the drug sensitive Plasmodium falciparum strain NF54. The 
cell mass extract and culture broth extract of strain PR3 demonstrated IC50 values of 39±5 and 56±5 ng/mL, 
respectively. The cell mass extract of strain UK1 demonstrated an IC50 value of 298±4 ng/mL.  
A polyphasic taxonomic approach was used to characterise a soil actinobacterium (strain SK5) that was 
isolated from Stellenbosch, Western Cape, South Africa. Based on 16S rRNA gene sequence analysis, 
strain SK5 was assigned to the genus Kribbella. The genus identification was confirmed following the 
identification of key Kribbella chemotaxonomic characters, namely the presence of i) MK-9(H4) as the major 
menaquinone; ii) LL-diaminopimelic acid; iii) anteiso-C15:0, iso-C16:0 and iso-C15:0 as the main fatty acids; and 
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iv) phosphatidylcholine in the polar lipid profile. Phylogenetic analysis of the 16S rRNA gene and a 
multilocus sequence analysis of five concatenated housekeeping genes (gyrB, rpoB, recA, relA, and atpD) 
revealed the closest genomic relatives as the type strains of Kribbella aluminosa, Kribbella karoonensis, 
Kribbella pittospori, Kribbella shriazensis and ‘Kribbella soli’. The genetic distance values between the 
concatenated housekeeping gene sequences for K. aluminosa, K. karoonensis, K. pittospori, K. shirazensis 
and ‘K. soli’ were 0.050, 0.053, 0.056 0.045 and 0.030, respectively. Phenotypic comparisons identified 
differences between strain SK5 and the type strains of the above mentioned Kribbella species. The 
concatenated-gene genetic distance between strain SK5 and the type strain of ‘Kribbella sindirgiensis’ was 
0.016, but a phenotypic comparison between these closely related strains was not possible, as the type 
strain of ‘K. sindirgiensis’ was not available. Strain SK5 is preliminarily presented as the type strain of a 
novel species for which the name ‘Kribbella stellenboschensis’ sp. nov. is proposed. DDH against ‘K. soli’ 
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‘Rare’ actinobacteria are incredibly relevant as sources of novel antibiotics (Lazzarini et al., 2000), because 
their isolation increases the chances of discovering chemically diverse secondary metabolites. It is for this 
reason that strong antibiotic producers within the rarer genera of actinobacteria are sought after as sources 
of bioactive lead compounds for development as pharmaceutical drugs. Members of the genus Kribbella 
are not well known as antibiotic producers, but Kribbella antibiotica YIM 31530T produces an antifungal 
agent (Li et al., 2004) and Kribbella sandramycini ATCC 39419T (Park et al., 1999) produces an antitumour 
agent, sandramycin. There has also been the recent description of kribbellosides: new RNA 5’-triphosphate 
inhibitors isolated from Kribbella sp. MI481-42F6, which exhibit antifungal activity (Igarashi et al., 2017). 
The genus Kribbella, of the family Nocardioidaceae, was established by Park et al. (1999) when two strains, 
previously identified as members of the genus Nocardioides, were identified as distinct from the rest of the 
genus Nocardioides based on 16S rRNA gene sequence analysis. The genus description was later 
emended by Everest et al. (2013). Kribbella species are aerobic, Gram-stain positive and generally form 
colonies that do not have distinctive colouration. They form colonies that are wrinkled and pasty to soft-
leathery. If spores are produced on agar plates, the spore mass is often white (Evtushenko & Krausova, 
2012). Kribbellae form extensively branched vegetative hyphae, which often undergo varying degrees of 
fragmentation in both the substrate and aerial hyphae, as well as in liquid culture (Evtushenko & Krausova, 
2012). The Kribbella genus has the following defining chemotaxonomic features: i) The cell wall 
peptidoglycan contains LL-diaminopimelic acid; ii) MK-9(H4) is the major menaquinone; iii) C15:0 anteiso, 
C16:0 iso and C15:0 iso are usually the predominant cellular fatty acids; iv) phosphatidylcholine (PC) is the 
major polar lipid; and v) the DNA G + C content is typically 67 – 71.3 mol% (Evtushenko & Krausova, 2012)  
At the time of writing, the genus is comprised of 24 species with validly-published names according to the 
list of prokaryotic names with standing in nomenclature (LPSN) (http://www.bacterio.net/kribbella.html). 
Recently published species names that have not yet been validated are ‘Kribbella podocarpi’ strain YPL1T 
(KM382222) (Curtis et al., 2017), ‘Kribbella sindirgiensis’ strain FSN23T (JN896614) (Ozdemir‑Kocak et al., 
2017a), ‘Kribbella soli’ FMN22T (JN896613) (Ozdemir‑Kocak et al., 2017b), and ‘Kribbella qitaiheensis’ 
NEAU-GQTH2-3T (NR148308) (Guo et al., 2015). The majority of Kribbella species have been isolated from 
soil (Trujillo et al. 2006) with some species being described as endophytes of various plant species 
(Kaewkla & Franco, 2016; Kaewkla & Franco, 2013; Trujillo et al., 2006; Song et al., 2004; Curtis et al., 
2017). 
Recent advancements in the genus include the MLSA of five concatenated housekeeping genes to refine 
the phylogeny of the Kribbella genus (Curtis & Meyers, 2012). The MLSA built on the gyrB gene work of 
Kirby et al. (2010) and demonstrated the potential for a concatenated sequence of five housekeeping genes 
(gyrB-rpoB-recA-relA-atpD) to be used in determining the phylogenetic relationships of species within the 
genus Kribbella and underpin taxonomic conclusions. This work by Curtis & Meyers (2012) showed that 
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the gyrB, rpoB, recA, relA and atpD genes share 100% gene sequence similarity between the type strain 
and non-type strains of the same species.  
The aims of this chapter are three-fold: i) to determine the antibiotic biosynthetic potential of selected 
actinobacterial isolates to produce ansamycin, glycopeptide, non-ribosomal peptide and Type-II (aromatic) 
polyketide antibiotics; ii) to extract the antibiotics from strains PR3, SK5, UK1 and Y30 and analyse the 
crude extracts for activity against M. aurum A+, Staphylococcus aureus ATCC 25923, and Escherichia coli 
ATCC 25922 with emphasis on strain SK5; and iii) to determine the taxonomic position of strain SK5 within 
the genus Kribbella using a polyphasic taxonomic approach. 
A polyphasic taxonomic approach compares multiple features of a microbe to known species to attain a 
more robust description of the proposed novel species (Busse et al., 1996; Ludwig, 2007). The different 
features assessed in this study were genotypic, phenotypic and chemotaxonomic characters. Genotypic 
analysis allows for the identification of an isolate to the genus level and assessment of potential novelty 
based on one gene (such as the 16S rRNA gene) or a concatenated sequence of housekeeping genes. 
The analysis of an MLSA performed by a previous student in the lab (Dr Sarah M. Curtis) provided strong 
evidence that strain SK5 represents a new species in the genus Kribbella. A series of phenotypic tests were 
used to differentiate strain SK5 from the type strains of the most closely related known species (determined 
from the MLSA) and chemotaxonomic analyses were performed to confirm that strain SK5 has 
chemotaxonomic markers that are consistent with membership of the Kribbella genus. Strain SK5 was 
selected for characterization because it demonstrated very strong antibiotic activity against M. aurum A+ 





3.3 Methods & Materials 
3.3.1 Antibiotic biosynthetic potential 
3.3.1.1 PCR amplification 
DNA was extracted as described in section 2.3.3.1. 
Primers specific to antibiotic biosynthetic gene clusters were used to assess the antibiotic biosynthetic 
potential of select isolates to produce Type-II (aromatic) polyketide, ansamycin (Type-I polyketide), 
glycopeptide, and non-ribosomal peptide (NRP) antibiotics. Primer pairs are listed in Table 6. Type-II 
(aromatic) polyketides were detected by the amplification of the polyketide synthase gene pair, keto 
synthase alpha (KSα) and ketosynthase beta (KSβ). Ansamycins were detected by amplification of a 
section of the 3-amino-5-hydroxy-benzoic acid (AHBA) synthase gene. Glycopeptide antibiotics were 
detected by amplification of the glycopeptide monooxygenase B (oxyB) gene. NRP antibiotics were 
detected by amplification of conserved motifs of adenylation (A) domains of non-ribosomal peptide 
synthetase (NRPS) genes. 
 
Table 6: PCR primers used to identify the presence or absence of key antibiotic biosynthetic gene clusters to determine the antibiotic 
biosynthetic potential of environmental actinobacterial isolates. ‘F’ denotes a forward primer and ‘R’ denotes a reverse primer. I = 
Inosine. Matching colours indicates primer pairs.  
 
PCR was performed in 50 μL reactions with the following components: 2 mM MgCl2, 150μM of each dNTP, 
0.5 μM of each primer (1.5μM for NRPS PCR), 1U Super-Therm Taq polymerase (JMR Holdings, USA), 
and ~500ng/μL of template DNA. Table 7 shows the PCR programmes used to amplify the different genes. 
PCR products were electrophoresed on 0.8% agarose gels containing 0.8μg/mL EtBr. PstI-digested λ DNA 







Primer Primer sequence Expected fragment size (bp) Reference 
ARO-PKS-F 5’-GGCAGCGGITTCGGCGGITTCCAG-3’ 
492 – 630 Wood et al., 2007 
ARO-PKS-R 5’-CGITGTTIACIGCGTAGAACCAGGCG-3’ 
ANSA-F 5’-CCSGCSTTCACSTTCATCTC-3’ 
640 Wood et al., 2007 
ANSA-R 5’-AISYGGAICATIGCCATGTAG-3’ 
Foxy 5’-CTGGTCGGCAACCTGATGGAC-3’ 
590 Wood et al., 2007 
Roxy 5’-CAGGTACCGGATCAGCTCGTC-3’ 
A3F 5’-GCSTACSYSATSTACACSTCSGG-3’ 




 Table 7: PCR programmes for the amplification of key genes within antibiotic biosynthetic gene clusters. 
 
3.3.1.2 Sequencing and blastn analysis 
The same steps were followed as in section 2.3.3.3, with the exception that the sequencing primers used 
were dependent on the primers used in the PCR and the resulting sequences were compared to the 
GenBank database using a basic blastn search 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch). 
 
3.3.2 Organic compound solvent extraction 
Bacterial cultures were grown in small volumes of broth, prior to upscaling to a larger volume, for more cell 
mass and thus antibiotic production. Initial cultivation was in 250 mL Erlenmeyer flasks containing 15 mL 
ISP2 medium at 30°C, with shaking, for four days, or until sufficient cell mass had accumulated. The 15-
mL culture was inoculated into a 1 L Erlenmeyer flask containing 100 mL ISP2 broth and incubated for 
another 10 days at 30°C, with shaking, to allow for the production of antibiotic/s. The purity of the cultures 
was assessed by Gram stain and streaking for single colonies on ISP2 agar. 
The cell mass was separated from the broth by filtering the culture through a paper coffee filter (size 102, 
House of Coffees). Methanol (MeOH) was added to the cell mass in a beaker such that the cells were 
completely submerged. The beaker was covered with foil and placed on a shaker (120 rpm) at room 
temperature for one hour to extract organic compounds from the cell mass into the MeOH. The cell mass 
was separated from the cell mass extract (in MeOH) by filtering through a paper coffee filter into a 250 mL 
glass beaker and the cell mass extract was evaporated to dryness in a fume hood. The dried cell mass 
extract was concentrated by a factor of 19.2 by dissolving in 6 mL MeOH and transferred to 3 X 2 mL 
microfuge tubes before being evaporated to dryness in a fume hood. The dried cell mass extract was 
weighed and stored in the microfuge tubes at -20°C. Ethyl acetate (EtOAc) was added to the culture broth 
at a third of the total culture volume (approximately 30 mL) in a separating funnel. The mixture was shaken 
vigorously to extract mid-polarity organic compounds from the culture broth into the EtOAc, then left to 
Step Temperature (°C) Time 
  
Aromatic, 
oxyB, AHBA          NRPS  
1. (Initial denaturation) 96 2 min 5 min 
2. (Denaturation) 96 45 s 30 s 
3. (Annealing) 56 (AHBA), 60 (oxyB), 64 (Aromatic & NRPS) 30 s 90 s 
4. (Extension) 72 2 min 4 min 
5. (Final extension) 72 5 min 10 min 
6. (Hold) 20 20 min 20 min 
Steps 2 to 4 were repeated for 30 cycles 
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stand for one hour to allow the aqueous and organic phases to separate. The aqueous phase was then 
drained into a glass beaker and the organic solvent layer was poured into a separate glass beaker and 
covered with foil. The extraction of the culture broth was repeated twice (i.e. three extractions altogether) 
to ensure maximum organic compound extraction. The three EtOAc extracts were pooled, mixed vigorously 
and left overnight in the separating funnel. The aqueous phase was discarded and the organic phase was 
dispensed into a 250 mL glass beaker and evaporated to dryness in a fume hood. The dried culture broth 
extract was concentrated by a factor of 19.2 by dissolving in 6 mL EtOAc and transferred to 3 X 2 mL 
microfuge tubes before being evaporated to dryness in a fume hood. The dried culture broth extract was 
weighed and stored in the microfuge tubes at -20°C. The extracts were tested for activity against different 
test bacteria by spot bioautography (Betina, 1973). 
 
3.3.3 Spot bioautography 
Each of the 2 mL microfuge tubes, containing the dried down and concentrated cell mass and culture broth 
crude extract fractions (see section 3.3.2) were re-dissolved in 500 µL MeOH (cell mass crude extract) or 
500 µL EtOAc (culture broth crude extract). The spot tests were performed by pipetting 5µL of crude extract 
from each of the concentrated factions, separately, onto a silica TLC plate (Merck 1.05554.0001). The TLC 
strips were left for approximately 5 min to allow the solvents to evaporate. The tests were repeated with 
10µL of crude extract if weak or doubtful activity was initially observed.  
Extracts obtained as described in section 3.3.2 were tested for activity against test bacteria M. aurum A+, 
E. coli ATCC 25922 and S. aureus ATCC 25923 using bioautography. The test bacteria were grown 
overnight at 37°C, with shaking, in universal glass bottles (standard containers) containing 5 mL 2YT broth. 
The purity of the cultures was confirmed by Gram stain and streaking for single colonies on 2YT agar. The 
optical density of the test bacterial cultures was determined as described in section in 2.3.2 and each culture 
was diluted to an OD600nm of 0.5 with sterile 2YT broth. Sterile non-absorbent cotton wool was used to dab 
the diluted test bacterial culture onto the silica TLC plates containing the dried extracts. The silica plates 
were then placed in a sealed plastic container with damp paper towel and left overnight (14-18 hours) at 
37°C. Sterile non-absorbent cotton wool was then used to dab on a 0.25% solution of thiazolyl blue 
tetrazolium bromide (MTT) (Sigma; M2128) that was prepared in phosphate buffered saline (1.78g 
Na2HPO4; 8.50g NaCl; 1l distilled water; pH 7.3). The MTT-treated TLC plate was left at 37°C for one hour 
or until a colour change was observed. MTT is reduced to an insoluble formazan derivative in the presence 
of actively respiring cells. Upon reduction, MTT turns from yellow to blue/purple, so the entire TLC is 
expected to turn blue/purple. A positive result for antibiotic activity is indicated by a lack of colour change 
at the sites where the extracts were applied to the TLC plate. The silica plates (developed bioautograms) 




3.3.4 Thin layer chromatography 
Five (5) -10 µL of crude antibiotic extract (amount dependent on the antibiotic strength of the extract) was 
placed on a 1.5 X 8 cm long silica TLC plate and the solvents were allowed to evaporate in a fume hood. 
A line was drawn 1.5 cm from the end of the silica plate with a pencil to mark where the extract should be 
placed (the chromatography origin). Concurrently, a TLC chamber was set up with the appropriate organic 
solvent (the mobile phase) in a 250-mL glass beaker containing solvent saturation pads (Gelman Instrument 
Company, Ann Arbor, Michigan) as a wick, and foil to cover the beaker (to limit the evaporation of the 
solvent from the beaker). The volume of solvent added was such that the bottom 0.5cm of the silica TLC 
plate was submerged in the solvent (e.g. 20 mL solvent in a 250-mL beaker). The TLC chamber was set 
up 30 min prior to performing the chromatography to develop a solvent-saturated atmosphere in the beaker 
(to limit the evaporation of the mobile phase directly from the TLC plate during chromatography). 100% 
EtOAc and 100% MeOH were the two mobile phases used. The silica TLC plates (with the concentrated 
extracts loaded at the origin) were placed in the TLC chamber and the solvent allowed to run up the plate 
until it was 0.5cm from the top of the plate. The plate was removed and the solvent allowed to evaporate in 
the fume hood. Bioautography was performed on the TLC plate as in section 3.3.3. 
Two-dimensional (2D) TLC was performed on the extracts using EtOAc as the first-dimension mobile phase 
and MeOH as the second-dimension mobile phase. An 11.5-by-11.5cm silica TLC plate was used and a 
10-by-10cm square was marked with pencil within. Five (5) -10 µL of extract (amount dependent on the 
antibiotic strength of the extract) was placed on the silica TLC plate at one corner of the 10-by-10cm square 
and the direction of development was marked with an arrow. A saturated TLC chamber was created, as 
described above, and the silica TLC plate containing the dried extract was placed in the chamber containing 
EtOAc for the first-dimensional run until the solvent reached the 10cm mark. The plate was removed and 
the solvent allowed to evaporate in a fume hood. The TLC plate was rotated 90° and then the second 
dimension was developed in the TLC chamber containing MeOH as the mobile phase. Bioautography was 
performed on the TLC plate as described in section 3.3.3. Cerium (IV) ammonium sulphate (CAS) (63g of 
Ce(NH4) SO4, initially dissolved in 500ml of 1M H2SO4 and made up to a final volume of 1L with deionised 
water) was dabbed on to a second 2D TLC plate of the same crude extract, using sterile non-absorbent 
cotton wool, and then heated at 110°C to note how many organic compounds are present (visible as brown 
spots on the TLC plate). 
 
3.3.5 Testing for antiplasmodial activity 
The crude cell mass and culture broth extracts were also screened for antiplasmodial activity against 
Plasmodium falciparum strain NF54 (chloroquine sensitive) by Mr. Daniel Watson (PhD student, 
Department of Clinical Pharmacology, University of Cape Town). Using a modified method of Trager & 
Jensen (1976), the asexual erythrocyte stages of P. falciparum were maintained as continuous in vitro 
80 
 
cultures. The in vitro antiplasmodial efficacy was determined by the parasite lactate dehydrogenase (pLDH) 
assay, using a modified method of Makler et al. (1993). The crude extracts were tested in quadruplicate, 
twice, using chloroquine and artesunate as the positive controls for antiplasmodial activity. 
 
3.3.6 Characterisation of strain SK5 
3.3.6.1 Genotypic characterisation 
3.3.6.1.1 16S rRNA gene sequence amplification 
Genomic DNA was extracted as described in section 2.3.3.1 and the 16S rRNA gene sequence was 
amplified via PCR as described in section 2.3.3.2. 
 
3.3.6.1.2 Phylogenetic analysis 
The 16S rRNA gene phylogeny was constructed as described in section 2.3.3.4.1. 
 
3.3.6.1.3 Multilocus sequence analysis 
Multilocus sequence analysis (MLSA), to compare strain SK5 to all described species in the Kribbella 
genus, was performed by Dr. Sarah M. Curtis as per Curtis & Meyers (2012). Five housekeeping genes 
were used: gyrB, rpoB, recA, relA and atpD. Genetic distances were calculated using the Kimura 2-
parameter model in MEGA 6 (Curtis & Meyers, 2012). The gyrB, rpoB, recA, relA and atpD gene sequences 
were determined by Ms Marli de Kock (a former intern in the research group) and the author. 
 
3.3.6.2 Phenotypic characterisation 
3.3.6.2.1 Colony morphology and pigmentation 
The colour of the aerial and substrate mycelia and the presence of any diffusible pigments were assessed 
using the following ISP media: inorganic salts-starch agar (ISP4; colour of substrate and aerial mycelia), 
ISP5 (production of a diffusible pigment), and ISP6 and ISP7 (production of melanin). These ISP media 
were prepared according to Shirling &Gottlieb (1966) and the cultures were incubated at 30°C for 7 days. 
General morphological features (aerial mycelium, colony shape and branching pattern of hyphae) was 
determined on ISP2 agar. 
3.3.6.2.2 Physiological characterisation 
To determine whether strain SK5 belongs to a novel species, physiological testing was done in parallel with 
the strain’s closest genomic relatives that were selected based on the 16S rRNA gene and MLSA 
phylogenetic trees. See Table 8 for the list of type strains used. 
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Table 8: Type strains of the closely related Kribbella species                    
used in the physiological comparison to strain SK5. 
 
 
For testing compounds as sole carbon sources, a basal mineral salts agar (BMSA) was prepared according 
to Shirling & Gottlieb (1966). Carbon sources utilised by strain SK5 were determined as per the methods 
of Shirling & Gottlieb (1966). Carbon sources were filter sterilised separately and then added to the BMSA 
at a final concentration of 1% (w/v). Strain SK5 and the type strains listed in Table 8 were inoculated onto 
the agar plates and the presence or absence of growth was recorded every 7 days for 21 days at 30°C. 
Nitrogen sources utilised by strain SK5 were determined as per the methods of Williams et al. (1989). All 
nitrogen sources were filter sterilised separately and then added to the BMSA (for nitrogen sources) at a 
final concentration of 0.1% (w/v). Strain SK5 and the type strains in Table 8 were inoculated onto the agar 
plates and the presence or absence of growth was recorded after 15 days at 30°C. 
The remaining physiological tests were performed as per the methods of Williams et al. (1989). Growth in 
the presence of inhibitory compounds was determined on Bennett’s medium (Atlas, 2004) and observed 
after 14 days at 30°C. Growth in the presence of NaCl was determined on Bennett’s medium with 3%, 4%, 
5% and 6% (w/v) NaCl after 14 days at 30°C. Degradation of adenine, allantoin, arbutin, guanine, 
hypoxanthine, Tween 80, L-tyrosine and xanthine were determined on modified Bennett’s medium (Locci, 
1989) after 21 days at 30°C. Degradation of urea was determined after 14 days growth at 30°C, based on 
the methods by Williams et al. (1989). Degradation of gelatin was determined on modified Bennett’s 
medium after 7 days at 30°C. Hydrolysis of pectin was determined after 7 days growth at 30°C, based on 
the methods by Williams et al. (1989). The pectin hydrolysis medium was prepared as in Locci (1989). 
Hydrolysis of DNA was determined using Difco DNase medium (prepared according to the manufacturer’s 
instructions) after 7 days growth at 30°C by flooding the plates with 0.25M hydrochloric acid. Growth at 
22°C, 30°C, 37°C and 40°C was determined on Bennett’s medium after 21 days. Growth at pH 4.3, 5, 7 
and 9 was determined after 21 days at 30°C on Bennett’s medium. 
Catalase and oxidase tests were done to determine whether strain SK5 possesses catalase and can 
produce cytochrome C oxidase, respectively. The presence of catalyse was determined by the observation 
of bubbles when cell mass was added to 10 µL of 9% hydrogen peroxide. Cytochrome C oxidase was 
confirmed to be present when filter paper saturated with 1% N, N, N′, N′-tetramethyl-p-phenylenediamine 
(TMPD) turned purple after the addition of cell mass. 
 
Strain Strain number 
Kribbella aluminosa  DSM18824T 
Kribbella karoonensis Q41T 
Kribbella pittospori NRRL B-248113T 
Kribbella shirazensis DSM45490T 
‘Kribbella soli’ KCTC 29219T 
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3.3.6.3 Chemotaxonomic characterisation 
3.3.6.3.1 Diaminopimelic acid analysis 
A 15 mL ISP2 broth medium was inoculated with strain SK5. After 4 days at 30°C the culture was transferred 
to a 100 mL ISP2 broth medium in a 1L Erlenmeyer flask. After another 4 days at 30°C, the culture was 
transferred to a 1L ISP2 broth medium in a 5 L Erlenmeyer flask. The cell mass from the 1 L culture was 
harvested after 10 days at 30°C by centrifugation at 12 000 rpm for 10 minutes (22 100 X g). A Gram stain 
and streak for single colonies confirmed no contamination. The cell mass was washed twice with 
approximately 20 mL sterile distilled water each time and then resuspended in 20 mL sterile distilled water 
in a round-bottom flask. The cell mass was freeze dried and weighed. The DAP isomer was determined 
using a method from Hasegawa et al. (1983), with the following alterations: dried cells were used instead 
of colonies from an agar plate and the solvent system was methanol/0.05 M potassium hydrogen phthalate 
buffer (pH 4) (2:1, v/v; Schön& Groth, 2006). TLC was performed on cellulose plates (MERCK; 
1.0552.0001) with a 1% commercial DAP standard (Sigma; D1377-5G). 
 
3.3.6.3.2 Whole-cell sugar pattern analysis 
The cell mass was prepared as described in section 3.3.6.3.1, and the whole cell sugar pattern (WCSP) 
was analysed based on the methods of Hasegawa et al. (1983). TLC was performed on cellulose plates 
(MERCK; 1.0552.0001) along with two different sugar standards: i) glucose, mannose, and ribose; each at 
1% (w/v); ii) galactose, arabinose, and ribose; each at 1% (w/v). The solvent system used was acetate-
pyridine-distilled water (100:35:25 v/v). 
 
3.3.6.3.3 Polar lipid analysis 
The cell mass was prepared as described in section 3.3.6.3.1 to extract the polar lipids, and their pattern 
was determined based on the methods of Komagata & Suzuki (1987) and Minnikin et al. (1984). Two-
dimensional TLC was performed and the polar lipids were detected using the following reagents: 1.3% 
molybdenum blue reagent (Sigma; M1942) for phospholipids, 1% (v/v) anisaldehyde (Sigma; A88107) for 
glycolipids, and 1% (w/v) ninhydrin (Merck; 6762) for aminolipids. The anisaldehyde stain was prepared as 
per http://lcso.epfl.ch/files/content/sites/lcso/files/load/TLC_Stains.pdf. The ninhydrin stain was prepared in 
99% ethanol. 
Chromatography for sections 3.3.6.3.1, 3.3.6.3.2, and 3.3.6.3.3 was performed in a TLC chamber prepared 
30 minutes in advance, as described in section 3.3.4.  
 
3.3.6.3.4 Menaquinone analysis 
The cell mass was prepared as described in section 3.3.6.3.1. The menaquinones were analysed by the 
Identification Service, DSMZ (Braunschweig, Germany) after extraction using the methods of Komagata & 
Suzuki (1987) and Minnikin et al. (1984).  
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3.3.6.3.5 Predominant fatty acids (FAME pattern) 
The dried cell mass was prepared as described in section 3.3.6.3.1. The FAME pattern analysis was carried 





3.4 Results & Discussion 
3.4.1 Antibiotic biosynthetic potential 
PCR amplification of conserved regions of core genes in antibiotic biosynthetic gene clusters implies the 
potential of the strain to produce the antibiotic being screened for. In the following sub-section, the potential 
for seven strains to produce Type-II polyketide, ansamycin, glycopeptide and non-ribosomal peptide 
antibiotics is assessed. These strains were chosen because they had moderate to very strong antibiotic 
activity against M. aurum A+ and were interesting phylogenetically (Chapter 2).  
The potential for strains M27, PR10, PR28, PR47, SK5, UK1, and Y10 to produce a Type-II polyketide by 
amplification of a DNA fragment from the tandem KSα and KSβ genes is shown in Figure 11. A band in the 
size range 492-630bp indicates a positive result. Strain Y10 does not have the potential to produce a Type-
II polyketide antibiotic, as indicated by no band on the gel. The amplified product of strain SK5 is smaller 
than the other strains (~ 340bp), suggesting that this was the result of off-target amplification by the PCR 
primers and that strain SK5 should be considered to have given a negative result for the presence Type-II 
polyketide biosynthetic genes. The PCR products with a band were prepared and sent for sequencing 
(section 3.3.1.2). Upon analysis of the chromatograms, the KSα-KSβ sequences for strains PR10, PR28 
and SK5 were messy, suggesting the presence of more than one KSα-KSβ sequence and thus more than 
one Type-II polyketide antibiotic biosynthetic gene cluster. The PCR was repeated with these strains and 
the PCR products were cloned into the pGEM-T-easy vector system (as per the manufacturer’s instructions) 
and then more than one clone was sequenced using the ARO-PKS-F primer. This ensured the sequencing 
of a single KSα-KSβ sequence at a time. Table 9 shows the results of a standard blastn search against the 
GeneBank database using the sequenced PCR amplified KSα-KSβ gene sequences of strains M27, PR10, 
PR28, PR47, and UK1. Strains PR10 and PR28 each had two cloned KSα-KSβ gene sequences. The two 
cloned KSα-KSβ gene sequences for strain PR10 sequences were identical (Table 9). The two cloned KSα-
KSβ gene sequences for strain PR28 sequences had different top hits and thus represent KSα-KSβ gene 
sequences from different Type-II polyketide antibiotic biosynthetic pathways (Table 9).  
The potential for strains M27, PR10, PR28, PR47, SK5, UK1, and Y10 to produce an ansamycin antibiotic 
by amplification of the AHBA synthase gene is shown in Figure 12. Only Micromonospora strain M27 
demonstrated the potential to produce an ansamycin antibiotic due to the presence of a band of 




























Figure 12: Gel electrophoresis to indicate the antibiotic biosynthetic potential of the strains to produce an ansamycin antibiotic with 
the detection of the AHBA gene by PCR using the primer pair ANSA-F & ANSA-R. 
1. strain UK1; 2. strain M27; 3. strain Y10; 4. PstI-digested λ molecular marker; 5. strain PR28; 6. strain PR47; 7. strain PR10; 8. 
strain SK5.  
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Figure 11: Gel electrophoresis to indicate the antibiotic biosynthetic potential of the strains to produce a Type-II polyketide antibiotic 
with the detection of the KSα-KSβ genes by PCR using the primer pair ARO-PKS-F & ARO-PKS-F. 
1. strain SK5; 2. strain PR47; 3. PstI-digested λ molecular marker; 4. strain PR28; 5. strain UK1; 6. strain PR10; 7. PstI-digested λ 


















The potential for strains M27, PR10, PR28, PR47, SK5, UK1, and Y10 to produce a glycopeptide antibiotic 
by the amplification of the oxyB gene is shown in Figure 13. Only Micromonospora strain M27 showed the 
potential to produce a glycopeptide antibiotic which is demonstrated by a band of approximately 600 bp, 
indicative of a positive result for the presence of the oxyB gene. The double band in Figure 13 could not be 
eliminated. Changing the PCR protocol led to no PCR product when the annealing temperature was 
increased and/or the MgCl2 concentration altered.  Thus, no sequence data for the oxyB gene from strain 
M27 could be obtained. 
The potential for strains M27, PR10, PR28, PR47, SK5, UK1, and Y10 to produce a non-ribosomal peptide 
antibiotic by amplification of the A domain is shown in Figure 14. Strains PR10, PR28, PR47, UK1, and Y10 
show the potential to produce a non-ribosomal peptide antibiotic due to the amplification of a DNA fragment 
of the expected size (approximately 700bp; Figure 14). PCR products were cloned into the pGEM-T-easy 
vector system (as per the manufacturer’s instructions) and the clones were sequenced using the 17-mer, 
M13F vector primer (5’-GTAAAACGACGGCCAGT-3’). Table 10 shows the results of a standard blastn 
search against the GeneBank database using the sequenced PCR amplified A domain sequences for 
strains PR10 (two different clones) and PR28 as well as the predicted substrate specificity of the A domains 
based on the NRPSpredictor2 software (Röttig et al., 2011; Rausch et al., 2005). The blastn top hits for the 
two cloned sequences of strain PR10 are different, implying the presence of least two different non-
ribosomal peptide biosynthesis pathways in this strain (Table 10). However, the substrates that the A 
domains would bind to, for the two strain PR10 clones, are predicted to be hydrophobic and aliphatic, with 
scores of 0.93 for clone one and 0.47 for clone two, according to NRPSpredictor2 (Table 10). The latter of 
the two scores is low and thus inconclusive. For strain PR28, the A domain is predicted to bind to a 
hydrophilic amino acid, albeit with a low score of 0.21 (Table 10). These substrate specificity predictions of 
the NRPS A domains should not be relied upon because of the low scores.  
An attempt was made to screen strains PR3 and Y30 for their antibiotic biosynthetic potential, but low-
quality DNA prevented this. The observed antibiotic activities of these strains (M27, PR10, PR28, PR47, 
SK5, UK1, and Y10) against M. aurum A+ could thus be attributed to one of the antibiotics that they have 
the demonstrated potential to produce. Knowing the type of antibiotic that a strain has the potential to 
produce can be useful for determining the appropriate extraction and purification techniques for that class 
of antibiotics (Wood et al., 2007). However, a positive PCR result only implies the potential for a strain to 
produce a specific type of antibiotic. There are important caveats to consider, such as the following false 
positives: the entire biosynthetic gene cluster may not be present and thus a functional antibiotic will not be 
made despite a positive result, or the biosynthetic gene cluster may be silent. There are also false negatives 
to consider, such as sequence variation in the primer binding site that will lead to a negative result. 
Additionally, one can only screen for the potential of a strain to produce known classes of antibiotics (Wood 
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Figure 14: Gel electrophoresis to indicate the antibiotic biosynthetic potential of the strains to produce a non-ribosomal peptide 
antibiotic with the detection of the A domain by PCR using the primer pair A3F&A7R. 










Figure 13: Gel electrophoresis to indicate the antibiotic biosynthetic potential of the strains to produce a glycopeptide antibiotic 
with the detection of the oxyB gene by PCR using the primer pair Foxy/Roxy. 
1. strain UK1; 2. strain M27; 3. strain Y10; 4. PstI-digested λ molecular marker; 5. strain PR28; 6. strain PR47; 7. strainPR10; 8. 
strain SK5.  
 










Table 9: Standard blastn search results against the GenBank database for the isolates that showed the potential to produce a Type-














Table 10: Standard blastn search results against the GenBank database for the isolates that showed the potential to produce a non-
ribosomal peptide antibiotic. 
  





Micromonospora aurantiaca ATCC 27029 
(CP002162) -  β -ketoacyl synthase 
98 425 
PR10 (clone 1) 
Streptomyces sp. 3124.6 (LT670819) 
minimal PKS ketosynthase (KS/KS alpha) 
minimal PKS chain-length factor (CLF/KS β) 
88 457 
PR10 (clone 2) 
Streptomyces sp. 3124.6 (LT670819) 
minimal PKS ketosynthase (KS/KS alpha) 
minimal PKS chain-length factor (CLF/KS beta) 
88 459 
PR28 (clone 1) 
Streptomyces antibioticus strain NRRL 3238  
oviedomycin biosynthetic gene 
cluster(KY129858) 
82 454 
PR28 (clone 2) 
Streptomyces venezuelae strain NRRL B-
65442 (CP018074) 
ketosynthase chain-length factor 
83 453 
PR47 
Streptomyces sp. strain MM19  




Streptomyces sp. CCM_MD2014, (CP009754) 
β -ketoacyl synthase 
99 422 










Streptomyces anulatusATCC 11523 
Actinomycin biosynthetic gene 
cluster(HM038106)   
82 650 






Streptomyces sp. strain MM108 non-
ribosomal peptide synthetase 3 (nrps3) 
gene(KX708387) 
75 604 
PR28 Small clusters: 
asp,asn 






3.4.2 Solvent extract activity 
3.4.2.1 Streptomyces species 
Streptomyces strains PR28, UK1, and Y30 were selected for solvent extraction of their antibiotics, because 
they had moderate to very strong antimycobacterial activity (Table 2) and were also phylogenetically 
interesting (see section 2.4.4.3). 
Solvent extraction was performed on both the cell mass (MeOH) and the culture broth (EtOAc) of each 







All three strains had activity in the cell mass extract and not the culture broth extract, implying that the active 
compounds were located within the cells and not excreted into the broth in high concentrations.   
Further study should be done on these crude extracts to assess their potential for future work. 
Bioautography against other test bacteria can be done to determine the specificity of the active compound/s. 
In addition, 1D TLC and 2D TLC can be done to determine whether there is more than one active compound 
present in the crude cell mass extract. TLC will also identify the retention factor (Rf) of the compounds under 
different solvent conditions, which will assist in purifying the active compound/s. 
 
3.4.2.2 Kribbella species (strain SK5): first extraction 
Strain SK5 was selected for solvent extraction of its antibiotic/s, because this Kribbella isolate exhibited 
very strong antimycobacterial activity, which is unusual for the genus (Table 2).  
Solvent extraction was performed on both the cell mass (MeOH) and the culture broth (EtOAc). The 
concentrated extracts were applied to silica TLC plates and subjected to spot test bioautography (Figure 
16).  
Figure 15: Bioautography of Streptomyces strains PR28, UK1, and Y30 cell mass and culture broth extracts against test bacterium 
M. aurum A+. 1. strain Y30 cell mass extract; 2. strain Y30 culture broth extract; 3. strain UK1 cell mass extract; 4. strain UK1 
culture broth extract; 5. strain PR28 cell mass extract; 6. strain PR28 culture broth extract. 
5 6 3 4 1 2 
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Activity was observed in the cell mass extract against M. aurum A+, implying that the active compounds 
are located within the cells and not excreted into the broth in high concentrations (Figure 16). To assess 
the specificity of the antibiotic compound/s, the activity of strain SK5’s cell mass extract and culture broth 
extract were tested against two other test bacteria, namely E. coli ATCC 25922 (Gram negative) and S. 
aureus ATCC 25923 (Gram positive). Both the cell mass and culture broth extracts did not display any 
activity against E. coli ATCC 25922, but the cell mass extract did exhibit activity against S. aureus ATCC 





1D TLC was done on strain SK5’s crude cell mass extract to determine how many active compounds were 
present (Figure 17). This method also provides the Rf value of each active compound, giving valuable 
information for future work when purifying the active compound/s. However, these results could not be 
replicated. Each time a crude extract was obtained, one round of spot test bioautography could be done 
before the extract lost activity, despite care taken to ensure that the extract was not out of the freezer (-
20°C) for long periods at a time. This was repeatedly observed over a set of 6 extractions and is indicative 
of a labile compound. It is important to note that the strain SK5 culture used in this set of extractions was 
incubated at a time when the 30°C incubator was experiencing fluctuating temperatures. The incubator 
would occasionally drop to ~25°C throughout the day for the entire incubation period. The temperature did 







Figure 17: 1D thin layer chromatography, with different solvent systems, on the cell mass extract of strain SK5, which was then 
subjected to bioautography against the test bacterium M. aurum A+. 1. 100% hexane as the mobile phase; 2. 100% EtOAc as the 
mobile phase; 3. 100% MeOH as the mobile phase.  
Arrows mark the active spot with the Rf value displayed at the side. 
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Figure 16: Initial spot test bioautography results for the Kribbella strain SK5 cell mass and culture broth solvent extracts against 
different test bacteria. 1. cell mass extract activity against M. aurum A+; 2. culture broth extract activity against M. aurum; 3. cell 
mass extract activity against E. coli ATCC 25922; 4. culture broth extract activity against E. coli ATCC 25922; 5. cell mass extract 
activity against S. aureus ATCC 25923; 6. Culture broth extract activity against S. aureus ATCC 25923. 




3.4.2.3 Kribbella species (strain SK5): second extraction 
The activity of strain SK5’s crude cell mass and culture broth extracts were assessed once again when the 
incubator was restored to a constant temperature (30°C). Very interestingly, the location of activity (cell 
mass vs culture broth) changed when the solvent extraction took place with an SK5 culture that had been 
grown at a constant temperature of 30°C for the entire incubation period (Figure 18). Antibiotic activity 
against M. aurum A+ and S. aureus ATCC 25923 was recorded in the culture broth extract, and no longer 
in the cell mass extract (Figure 18). As before, activity was not recorded against E. coli ATCC 25922 (data 
not shown). In addition to the change in location of the active compound/s, the activity was stable. This is 
the first piece of evidence that the compound/s is not the same as what was previously extracted when the 
incubator thermostat was faulty (because the active compound/s is not labile), which implies that strain SK5 
can make more than one antimycobacterial compound. The environment in which the bacteria grow has a 
huge impact on the biosynthesis of secondary metabolites. The availability of nutrients, nutrient 
composition, and changes in growth conditions in general can affect the production of antibiotics (Martin & 






Concurrently, strain SK5 was also grown at room temperature (~22°C) prior to solvent extraction, as 
described in section 3.3.2, to determine whether any changes in activity could be attributed to changes in 
growth temperature. When strain SK5 was grown at room temperature (~22°C) over the entire incubation 
period, activity against M. aurum A+ and S. aureus ATCC 25923 was also recorded in the culture broth 
extract and not in the cell mass extract (Figure 19). This is the same activity profile that was observed with 
the crude extract from the strain SK5 culture that was incubated at a constant temperature of 30°C for the 
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Figure 19: Bioautography of the cell mass and culture broth solvent extracts of strain SK5 against the test bacteria M. aurum A+ 
and S. aureus ATCC 25923. Strain SK5 was incubated at 22°C prior to solvent extraction 1. culture broth extract activity against 
M. aurum A+; 2. cell mass extract activity against M. aurum A+. 3. culture broth extract activity against S. aureus ATCC 25923; 4. 
cell mass extract activity against S. aureus ATCC 25923.  
Figure 18: Bioautography of the cell mass and culture broth solvent extracts of strain SK5 against test bacteria M. aurum A+ and 
S. aureus ATCC 25923. Strain SK5 was incubated at 30°C prior to solvent extraction. 1. culture broth extract activity against S. 
aureus ATCC 25923; 2. cell mass extract activity against S. aureus ATCC 25923; 3. culture broth extract activity against M. aurum 
A+; 4. cell mass extract activity against M. aurum A+.  
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However, the same location of activity (cell mass vs culture broth) does not mean that the compounds being 
produced are the same. Thus, 1D TLC and bioautography against M. aurum A+ and S. aureus ATCC 25923 
on both crude culture broth extracts (22°C culture and 30°C culture) were done to note the number of active 
compounds and their respective Rf values (Figure 20). These TLC data will illustrate whether the active 
compounds in the different crude culture broth extracts are the same (22°C culture and 30°C culture), as 
well as whether the activity against M. aurum A+ and S. aureus ATCC 25923 are caused by the same 
active compound/s. The 1D TLC profiles across all the solvent runs were almost identical, regardless of 
where the crude culture broth extract was from (22°C culture vs 30°C culture) or what the test bacterium 
was (M. aurum vs S. aureus). The Rf values in a 100% EtOAc solvent system were 0.36-0.37 for all TLC 
runs, and the Rf values in a 100% MeOH solvent system were 0.73-0.75 for all TLC runs (Table 11; Figure 
20). These Rf values are different to those observed in Figure 17, which showed the TLC results of the 
culture broth extract after the SK5 culture was incubated during fluctuating temperatures. These results 
imply four things: i) growing the culture at a constant temperature of 22°C or 30°C does not change the 
number of active compounds produced against M. aurum A+ and S. aureus ATCC 25923; ii) the same 
active compound is produced whether the culture incubation temperature is stable at 22°C or 30°C; iii) this 
active compound (Rf = 0.36-0.37 in 100% EtOAc) is active against both M. aurum A+ and S. aureus ATCC 
25923; and iv) the active compound produced during incubation at a fluctuating temperature is different to 
that of the active compound produced under a stable incubation temperature, as concluded from the 
differing Rf values (Table 11). It should be borne in mind that the incubation temperature range when the 
incubator thermostat was faulty was 25-30°C and that the two constant cultivation temperatures were 22°C 
and 30°C, as the facilities to incubate at a constant temperature of 25°C were not available. However, given 
that the same antibiotic was produced at 22°C and 30°C, it seems that it is not the incubation temperature 
alone that determines which antibiotic is produced, but rather the variation in the incubation temperature 
over time during cultivation (i.e. the temperature profile). As there is no record of the temporal variation in 
the incubation temperature while the incubator thermostat was faulty, it would probably be impossible to 
reproduce the conditions required for strain SK5 to produce the antibiotic with an Rf of 0.56 (100% MeOH). 
 
Table 11: Summarised Rf values of the active compound/s for the cell mass and culture broth extracts from the first and second 
extractions against test bacteria M. aurum A+ and S. aureus ATCC 25923. The numbers in brackets indicate the temperature that 
strain SK5 was incubated at prior to solvent extraction as described in 3.3.2.  
 
Extract Test bacterium Solvent system Rf value 
First extraction – Fluctuating incubation temperatures (~25°C to ~30°C) 
Cell mass extract  M. aurum A+ 100% EtOAc 0.4 & 0.54 
Cell mass extract  M. aurum A+ 100% MeOH 0.56 
Second extraction – Stable incubation temperatures 
Culture broth extract (22°C) M. aurum A+ 100% EtOAc 0.37 
Culture broth extract (30°C) M. aurum A+ 100% EtOAc 0.37 
Culture broth extract (22°C) M. aurum A+ 100% MeOH 0.72 
Culture broth extract (30°C) M. aurum A+ 100% MeOH 0.73 
Culture broth extract (30°C) S. aureus ATCC 25923 100% EtOAc 0.36 
Culture broth extract (30°C) S. aureus ATCC 25923 100% MeOH 0.73 
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It is well known that changes in nutritional factors and growth conditions can lead to varying secondary 
metabolite production (Tormo et al., 2003). The experiment to change the growth temperature was done to 
try and determine whether the lower temperature observed during the first few rounds of antibiotic extraction 
(when the incubator was not maintaining a stable temperature) was responsible for the change in location 
and identity of the active compounds produced. The Rf values show that the same active compound is 
made regardless of what the stable growth temperature is. The only difference between the extracts in 
section 3.4.2.2 and 3.4.2.3 is that they were extracted from cultures that were grown under fluctuating 
temperature conditions or stable temperature conditions, respectively. Thus, it is possible that the 
fluctuating temperatures led to a different stress response, which triggered the production of a different 
















Figure 20: Thin layer chromatography, with different solvent systems, on the culture broth extract of strain SK5, which was subjected 
to bioautography against the test bacteria M. aurum A+ (1 to 4) and S. aureus ATCC 25923 (5 & 6). Strain SK5 was subjected to 
different growth temperatures (22°C or 30°C) prior to extraction which are indicated in the following: 1. 100% EtOAc as the mobile 
phase – incubation temperature was 22°C; 2. 100% EtOAc as the mobile phase – incubation temperature was 30°C; 3. 100% 
MeOH as the mobile phase – incubation temperature was 22°C; 4. 100% MeOH as the mobile phase – incubation temperature 
was 30°C; 5. 100% EtOAc as the mobile phase – incubation temperature was 30°C; 6. 100% MeOH as the mobile phase – 
incubation temperature was 30°C. 
Arrows mark the active spot with the Rf value displayed at the side. 
OR is the origin. SF is the solvent front.  
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Two-dimensional TLC and bioautography with the test bacteria M. aurum A+ and S. aureus ATCC 25923 
were done to determine whether the single active spots observed in the 1D TLC are caused by a single 
compound or multiple compounds with very similar chromatographic behaviour (Figure 21A, 21B). 
Furthermore, a CAS stain was performed after a 2D TLC run to determine how many organic compounds 
are present in the crude extract, thus assessing the extract’s purity (Figure 21C). The CAS stain showed 
that there was no brown spot on the TLC plate corresponding to the antibacterial active spot. This suggests 
that the active molecule could not be oxidised by CAS. The CAS stain showed the presence of multiple 
brown spots with different Rf values (Figure 21C). To further purify the active compound, silica column 
chromatography can be carried out using the solvent systems already established. Preparative HPLC could 

















Figure 21: Two-dimensional TLC of the culture broth extract 
of strain SK5. A) bioautography of the TLC plate against 
test bacterium S. aureus ATCC 25923. B) bioautography of 
the TLC plate against test bacterium M. aurum A+. C) CAS 
stain of the TLC plate.  
 
*, indicates the origin of the cell mass extract.  
1. The first dimension run with 100% EtOAc.  
2. The second dimension run with 100% MeOH.  














3.4.2.4 Comparing strain SK5 crude extract to nocardamine 
The antibiotic/s produced by Kribbella strain SK5 were also analysed by Mr Kojo Acquah (PhD student, 
Department of Chemistry, University of Cape Town). The antibacterial molecules in the culture broth extract 
of strain SK5 were purified by HPLC. The structures of the compounds were elucidated using both 
spectrometric (High Resolution Liquid Chromatography Mass Spectrometry (HR-LCMS)) and spectroscopic 
(1D and 2D Nuclear Magnetic Resonance (NMR)) Spectroscopy. Several siderophores, including 
nocardamine and desferrioxamines were purified (personal communication, Kojo Acquah). Nocardamine 
was of particular interest, because it has been shown to have antimycobacterial activity (Kalinovskaya et 
al., 2011). Thus, to identify whether the active compound in the crude extract of strain SK5 prepared by the 
author was nocardamine, side-by-side spot bioautography analysis was done (Figure 22). As reported 
before, the culture broth extract has activity against both M. aurum A+ and S. aureus ATCC 25923. 
Nocardamine, on the other hand, only exhibits activity against M. aurum A+ (Figure 22). This implies that 
the active compound in the culture broth extract is not nocardamine. However, it may be that S. aureus 
ATCC 25923 is less susceptible to nocardamine than M. aurum A+ is and thus would require a greater 
amount of nocardamine for inhibitory activity to be seen. Side-by-side 1D TLC of nocardamine and the 
strain SK5 crude antibiotic extract, followed by bioatography against M. aurum A+, will show whether the 
Rf value of nocardamine is the same as the Rf value of the active compound in the crude culture broth 
extract.  
If it is shown that the active compound from the culture broth is not nocardamine, then another round of 
scaled-up purification will need to be done to start purifying the active compound. Structural analysis will 






3.4.3 Testing for antiplasmodial activity 
Malaria is a severe disease, caused by the Plasmodium parasite, which was responsible for 445 000 deaths 
worldwide in 2016 (http://www.who.int/malaria/en/). Despite major efforts to reduce the incidence of malaria 
since the 1990’s, the impact of malaria is still severe, particularly amongst children. The WHO recommends 
artemisinin based combination therapies (ACTs) as the first line of treatment for malaria, because of their 
efficacy. However, as with M. tuberculosis, resistance to the current front-line drugs leads to the dire need 
Figure 22: Bioautography of the culture broth extract against 1. M. aurum A+ and 2. S. aureus ATCC 25923. Spot bioautography of 
purified nocardamine from the culture broth extract against 3. M. aurum A+ and 4. S. aureus ATCC 25923.  
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for novel compounds that may be partnered with or replace the current ACTs. It is for this reason that a 
UCT PhD student in the Department of Clinical Pharmacology, Faculty of Health Sciences (Mr Daniel 
Watson), is looking at actinobacteria as a source of natural products that can be used to treat malaria.  
Three Streptomyces strains isolated in this study (PR3, SK5, and UK1) were analysed for antimalarial 
activity by Daniel Watson (as described in section 3.3.5) against the chloroquine sensitive strain P. 
falciparum NF54. The IC50 (ng/mL) was determined for the crude cell mass and culture broth extracts. The 
IC50 is the concentration needed to kill half of the parasite population. It was found that strain PR3 had the 
strongest antimalarial activity in the cell mass extract (IC50 = 39 ± 5 ng/mL) with slightly weaker activity (but 
still strong) in the culture broth extract (Table 12). Strain UK1 only showed antimalarial activity in the cell 
mass extract, while strain SK5 exhibited no antimalarial activity in either extract (Table11). The activities of 
the positive controls used (chloroquine and artesunate) were within the accepted range of activity against 
P. falciparum NF54 (Appendix B).  
 
Table 12: Antiplasmodial activity of select actinobacterial crude extracts against Plasmodium falciparum NF54.  
n/a: No activity. 
P. falciparum NF54 
IC50 (ng/mL) 
Strain SK5 Strain PR3 Strain UK1 
Cell Mass (Ethyl Acetate) n/a 39 ± 5 298 ± 4 
Culture Broth (Ethyl Acetate) n/a 56 ± 5 n/a 
The promising activities demonstrated by strains PR3 and UK1 are being investigated by Mr Watson in his 
PhD studies. The low IC50 values are indicative of good hits that have the potential to be drug candidates. 
Pink et al. (2005) stated that one of the criteria for antiplasmodial drug discovery is that the crude extract 
should have in vitro activity against whole protozoa of ≤ 1µg/mL (≤ 1000ng/mL). Upscaling of growth to 
extract more material and then purification of the active compound/s is necessary so that concentrated 
fractions can be tested. The structure/s of these strong active compound/s can then be elucidated. If these 
compound/s prove to be novel (or are molecules with known structures that were not known to be active 
against Plasmodium species), they can be pursued further as potential drug leads.  
 
3.4.4 Characterisation of Kribbella strain SK5 
3.4.4.1 Phylogenetic characterisation 
 
3.4.4.1.1 16S rRNA gene phylogeny 
The closest relatives of strain SK5 based on an EzBioCloud blastn analysis of the 16S rRNA gene 
sequences were Kribbella karoonensis Q41T (99.72%), ‘Kribbella soli’ FMN22T (99.59%), Kribbella 
shirazensis UTMC693T (99.57%), Kribbella swartbergensis HMC25T (99.36%), Kribbella aluminosa 
HKI0478T (99.29%), Kribbella hippodromi S1.4T (98.99%), Kribbella ginsengisoli Gsoil001T (98.82%), 
Kribbella jejuensis HD9T (98.76%), Kribbella solani DSA1T (98.75%), and Kribbella pittospori PIP158T 
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(98.74%). ‘K. sindirgiensis’ FSN23T (Ozdemir‑Kocak et al., 2017a; JN896614; 98.61%) and ‘K. podocarpi’ 
YPL1T (Curtis et al., 2017; KM382222; 99.59%), which are in the same clade as strain SK5 (Figure 23), did 
not appear in the blastn search. Interestingly, ‘K. sindirgiensis’ has a particularly low 16S rRNA gene 
sequence similarity to strain SK5 (98.61%).  
 
The phylogenetic position of strain SK5 within the genus Kribbella was determined via the construction of 
a maximum likelihood tree using the 16S rRNA gene sequences (Figure 23). The closest relatives based 
on the 16S rRNA gene phylogeny were K. shirazensis, ‘K. soli’, K karoonensis, and ‘K podocarpi’ with low 
bootstrap support (58%). K. jejuensis, K. aluminosa, and ‘K. sindirgiensis’ were on the periphery of the 
strain SK5 clade, however with low bootstrap support (67%). This low bootstrap support implies that the 
clustering may change when additional strains are added to the tree. The asterisk at the node uniting these 
strains indicates that the overall topology of the clade is conserved, but the positions of the species within 
the clade vary between the neighbour-joining and maximum likelihood trees. High sequence similarity is 
observed in the 16S rRNA gene sequences amongst closely related species. Thus, other genes should 
also be assessed which have a higher rate of change over time.  
 
3.4.4.1.2 MLSA 
To obtain a more robust phylogenetic comparison of strain SK5 to the known members of the Kribbella 
genus, a phylogenetic tree based on the concatenated sequences of five housekeeping genes (gyrB, rpoB, 
recA, relA, and atpD) was constructed (Figure 24).  
Strain SK5 grouped with ‘K. sindirgiensis’ and ‘K. soli’ with very strong bootstrap support (100%) (Figure 
24). The genetic distances between the concatenated sequences of the different Kribbella type strains were 
calculated by Dr Sarah Curtis, as described in Curtis & Meyers (2012). Curtis & Meyers (2012) proposed 
that a genetic distance threshold be used as a species delineation tool. Kirby et al. (2010) first noted that a 
genetic distance of 0.04 was sufficient to distinguish between species when using the gyrB gene. Using the 
five-concatenated genes, it was noted that all Kribbella type strains could also be distinguished by a genetic 
distance of 0.04 (Curtis & Meyers, 2012). A genetic distance greater than 0.04 implies a DNA relatedness 
of less than 70% by DDH. The genetic distances revealed that the type strains of ‘K. sindergiensis’ and ‘K. 
soli’ are very closely related to strain SK5, with values of 0.016 and 0.024, respectively (Table 13). As these 
genetic distance values are below 0.04, DDH will be required to determine whether strain SK5 belongs to 
a different genomic species to ‘K. sindergiensis’ and ‘K. soli’. The low genetic distance value of the 
housekeeping genes between strain SK5 and ‘K. sindirgiensis’ is interesting, because the 16S rRNA gene 
sequence similarity between the two (98.61%) suggested that DDH is not required to distinguish strain SK5 
from ‘K. sindirgiensis’ because the sequence similarity is less than 98.7% (Meier-Kolthoff et al. 2013). 
However, due to the low genetic distance value calculated (0.016), DDH will need to be done to confirm 
that strain SK5 belongs to a unique genomic species. However, because strain SK5 has a concatenated 
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gyrB-rpoB-recA-relA-atpD sequence that is not identical to any of the type strains of known Kribbella 
species, one can deduce (with reasonable confidence) that strain SK5 represents a novel species in the 
genus Kribbella, because Curtis & Meyers (2012) reported that the gyrB, rpoB, recA, relA and atpD genes 
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Figure 23: Maximum likelihood tree of the Kribbella genus using partial 16SrRNA gene sequences of 1329bp. Bootstrap values were 
calculated from 1000 resampled datasets. Bootstrap values above 70% are shown. Asterisks indicate topological conservation between 
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Figure 24: Phylogeny of the Kribbella genus using a five-gene concatenated sequence (gyrB, rpoB, recA, relA, and atpD) based on the 
maximum likelihood method.  The total concatenated sequence length was 4099bp. Bootstrap values were calculated from 1000 
resampled datasets. Bootstrap values above 70% are shown. Asterisks indicate topological conservation between the neighbour-joining 
and maximum likelihood methods. Microlunatus phosphovorus NM-1T was used to root the tree. The scale bar indicates 20 nucleotide 





Table 13: Genetic distances using the gyrB-rpoB-recA-relA-atpD concatenated sequence of 4099bp. Values in red indicate genetic 






 Strain  Strain SK5 ‘K. sindirgiensis’ 
Kribbella strain SK5 strain SK5T N/A 0.016 
Kribbella alba DSM15500T 0.087 0.088 
Kribbella albertanoniae BC640T 0.075 0.074 
Kribbella aluminosa DSM18824T 0.050 0.052 
Kribbella aluminosa HKI0480 0.050 0.052 
Kribbella aluminosa HKI-479 0.050 0.052 
Kribbella amoyensis NRBC107914T 0.069 0.066 
Kribbella antibiotica DSM15501T 0.078 0.082 
Kribbella catacumbae DSM19601T 0.083 0.083 
Kribbella catacumbae BC628 0.083 0.083 
Kribbella catacumbae BC630 0.083 0.083 
Kribbella catacumbae BC632 0.083 0.083 
Kribbella endophytica DSM23718T 0.078 0.079 
Kribbella flavida CIP107494T 0.071 0.072 
Kribbella ginsengisoli DSM17941T 0.076 0.078 
Kribbella hippodromi  S1.4T 0.053 0.053 
Kribbella italica BC637T 0.075 0.076 
Kribbella jejuensis CIP108509T 0.053 0.055 
Kribbella karoonensis Q41T 0.053 0.054 
Kribbella koreensis CIP108301T 0.076 0.077 
Kribbella lupini LU14T 0.074 0.075 
Kribbella mirabilis  XMU706T 0.079 0.077 
Kribbella pittospori  NRRL B-248113T 0.056 0.056 
‘Kribbella podocarpi’ YPL1T 0.045 0.046 
‘Kribbella qitaiheensis’ JCM30343T 0.074 0.074 
Kribbella sancticallisti DSM19602T 0.079 0.076 
Kribbella sancticallisti BC634 0.079 0.076 
Kribbella sandramycini DSM15626T 0.068 0.066 
Kribbella shirazensis DSM45490T 0.045 0.044 
‘Kribbella sindirgiensis’ FSN23T 0.016 N/A 
Kribbella solani CIP108508T 0.055 0.054 
Kribbella solani YB2 0.055 0.054 
‘Kribbella soli’ FMN22T 0.030 0.024 
Kribbella swartbergensis HMC25T 0.057 0.057 
Kribbella yunnanensis DSM15499T 0.071 0.073 
Microlunatus phosphovorus NM-1T 0.207 0.206 
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3.4.4.2 Phenotypic characterisation 
Strain SK5 was phenotypically compared to its closest phylogenetic relatives identified in section 3.4.4.1.  
K. karoonensis was selected because it was the top hit based on an EzBioCloud blastn analysis with 
99.72% 16S rRNA gene sequence similarity and it grouped with strain SK5 in the 16S rRNA and 
concatenated gene trees (Figures 23 and 24) with a genetic distance of 0.053 in the concatenated gene 
sequence (Table 13). K. aluminosa, K. pittospori, and K. shirazensis were chosen because their 
phylogenetic positions in Figures 23 and 24 implied that they were closely related species with low 
sequence variation (denoted by shorter branch lengths). As well as being a close relative in the phylogenetic 
analyses in Figures 23 and 24, ‘K. soli’ has a low genetic distance value of 0.030 when compared to strain 
SK5 (Table 13). ‘K. sindirgiensis’ could not be included because it was not available. 
 
3.4.4.2.1 Colony morphology and pigmentation 
Morphologically, strain SK5 and the Kribbella species in Table 8 all formed colonies with a wrinkled 
appearance. In broth culture, strain SK5 and all the comparative Kribbella species in Table 8 formed 
vegetative hyphae that fragmented to form irregular rod-shaped cells. 
 
Members of the Kribbella genus tend to have colony colours of off-white, beige, white or pale yellow. 
However, some Kribbella colonies are pale orange or yellow-orange (Evtushenko & Krausova, 2012). Strain 
SK5, K. aluminosa, K. karoonensis, K. shirazensis, and ‘K. soli’ have similar colony colours, namely, 
beige/off-white colonies with a white spore mass on ISP2, ISP3 and ISP4. K. pittospori had the same colony 
colour on these media, but did not sporulate. No pigmentation was produced by any of the strains on ISP5, 
ISP6, or ISP7.  
 
3.4.4.2.2 Physiological characterisation 
Table 14 shows the phenotypic differences between strain SK5 and its closest relatives.  
K. aluminosa, K. karoonensis, K. pittospori, K. shirazensis, ‘K. soli’ and ‘K. podocarpi’ displayed 2, 5, 13, 6, 







Table 14: Phenotypic characteristics of strain SK5 and its closest phylogenetic relatives. 1. strain SK5; 2. K. aluminosa DSM18824T; 
3. K. karoonensis Q41T; 4. K. pittospori NRRL B-248113T; 5. K. shirazensis DSM45490T; 6. ‘K. soli’ KCTC 29219T.  
++, strong positive; +, positive; +(w), weak positive; -, negative; D, results differ from the original description of the species. The 

















3.4.4.3 Chemotaxonomic characterisation 
The isomer of diaminopimelic acid was determined to be LL-DAP, which is characteristic of the Kribbella 
genus (Figure 25). The polar lipid profile of strain SK5 contains phosphatidylcholine (PC), which is the 
characteristic polar lipid of the Kribbella genus based on the emended genus description by Everest et al. 
(2013) (Figure 26A). In addition to PC, strain SK5 has the following polar lipid profile: diphosphatidylglycerol 
(DPG), phosphatidylinositol (PI), four unidentified phospholipids, and eight unidentified amino lipids 
(Figures 26A and 26B). There were no glycolipids (Figure 26C). The whole-cell sugar analysis revealed the 
presence of ribose, glucose, and an unidentified pentose sugar (Figure 26D). There are no diagnostic 
Test 1 2 3 4 5 6 
Utilisation as sole carbon source (21) 
      
inulin ++ ++ - - - -D 
sodium acetate + + + - - - 
sodium citrate - - +(w) - - - 
Utilisation as sole nitrogen source (15) 
      
DL-α-amino-n-butyric acid ++ ++ ++ - + ++ 
L-cysteine - + +(w) - - - 
L-histidine ++ ++ ++ - - ++ 
L-methionine + + + - + + 
L-phenylalanine + + + - + ++ 
Growth temperatures & pH (14) 
      
40°C - - ++ - ++ - 
pH4.3 ++ ++D ++ ++ - ++ 
Degradation 
      
Xanthine (21) + + + - + +D 
Adenine (21) ++ ++ ++ - ++ ++ 
L-Tyrosine (21) + ++ ++ ++ ++D ++ 
Urea (14) ++ ++ ++ - ++ +(w) 
Allantoin (14) + - ++ - ++ +(w) 
Growth in presence of inhibitory compounds (%w/v) 
(14) 
      
3%NaCl ++ + ++ - ++ ++ 
4%NaCl +(w) +D +(w) - + - 
5%NaCl - - +D - - - 
0.3% Phenylethanol - - - - + - 
Nitrate Reduction (14) + +(w) + - + + 
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sugars in the whole-cell sugar pattern for members of the Kribbella genus (Everest et al., 2013). The fatty 
acid profile of strain SK5 is displayed in Table 15. The major fatty acids were anteiso-C15:0 and iso-C16:0 at 
37.55% and 13.72%, respectively. Iso-C15:0 was present at 8.65%. As expected for the Kribbella genus, 
anteiso-C15:0 is the predominant fatty acid in strain SK5. Analysis of the respiratory quinones for strain SK5 


















Figure 25: Thin layer chromatography profile to identify the isomer of diaminopimelic acid in the peptidoglycan layer of strain SK5T. 









































Figure 26: Identification of the polar lipid profile using two-dimensional TLC (A, B, & C) and the whole-cell sugar pattern using one-
dimensional TLC (D) for strain SK5. Polar lipids were detected with (A) molybdenum blue, (B) ninhydrin, and (C) p-anisaldehyde.  
Whole-cell sugar pattern (D).  











































Table 15: Cellular fatty acid composition (%) of strain SK5. The cells were grown on ISP2 agar for 5 days at 28°C, under aerobic 
conditions. Fatty acids in red are the major components of the fatty acid profile for strain SK5. 
 







iso- C15:1G 0.47 
anteiso-C15:1A 1.34 
iso- C15:0 8.65 
anteiso- C15:0 37.55 
C15:0 ω6c 1.07 
C15:0 - 
iso- C16:1H 1.28 
iso- C16:0 13.72 
Unknown 15.669 0.50 
anteiso-C16:0 0.80 
Sum in feature 3* 4.31 
C16:0 1.44 
iso-C17:1 ω9c 5.16 
Sum in feature 4# 0.33 
iso-C17:0 3.88 
anteiso-C17:0 4.34 
C17:1 ω8c 1.33 
C17:1 ω6c 3.65 
C17:0 1.10 
C17:0 10 methyl 0.62 
iso-C18:0 0.39 
C18:1 ω9c 0.19 
*Sum in feature 3 contains C16:1 ω7c and/or iso-C15:0 2-OH 
# Sum in feature 4 contains iso-C17:1 I and/or anteiso-C17:1 B 
 
The polyphasic taxonomic characterisation of strain SK5 suggests that it represents a novel species in the 
genus Kribbella. Although there are only 2 phenotypic differences between the type strain of K. aluminosa 
and strain SK5, the concatenated-gene genetic distance between strain SK5 and the type strain of K. 
aluminosa is 0.05 (Table 13). A genetic distance greater than 0.04 indicates that DDH is not necessary to 
prove that the type strain of K. aluminosa and strain SK5 belong to different genomic species (Curtis & 
Meyers, 2012). The recently described species, ‘K. sindirgiensis’ (Ozdemir‑Kocak et al., 2017a), has low 
16S rRNA gene sequence similarity to strain SK5 (98.61%). However, ‘K. sindirgiensis’ is the closest 
phylogenetic relative based on the concatenated gene phylogenetic tree (Figure 24) and the concatenated-
genetic distance between the type strain of ‘K. sindirgiensis ’and strain SK5 is only 0.016 (Table 13). 
Therefore, the type strain of ‘K. sindirgiensis’ will need to be added to the comparative table of phenotypic 
characteristics, when it becomes available. The concatenated-gene genetic distance between the type 
strain of ‘K. soli’ and strain SK5 is 0.030, which is also below the 0.04 threshold for distinguishing between 
species in the genus Kribbella. Thus, DDH will have to be carried out between the type strain of ‘K. 
sindergiensis’ and strain SK5 and between the type strain of ‘K. soli’ and strain SK5 to prove that strain 
SK5 is a novel species. Although low, the fact that the concatenated-gene genetic distances are above 
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zero suggests that strain SK5 does belong to a new genomic species, as the type strain and non-type 
strains of the same species have been shown to have identical gene sequences for the atpD, gyrB, recA, 
relA and rpoB genes (Kirby et al, 2010; Curtis & Meyers, 2012).  
 
3.4.4.4 Description of Kribbella stellenboschensis sp. nov. 
Kribbella stellenboschensis (stell.en.bosch’en.sis. N.L. fem. adj. belonging to Stellenbosch, South Africa, 
from where the type strain was isolated). 
Kribbella stellenboschensisis a Gram-stain positive actinobacterium with wrinkled/folded, off-white/beige 
colonies. Hyphae fragment into rod-shaped elements during growth in liquid culture. Oxidase and catalase 
positive. Does not produce any diffusible pigments. Grows at 22°C, 30°C and 37°C and at pH 4.3 - 9, but 
not at 40°C. Grows in the presence of 0.1% phenylethanol, 3% (w/v) NaCl (weakly at 4% (w/v) NaCl), but 
not in the presence of 5% (w/v) NaCl, 0.1% phenol, and 0.3% phenylethanol. Can utilise adonitol, α (+)-L-
arabinose, (+)-D-cellibiose, (-)-D-fructose, (+)-D-glucose, myo-inositol, inulin, α-lactose, (+)-D-mannose, (-
)-D mannitol, melibiose, raffinose, (+)-L-rhamnose, sucrose, (+)-D-xylose, salicin, and sodium acetate as 
the sole carbon source, but not sodium citrate. Can utilise DL-α-amino-n-butyric acid, L-arginine, L-
asparagine, L-histidine, 4-hydroxy-L-proline, L-methionine, potassium nitrate, L-serine, L-threonine, L-
valine and L-phenylalanine as sole nitrogen sources, but not L-cysteine. Can degrade xanthine, adenine, 
L-tyrosine, hypoxanthine, gelatin, urea, allantoin, Tween 80, arbutin and DNA, but not guanine. Cannot 
hydrolyse pectin. Can produce H2S and reduces nitrate to nitrite. The cell wall peptidoglycan contains LL-
diaminopimelic acid. The major menaquinone is MK-9(H4), while the minor components are MK-9(H2) and 
MK-9(H6). The major fatty acids are anteiso-C15:0 and iso-C16:0. The polar lipid profile is comprised of PC, 
DPG, PI, unidentified phospholipids and unidentified amino lipids.  
The type strain, SK5T, was isolated from a topsoil sample collected in the town of Stellenbosch, Western 
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 Kitasatospora cineracea strain SK-3255T (AB022875) 
 Kitasatospora niigatensis strain NBRC 16453T (AB249960) 
 Kitasatosporia setae strain NRRL B-16185 (U93332) 
 Kitasatospora phosalacinea strain NRRL B-16230T (AB022869) 
 Kitasatospora cheerisanensis strain YC75T (AF050493) 
 Kitasatospora saccharophila strain SK15T (AB278568) 
 Kitasatospora paranensis strain HKI 0190T (AY442268) 
 Kitasatospora terrestris strain HKI 0186T (AY442266) 
 Kitasatospora cystarginea strain ATCC 49931T (AY999887) 
 Kitasatosporia griseola strain JCM 3339T (U93320) 
 Kitasatospora cochleata strain ATCC 51235T (U93316) 
 Kitasatosporia paracochleatus strain M-13T (U93328) 
 Kitasatospora gansuensis strain HKI 0314T (AY442265) 
 Kitasatospora atroaurantiaca strain NRRL B-24282T (DQ026645) 
 Kitasatospora kazusensis strain SK60T (AB278569) 
 Kitasatosporia mediocidica strain ATCC 49055T (U93324) 
 Kitasatospora aburaviensis strain ATCC 23869T (AY999886) 
 Kitasatospora fumigata strain NBRC 15394T (AB184645) 
 Kitasatospora aureofaciens strain ATCC 23884T (AY207608) 
 Kitasatospora psammotica strain IFO 13971T (AY999862) 
 Kitasatospora herbaricolor strain NBRC 3838T (AB184801) 
 Kitasatospora nipponensis strain HKI 0315T (AY442263) 
 Kitasatosporia azatica strain ATCC 29755T (U93312) 
 Kitasatospora purpeofusca strain LMG 20283T (AJ781364) 
 Kitasatospora putterlickiae strain F18-98T (AY189976) 
 Kitasatospora sampliensis strain VT-36T (AY260167) 
 Kitasatosporia kifunense strain ATCC 51379T (U93322) 
 Kitasatospora arboriphila strain HKI 0189T (AY442267) 
 Kitasatospora viridis strain 52108aT (AY613990) 
 Kitasatospora misakiensis strain IFO 12891T (AB217605) 
 Kitasatospora cinereorecta strain NBRC 15395T (AB184646) 
 Kitasatospora albolonga strain NBRC 13465T (AB184425) 
 Strain PR3 























Appendix A: Maximum likelihood tree of the Kitasatospora genus using partial 16S rRNA gene sequences of 1347bp rooted with 
Tsukamurella paurometabola DSM 20162T (CP001966). Bootstrap values were calculated from 1000 resampled datasets. 
Bootstrap values above 70% are shown. Asterisks indicate topological conservation between the neighbour-joining tree and the 
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